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Preface and talk of the dissertation: 
Organic chemistry research is essential in the sustenance of all fields of our daily life. 
Our clothes, fuel, dyes, medicines, plastics, soap, cosmetics, plastics, polymers and other 
uncountable substances we use are made up of organic compounds. 
Synthetic organic chemistry lies in the core of pharmaceutical industry; it contributes to 
the synthesis of the isolated biologically active ingredients of natural products and 
mimics them, in addition, to the preparation of new previously designed compounds that 
can serve as drugs. For example, the synthesis of penicillin by Sheehan and Henery-
Logan [1] and of vancomycin by Nicolaou [2] and independently by Evans [3], in 
addition to the semi-synthetic process of Taxol by Holton, which allowed Taxol to be 
used clinically on a large scale [4-6], can be considered as breakthroughs in synthetic 
organic chemistry.  
Due to this essential role in our life, development of new synthetic methods with high 
chemo, regio- and stereoselectivities accompanied by ecologically and economically 
favorable production lies in the heart of organic chemistry.  
An important category of organic compounds is the group of highly functionalized 
benzenes. The regioselective synthesis of these compounds is a great challenge for 
synthetic organic chemists; due to their important roles in organic chemistry, natural 
product chemistry, analytical chemistry and materials science [7].  
The synthesis of highly substituted benzene compounds starting from acyclic precursors, 
in which the substitution pattern of the final product is governed by the structures and the 
patterns of the starting materials, received a great interest from synthetic organic 
chemists.  Formal [3+3] cyclizations of 1,3-bis(silyl enol ethers) with 1,3-dielectrophiles 
provide a convenient and regioselective approach to arenes. 
This synthetic approach has been extensively explored by our group. In continuation of 
the contributions of my previous and current colleagues, I have applied this approach for 
the synthesis of different substituted arenes, which are not easily accessible by other 
methods, namely: 4-hydroxyisophthalates, 1-hydroxyphthalates, 2-hydroxy-
terephthalates, 4-nitro- and 4-aminophenols and diaryl selenides.  
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Part 1: Introduction and background: 
 
1.1 1,3-Bis(silyl enol ethers): 
The acetoacetate unit is one of the fundamental building blocks in the biogenesis of natural 
products [9,10]. This fact implies, that 1,3-bis(silyl enol ethers) could be recruited for the 
synthesis of natural products, especially those including aromatic cores formed from 
condensation of acetoacetate and derivatives with poly-β-carbonyls.  
1.1.1 Synthesis of 1,3-bis(silyl enol ethers): 
Recently, Tanabe and co-workers [11], have reported a novel regio- and stereoselective 
synthesis of β-ketoester-derived tert-butyl (1Z,3E)-1,3-bis(TMS) dienol ethers 2 (Eq. 2), in 
one step using NaHMDS-TMSCl reagent.  
OtBu
OO
R
OtBu
OSiMe3Me3SiO
R
NaHMDS,TMSCl
CPME, 0-5 C to 20 C-25 C
1 2
Eq 1
 
 
This work was extended by varying the alkoxy group of the ester with a slight modification in 
the base used therein, thus (1Z)- and (1Z,3E)-1,3-bis(TMS)dienols were steroselectively 
prepared [12]. 
Simchen et al. [13], reported the one step synthesis of 1,3-bis(sily enol ethers) 4 derived from 
1,3-diketones, by treating their ether solution with two equivalents of NEt3–Me3SiOTf reagent 
(Eq. 2). This method lacks substrate generality and requires using expensive reagents. 
R
OO
R
OSiMe3Me3SiOMe3SiOTf , NEt3
Et2O, 20 C
3 4
R: alkyl, aryl Eq 2
 
 
The most widely used synthetic method to produce 1,3-bis(sily enol ethers) was reported by 
Chan and Molander [14], in which  1,3-dicarbonyl compounds 5 are converted to the 
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corresponding silyl enol ethers 6 using NEt3-Me3SiCl, further silylation, by treating 6  with 
LDA and subsequent addition of  Me3SiCl to gives 7 (Scheme 1).  
R(OR)
OO
R(OR)
OMe3SiOMe3SiCl, NEt3
C6H6, 20 C
5 6
R: alkyl
1-LDA
2-Me3SiCl
THF
R(OR)
OSiMe3Me3SiO
7  
Scheme 1: Chan and Molander synthesis of bis(silyl enol ethers). 
Barbero et al. [15, 16] reported a synthesis of 1,3-diketone-derived bis(silyl enol ethers) 9 by 
isoxazole ring cleavage and subsequent silylation (Eq. 3). 
 
N
O
R3R2
R1
LDA/ THF/ TMSCl/ -78 C or
Li/ THF/ TMSOTf / 0 C
OSiMe3Me3SiO
R
R1= Me, R2= Ac, R3= H R= CN
R1= R3= Me, R2= H R= H
R1= R2= R3 = Me R= Me
98
Eq 3
 
 
1.1.2 Side chain functionalization of 1,3-bis(silyl enol ethers): 
The functionalization of the arenes, resulted from the [3+3] cyclocondensation of 1,3-bis(silyl 
enol ethers) with dielectrophiles, is goverened by the substitution pattern of both the 1,3-
dinucleophile and the 1,3-dielectrophile, however, the functionlization of the side chain of 
1,3-bis(silyl enol ether) leads to ortho- functionalized phenols, where as the functionlization 
of the C-2 impedes the aromatization step, and aromatic ring will not form [17].  
The side chain elongation could be achieved by the reaction of the dianions of alkyl 
acetoacetates 10 with alkyl bromides or iodides 11 [18] (Eq.4). 
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OR1
OO 1) 2.5 eq LDA, 0 °C
2) R2-X -78 - 20 °C OR1
OO
R2
10 12
Eq 4
11
X= Br, I  
Alkyl 4-(thioaryloxy)acetoacetates 16, were prepared by reaction of alkyl 4-
chloroacetoacetates 15 with substituted thiophenols 13, while  alkyl 4-phenoxyacetoacetates 
17 were prepared by base mediated reaction of alkyl 4-chloroacetoacetates 15 and 
functionalized phenols 14 [19, 20] (Eq. 5). Alkyl 4-phenoxyacetoacetates 17 were also 
prepared by Claisen condensation of alkyl acetates 19 with the corresponding α-aryloxyacetic 
chlorides 18 [21] (Eq. 6). 
+ OR1
OO
Cl
XH
R2
X=S, NEt3, 30 m, CH2Cl2 OR1
OO
X
R2
X=O, KOH, DMSO, 20 °C, 5h
OR1
O
Cl
O
O
R2
+
LDA, THF, -78-20 °C OR1
OO
O
R2
Eq 5
Eq 6
13: X= S
14: X= O
15
16: X= S
17: X= O
18 19 17
 
 
4-Arylacetoacetates 21 were prepared by lithium diisopropylamide mediated reaction of alkyl 
acetates with the arylacetyl chlorides 20 [22] (Eq. 7).  
 
 
OR1
O
Cl
O
+
LDA, THF, -78-20 °C
OR1
OO
R2
R2
1920 21
Eq 7
 
The β-ketoesters 12, 15, 16, 17 and 21 were then converted to the corresponding 1,3-bis(sily 
enol ethers).  
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The 1,3-bis(silyl enol ethers) 22a-u (Table 1), were prepared and used in the current work. 
 
OR1
OSiMe3Me3SiO
22
R2
 
 
Table 1: Bis(silyl enol ethers) used in current work. 
 
Comp. No. R2 R1 
22a H Me 
22b H (CH2)2OMe 
22c H CH2Ph 
22d Me Me 
22e Me Et 
22f Et Me 
22g Et Et 
22h n-Bu Me 
22i n-Pen Me 
22j n-Hex Me 
22k n-Hep Me 
22l n-Oct Me 
22m n-Non Me 
22n n-Dec Me 
22o OMe Me 
22p OPh Me 
22q 4-MeC6H4 Me 
22r 4-ClC6H4 Me 
22s 4-(MeO)C6H4 Me 
22t O(2-MeC6H4) Et 
22u O(3-MeC6H4) Et 
22v OPh Et 
22w Cl Et 
 
Changing the alkyl group of the ester moeity of the dienes 22 affects the physical state of them 
(viscose to oil), for example, in 22w if R1 is methyl group the diene will be highly viscous and 
difficult to handle. 
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1.1.3 Storage of 1,3-bis(silyl enol ethers): 
1,3-Bis(silyl enol ethers) are highly reactive and readily affected by moisture and heat. Due to 
this high reactivity of 1,3-bis(silyl enol ethers), some precautions should be made in their 
storage. The freshly prepared 1,3-bis(silyl enol ethers) are stored under inert atmosphere 
(Argon gas) in cold environment. They can be stored at -30 oC for several months without 
decomposition or rearrangment. 
1.1.4 Reactivity of 1,3-bis(silyl enol ethers): 
1,3-Bis(silyl enol ethers), such as 1,3-bis (trimethylsiloxy)-1-methoxybuta-1,3-diene (22a), 
can be regarded as electroneutral equivalents of the dianion 23 (Fig. 1). The masked dianion 
22a reacts with electrophiles mostly in the presence of Lewis acids and leads to Michael 
adducts in its reactions with conjugated carbonyl compounds. This differs from 23, which is 
formed and reacted under strong basic conditions. It acts as a hard nucleophile in reactions 
with conjugated carbonyl compounds to give 1,2-adducts [23, 24].  
The fact that reactions of 22a are conducted under Lewis acids conditions gives more 
opportunites; electrophiles which are base sensitive could be used, thus 1,3-bis(silyl enol 
ethers) complement true dianions in synthetic organic chemistry. 
OSiMe3
OMeMe3SiO
OMe
OO
22a 23  
Figure 1: Masked and free dianions of methyl acetoacetate. 
 
Like true dianion 23, masked dianions 22 react with electrophiles at their terminal carbon 
atom (Fig. 2) with difference in reactivity. That could be demonstrated by, for example, 
reaction of both with bromine. Reaction of 23 gave a mixture of products, while 22a furnished 
selectively methyl 4-bromo-3-oxobutanoate in its reaction with one mole of bromine and 
methyl 2,4-dibromo-3-oxobutanoate with two moles [25].  The nucleophilic reactivity order of 
the both nucleophilic sites of 22a doesn’t change upon the alkylation of the side chain [17]. 
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In the cases in which the electrophiles are not reactive enough activation by Lewis acids such 
as titanium tetrachloride is needed [26].  
 
OSiMe3
OMeMe3SiO

  
Figure 2: Reactivity of masked dianion 22a. 
 
Although, the regioselectivites of both dianions and masked dianions are the same in most 
cases, masked dianions take the place of the free dianions to avoid their high basicity and 
reactivity, which lead to many side-reactions such as polymerization, decomposition, 
deprotonation, formation of open chain products, elimination, or SET-processes (reduction) 
[27]. 
1.1.5 Thermal rearrangement of 1,3-bis(silyl enol ethers): 
1,3-Bis(silyl enol ethers) 24, derived from β-ketoesters with substituents at C2, undergo 1,5 
silyl migration from oxygen to carbon to give 4-trimethylsilyl-3-trimethylsilyloxycrotonates 
25 (Eq. 8). This occurs upon standing at 20 oC and involves replacement of a strong O-Si bond 
with the weaker C-Si, which can be thermodynamically compensated by formation of stable 
ester carbonyl moiety [28]. Unsubstituted C2 1,3-bis(silyl enol ethers) rearrange in high yields 
to the corresponding products 25 on heating at 80-120 oC [29]. The presence of the C2 
substituent increases the population of the conformer that undergoes this rearrangement. 
 
SiMe3
O
OMe
R
Me3SiO
O
OMe
R
Me3SiO CH2SiMe3
24 25
R: H, Me, OMe Eq 8
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1.1.6 Dimerization of 1,3-bis(silyl enol ethers) promoted by TiCl4: 
1,3-Bis(silyl enol ethers) undergo oxidative dimerization in the presence of TiCl4 to give 26 or 
the open chain product 27, which converts to 26 under TiCl4 activation. TiCl4 acts as an 
oxidizing agent (Scheme 2) [30-32]. These undesired dimerizations could affect the yields of 
the [3+3] cyclizations of 1,3-bis(silyl enol ethers). 
OSiMe3
OMeMe3SiO
22a
O
CO2Me
CO2Me
OMe
OMe
O O
OO
TiCl4 / CH2Cl2
TiCl4 26
27
CH3CN
or CH2Cl2
 
Scheme 2: Dimerization of 22a promoted by TiCl4. 
 
1.2 Formal [3+3] cyclization reactions of 1,3-bis(silyl enol ethers) with 1,3-
dielectrophiles: 
One-pot cyclizations of 1,3-dicarbonyl dianions (true dianions) and 1,3-bis(silyl enol ethers) 
(masked dianions) with electrophiles provide a convenient strategy to a wide range of 
heterocyclic and carbacyclic ring systems. Extensive work has been done and still going in 
these cyclization reactions.  
Langer et al. reviewed the impressive work in this field: Cyclizations of free and masked 1,3-
dicarbonyl dianions with 1,2-dielectrophiles [33], one-pot cyclizations of dinucleophiles with 
oxalic acid-bis(imidoyl)dichlorides [34], reactions of 1,3-bis(silyl enol ethers) in general [27], 
syntheses of butenolides by cyclizations of silyl enol ethers with oxalyl chloride [35a] and  
domino reactions of bis(silyl enol ethers) with 4-silyloxybenzopyrylium triflates [35c] and 
iminium salts [35d].  
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In the following work, a strategy based on formal [3+3] cyclization reactions of 1,3-bis(silyl 
enol ethers) with 1,3-dielectrophiles for the synthesis of functionalized arenes was adopted.  
The formal [3+3] cyclizations of 1,3-bis(silyl enol ethers) could be performed with different 
types of 1,3-dielectrophiles, that have different patterns of substituents which provide a 
powerful tool for the construction of six memebered carbacycles.  
The 1,3-dielectrophiles used in formal [3+3] cyclizations with 1,3-bis(silyl enol ethers)   could 
be: 1,3-bis(acetals),  1,3-ketoacetals, 1,3-keto-S,O-acetals, 3-alkoxy-2-en-1-ones, 3-silyloxy-2-
en-1-ones, 1,1-diacylcyclopropanes, 1,1-diacylcyclopentanes and 3-oxoalkanoic acid 
derivatives [35b]. Lubbe et al. have recently reported the first cyclocondensation of 1,3-
bis(silyl enol ethers) with 1,1-bis(methylthio)-1-en-3-ones and 3-oxo-orthoesters [36, 37]. Lau 
et al. reported the cyclizations of 1,3-bis(sily enol ethers) with 3-acetyl-5-aryl-4,5-
dihydrofurans [38]. Sher et al. reported the cyclizations with 3,3-dimethoxypentanoyl chloride 
[39]. [3+3] cyclizations were also reported with 4-chloro-2-oxo-2H-chromene-3-carbaldehyde 
[40]. 
The term formal is used here to distinguish the cyclizations of 1,3-bis(sily enol ethers) with 
1,3-dielectrophiles from the pericyclic cyclizations. 
In the current research, two types of 1,3-dielectrophiles were used, namely: 3-silyloxy-2-en-1-
ones and 3-alkoxy-2-en-1-ones.  
1.2.1 Regioselectivity control in the cyclization reactions of 1,3-bis(silyl enol ethers) with 
1,3-dielectrophiles: 
Cyclizations of 1,3-bis(silyl enol ethers) with 1,3-dielectrophiles could be simplified as shown 
in (Fig. 3): fragment 1 represents the 1,3-bis(silyl enol ether) a 1,3-dinucleophile, with C4 
more nucleophilic than C2, whereas fragment 2 represents the 1,3-dielectrophile which can be 
various equivalents of β-dicarbonyl compounds.  
f ragment 1 f ragment 2  
Figure 3: Simplified representation of regioselectivity control in [3+3] cyclizations. 
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The regiochemistry of these cyclizations is controlled by the differential reactivities of both 
sites of each fragment. Depending on their experiments in competitive reactions of 22a with 
different electrophiles, Chan and co-workers reported that the order of reactivity of 
electrophiles toward 1,3-bis(sily enol ethers), follows that: aldehyde > conjugate position of β-
oxy-α,β-unsaturated ketone~isolated ketone> acetal or monothioacetal> conjugate position of 
β-oxy-α,β-unsaturated ester or ester carbonyl, thus their attempts to cyclize 22a with the mono 
silyl enol ether of its precursor failed [41]. 
 
1.2.2 Formal [3+3] cyclization reactions of 1,3-bis(silyl enol ethers) with 3-silyloxy-2-en-
1-ones: 
The TiCl4 mediated [3+3] cyclocondensation reactions of 1,3-bis(silyl enol ethers) with 3-
silyloxy-2-en-1-ones were firstly reported by Chan and co-workers [14a]. When these 3-
silyloxy-2-en-1-ones are derived from symmetrical 1,3-diketones, the cyclizations give 
phenols containing the same substituents located meta to the hydroxyl group, via the 
conjugate addition of the terminal carbon of the 1,3-bis(silyl enol ether) to the conjugate 
position of 3-silyloxy-2-en-1-ones, followed by cyclization and subsequent aromatization. 
Cyclizations of 3-silyloxy-2-en-1-ones derived from unsymmetrical 1,3-dicarbonyl precursors 
often proceed with low regioselectivity, according to the  suggestion  Chan [14a], this is a 
result of the TiCl4-mediated isomerisation of 3-silyloxy-2-en-1-ones (migration of the TMS-
group from one oxygen atom to the other), however, some regioselective reactions were 
reported [14a, 35b].  
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The mostly used protocol of this strategy is the use of 2-Sub-3-silyloxy-2-en-1-ones 28 
derived from symmetrical 1,3-diketones, simplified by (Eq. 9).  
OR1
OSiMe3Me3SiO
R3
OMe3SiO
OOH
OR1
R3
TiCl4
CH2Cl2
_ 78 to 20 °C,
20 h
+
Sub
Sub
R2
R2
R3
R3
28
22
29
Eq 9
 
 
Where Sub could, for example, be: Me [42], CH(Ph)2 [43], CN [44], Ph [45], -N=N-Ph [46], F 
[47], SPh [19], OPh, Cl [48], Ac [49], OAc [50]. 
 
1.2.3 Formal [3+3] cyclization reactions of 1,3-bis(silyl enol ethers) with 3-alkoxy-2-en-1-
ones: 
Chan and Brownbridge were the first to report a regioselective cyclocondensation of 1,3-
bis(silyl enol ether) with 3-alkoxy-2-en-1-one [14a]. Recently, I have been a member in a 
work-team within our group responsible for the investigation of the scope of the cyclizations 
of the type 2-acceptor-substituted 3-alkoxy-2-en-1-ones 30. Some of these cyclizations are 
still under study at the time of writing of this work. 
These cyclizations proceed with high regioselectivity; this might be explained by the fact that 
these substrates do not undergo TiCl4-mediated isomerisation, for more detailed information 
about this type of cyclization see [ref. 35b]. 
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This strategy could be simplified as in (Eq. 10). 
OR1
OSiMe3Me3SiO
TiCl4
CH2Cl2
_78 to 20 °C
12 h
+
R2
OR4 O
Acc
R3
OH O
OR1
R2
Acc
R4= alkyl
R3= alkyl, f luroalkyl, aryl
R3
regioisomer 31a
OH O
OR1
R2
Acc
regioisomer 31b
or22
30
Eq 10
R3
 
 
During the course of this research, it was noticed that these cyclizations mostly gave the 
regioisomer 31a, resulted from the initial attack of the terminal carbon of the diene onto the 
conjugate position of 30.  
These acceptor-substituents could be:  –SO2Ph [51], CN [44], -(CO)CO2R,  -(CO)CF3 and-
(CO)R  [52a,b], Cl [53], -SAr [54], -PO(OEt)2 [55] and others, will be included in this 
manuscript and the rest will be published in the due time.  
There are some reported cases in which 3-alkoxy-2-en-1-ones polymerized by TiCl4 [14a], a 
fact that could affect the yields of their [3+3] cyclizations. 
 
1.2.4 Suggested mechanism of 1,3-bis(silyl enol ether) cyclization with 1,3-
dielectrophiles: 
Titanium tetrachloride is a Lewis acid which has a great affinity for organic oxygenated 
compounds. Powerfull activation of carbonyl compounds by TiCl4 allows that silyl enol ethers 
can readily attack carbonyl compounds to form trimethylsilyl chloride and the titanium salt of 
the aldol-type products [56]. This fact allows us to draw a possible mechanistic pathway for 
the cycloaromatizations of 1,3-bis(silyl enol ethers) with 3-silyloxy-2-en-1-ones (Scheme 3). 
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Sub
Sub
Sub
Sub
Sub
R3
R3
OSiMe3
OMeMe3SiO
22 a
R3
OMe3SiO
OOH
OMe
R3
R3
O
Me3SiO
O
OMe
(Me3Si)2O
O O
OMe
R3
OTiCl3
Me3SiCl
D
H2O
TiCl4, CH2Cl2
_ 78 to 20 °C
14 h
TiCl4
R3
R3
R3
OMe3SiO
R3
TiCl4
_
+
R3
O
Me3SiO
O
OMe
TiCl3
Me3SiO
R3
B C
TiCl4
22 a
Me3SiCl
Me3SiCl
28
Sub
A
29
+
 
Scheme 3: Suggested mechanism for the cycloaromatization of 22a with 3-silyloxy-2-en-1-ones. 
 
It is suggested that the reaction starts by reaction of 28 with TiCl4 to give intermediate A, 
followed be the attack of the terminal carbon atom of 22a onto A to afford intermediate B. 
The elimination of TMS-siloxane intermediate C and subsequent cyclization gives 
intermediate D (Scheme 3). The elimination of titanium hydroxide (before or during the 
aqueous work-up) and aromatization results in the formation of 29.  
Due to the symmetrical structure of intermediate A, the attack of 22a on either terminal allylic 
carbon atom would result in the formation of the same product. 
In analogy to this, a general mechanistic pathway for the cyclocondensation of 1,3-bis(silyl 
enol ethers) with 3-alkoxy-2-en-1-ones could be also drawn as in Scheme 4.  
 
Introduction and background  
 
13 
 
OSiMe3
OMeMe3SiO
22a
R3
OR4O
OOH
OMe
R3
R3
O
Me3SiO
O
OMe
Me3SiCl
B
O O
OMe
R3
OTiCl3
D
H2O
TiCl4
CH2Cl2
_78 to 20 °C
14 h
+
TiCl4
R3
O
Me3SiO
O
OMe
C
TiCl3
R4O
R3
R4O O
_
+
TiCl4
A1
22a
TiCl4
Me3SiOR
4
Me3SiCl
Me3SiCl
R4 : alkyl
R3 : alkyl, aryl
Acc
Acc
Acc Acc
30
regioisomer 31a
Acc
Acc
R3
R4O O
_
+
TiCl4
OOH
OMe
regioisomer 31b
acc.
R3
mostly not formed
A2
 
 
Scheme 4: Suggested mechanism for the cycloaromatization of 22a with 3-alkoxy-2-en-1-ones. 
 
The formation of product 31a might be explained by reaction of 30 with TiCl4 to give 
intermediate A1, which is in resonance with intermeidate A2. The regioselectivity might be 
explained by the steric hindrance of the allylic carbon attached to the alkyl or the aryl group 
R3. Cyclization through intermediate A1 (Scheme 4) gives intermediate B, followed by 
formation of intermediate C. Cyclization via the central carbon intermediate D and 
subsequent aromatization gives 31a.  
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1.2.5 Regioselectivity tuning. Lewis acid chelation control in [3+3] cyclizations of 1,3-
bis(silyl enol ethers) with dielectrophiles: 
The ability of Lewis acids to form a five- or a six- membered chelation ring [57, 58] within 
the 1,3-dielectrophile leads to a selective activation of one of the two electrophilic centers, 
directing the reaction pathway to form exclusively one of the possible isomers. In case of 
unsymmetrical 3-silyloxy-2-en-1-ones, the Lewis acid promotes the TMS isomerization to 
form, exclusively, one isomer, which leads to a regioselective cyclization; this will be 
discussed in the second part of this manuscript. 
The TiCl4 mediated cyclization of alkoxy-substituted 1,1-diacylcyclopropanes 32 with 1,3-
bis(trimethylsilyloxy)-1,3-butadiene 22a furnished exclusively 5-chloroethyl-4-
(methoxymethyl)salicylate 33a (Scheme 5) via chelation of TiCl4 with the methoxy and the 
neighboring carbonyl group [59, 60]. Chelation effect was also observed in the presence of a 
neighbouring carbonyl group [52]. 
 
OSiMe3
OMeMe3SiO

OO
MeO
OH O
OMe
OMe
Cl
2 eq TiCl4 / CH2Cl2
-78 to 20 °C
OH O
OMe
Cl
OMe
OO
MeO
Cl4Ti
via
22a 32 A
33a
33b  
Scheme 5: Lewis acid chelation controlled formation of 33a. 
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1.2.6 Influence of the Lewis acid on the outcome of [3+3] cyclizations of 1,3-bis(silyl enol 
ethers): 
The choice of Lewis acid to activate the [3+3] cyclizations of 1,3-bis(silyl enol ethers) can 
affect the pathway of these  reactions. Sher et al.  reported that TiCl4 mediated cyclizations of 
1,3-bis(trimethylsilyloxy)-1,3-butadienes with 3,3-dimethoxypentanoyl chloride afforded 4-
hydroxysalicylates. But when TMSOTf was used as catalyst 6-hydroxysalicylates were formed 
[39]. This could be explained by selective activation of electrophilic centers by the Lewis 
acid. Specific Lewis acids activate specific functional groups.  
In other reactions the employment of different Lewis acids gave completely different products. 
The TiCl4 mediated reaction of 1,3-bis(trimethylsilyloxy)-1,3-butadienes with 1,1-dimethoxy-
4,4-dichlorobut-1-en-3-one gave  6-dichloromethyl-4-methoxysalicylates. When TMSOTf 
was employed, functionalized 2-(dichloromethyl)pyran-4-ones were formed in all cases [61]. 
The TiCl4 mediated formal [3+3] cyclocondensation of 1,3-bis(trimethylsilyloxy)-1,3-
butadienes 22 with 4,4-dimethoxy-1,1,1-trifluorobut-3-en-2-one (34) gave 4-methoxy-6-
(trifluoromethyl)salicylates 35, while Me3SiOTf-mediated cyclizations of 1,3-
bis(trimethylsilyloxy)-1,3-butadienes, containing no substituent located at carbon atom C-4 of 
the diene, resulted in formation of pyran-4-ones 37 (Scheme 6), while they gave  
Trifluoromethyl-substituted cyclohexenones 36 when C-4 was substituted [62].  However, the 
reasons for the influence of the Lewis acid on the regioselectivity of cyclization remain 
unclear at present. 
OR1
OSiMe3Me3SiO
R2
O
CF3
OMe
MeO
OH
CF3MeO
O
OR1
R2
TiCl4 / CH2Cl2
-78 to 20 C
O
O
R1
O
R2F3C
when R1= H
O
CF3R
3O
O
R2
R1
OH
when R1 H
22
Me3SiOTf / CH2Cl2
- 78 to 20 C

34 35
36 37  
Scheme 6: Influence of the type of Lewis acid on the regioselectivity of [3+3] cyclocondensations. 
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1.3 Highly functionalized arenes. Products of [3+3] cyclizations of 1,3-bis(silyl enol 
ethers) with 1,3-dielectrophiles:   
Highly functionalized arenes constitute an important class of organic compounds that are 
widely used in different fields of chemistry. 
The “classical approaches” for the synthesis of these arenes are based on the direct 
substitution of an existing benzene scaffold. The most common strategies based on this 
approach involve: electrophilic [63], or nucleophilic [64] substitution, metal-catalyzed 
coupling reactions [65], and metalation–functionalization reactions [66].  
However, these methods frequently have many drawbacks like: multi-step reaction sequences, 
low yields, and low positional selectivity of electron-donating or -withdrawing groups and/or 
from orienting effects of the substituents when applied to the synthesis of highly 
functionalized arenes.  
An efficient alternative approach for the synthesis of highly functionalized arenes is the 
“acyclic approach”, which relies on the construction of the aromatic backbones from acyclic 
precursors. These annulations  include: [3 + 2 + 1] Dötz reaction of Fischer carbene 
complexes [67], Danheiser alkyne-cyclobutenone [4 + 2] cyclization [68],  [4 + 2] 
cycloaddition of metalacyclopentadienes and alkynes [69], transition metal catalyzed [2 + 2 + 
2] and [4 + 2] cycloadditions [70],  Yamamoto [4 + 2] benzannulations of o-alkynyl 
benzaldehydes and alkynes [71],  1,6-electrocyclization reactions [72], [5 + 1] 
benzannulations between alkenoyl keteneacetals and nitroalkanes [73]  and [4 + 2] 
annulations of Baylis-Hillman adducts [74].  
Although these annulations afford variety of substituted arenes, they either lack of substrate 
generality or require the use of expensive catalysts and involve harsh conditions in some 
cases. 
The TiCl4 mediated [3+3] cyclocondensation reactions of 1,3-bis(silyl enol ethers) with 1,3-
dielectrophiles is a strategy which adopts the “acyclic approach”. Commercially available, 
easily-accessible building blocks with a wide range of substitution pattern could be used. 
These regioselective reactions are mostly done in one step under mild conditions with good to 
excellent yields. 
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In this Ph.D dissertation, this strategy for the synthesis of some highly functionalized arenes 
like was utilized: hydroxybenzodioates, 4-nitrophenols, 4-aminophenols and diaryl selenides. 
1.3.1 Mono-hydroxybenzodioates: 
Functionalized hydroxylated benzoates and benzodioates and their derivatives are of great 
interest as lead structures in pharmaceutical, industrial and agricultural chemistry and 
constitute valuable synthetic building blocks in synthetic organic chemistry [75]. Some of 
these molecules occur in natural products and have interesting pharmacological properties, 
including: analgesic, antipyretic, antimicrobial and fungicidal (compound 38) activity and act 
as inhibitors for some enzymes and inhibitors for the absorption of some steroids, such as, 
cholestrol and bile acid [76].  
Br
OH
OO
MeO OMe
38  
 
Figure 4: Fungicidal agent. 
 
Classically, synthetic approaches to mono-hydroxy benzodioates rely on the oxidations of 
appropriate benzene derivatives and on the functionalization of phenol or benzoic acid 
derivatives, including carboxylation of phenols, hydroxylation of aromatic halides and diesters 
[77- 81]. 
These methods suffer from: poor regioselectivity, harsh reaction conditions which can lead to 
the destruction of starting precursors. For more complex polyfunctionalized derivatives, 
highly functionalized or substituted starting materials are not easy accessible.  
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An alternative approach is based on the annulations of acyclic precursors. Examples of this 
approach, for the formation of 4-hydroxyisophthaltes, involve: The rhodium catalyzed 
cyclization reactions (Scheme 7) of alkynoates 39 with alkyl-, aryl-boronic acids and 
boroxines 40 and tin reagents [82]. 
 
Pr
O
OEt
CO2Et
CO2Et
Pr
HO
Pr
Ar
Pr
E/Zisomers
(Rh(OH)(cod))2
5 mol % Rh
+
(ArBO)3
CO2EtPr
SnMe3Ph
(Rh(OH)(cod))2
5 mol % Rh
39
40
41 42  
Scheme 7: Hayashi and co-workers synthesis of 4-hydroxyisophthalate. 
 
4-Hydroxyisophthalates 44 were also prepared by a Michael addition–Dieckmann cyclization 
sequence from methyl (E)-3-methoxy-4-methoxycarbonylbut-2-enoate (42) anion and methyl 
alkynoates 43 (Eq. 11) and by sodium salt of dimethyl 1,3-acetonedicarboxylate cyclization 
with  acetylenic esters [83]. 
R
OO
MeO OMe
HO
OMe
RMeO2C
OMe
CO2Me
CO2Me
+ NaH, DMF R: alkyl, phenyl
42 43 44
Eq 11
 
 
Cazes et al. in their research in the preparation of tetralones, prepared tetralones in which the 
aromatic rings are 4-hydroxyisophthalte by cyclocondensations of 3-methylcyclohexenones 
with ethoxymethylenemalonate [84]. Indolylmethyl acetates underwent, upon base-mediated 
reaction with electron-difficient alkynes, Michael addition followed by intramolecular 
cyclization and subsequent aromatization and gave substituted carbazoles containing 4-
hydroxyisophthaltes and 3-hydroxyphthalates [85]. 
Cyclizations of aromatic aldehydes 45 with β-ketoesters 10 (Scheme 8) followed by oxidative 
aromatization gave also 4-hydroxisophthalates 47 [86].  
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4-Hydroxisophthalates were also prepared by oxidative cyclization of ethyl 3-hydroxynon-4-
ynoate [87], condensation of methyl 4-(triphenylphosphoranylidene) acetoacetate with methyl 
5-methyl-2-(trifluoroacetyl)-2-hexenoate [88] and by [2+2+2] construction of 
polyfunctionalized cyclohexanones which then underwent aromatization [89]. 
O
H
O O
OR
+
Base
O
O
OH
O
RO
OR
oxidative reagent
OH
O
O
RO
OR
R: alkyl
1045 46 47
 
Scheme 8: Base mediated cyclization of diketoester with aromatic aldehydes. 
Langer and co-workers reported chealation controlled annulations (Scheme 9) of 1,3-bis(silyl 
enol ethers) 22 with enones 50 to form hydroxybenzodioates 51 [52a] and with  3-oxo-
bis(methylthio)ketenacetale 48 to form isophthaltes 49 [52b].  
 
Scheme 9: Langer et al. synthesis of hydroxybenzodioates.  
“Acyclic approach” protocols for the synthesis of 4-hydroxyisophthalates include also 
cycloaromatization reactions of methyl 4-carbomethoxy-5-methoxy-penta-2,4-dienoate with 
dimethyl malonate [90] and cyclizations of substituted ethyl 2-(4-oxo-1,4-dihydroquinolin-2-
yl)acetates with diethyl(ethoxymethy1ene)malonate to give acridinones containing 4-
hydroxyisophthalates [91]. 
OR1
OSiMe3Me3SiO
TiCl4
CH2Cl2
_ 78 to 20 °C
12 h
+R2
OH O
OR1
R2
O
R4 R1 : alkyl
R2 : H, Me
R3 : alkyl
R4 : alkyl
O OR3
OR3O
22 48
49
TiCl4
CH2Cl2
_ 78 to 20 °C
12 h
+
OH O
OR1
R2
OEt O
O
OEt
R1, R2: alkyl
R3: alkyl, aryl, ORO R3
O
OEt
OR350 51
SMe
MeS
SMeR4
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Cycloaddition of 1,3-bis(silyl enol ether) 52 with the allene 53 afforded the isophthalate 54 
(Eq. 12) [92]. 
OSiMe3
Me3SiO
MeO2C
+ .
CO2Me
CO2Me
CO2Me
CO2MeHO
MeO2Ca: neat, 105 °C
b: NH4F
52 53 54
Eq 12
 
 
The Diels-Alder cycloaddition (Scheme 10) of cyclopentadienone 55 with alkynylboronates 
56 gave boronic esters 57, subsequent oxidation gave the 2-hydroxyterephthalates 58 [93]. 
O
Ph
Ph
CO2Me
CO2Me
R B
O
O
+ mesitylene
CO2Me
CO2Me
Ph
Ph
R
B
O
Oref lux
CO2Me
CO2Me
Ph
Ph
R
OH
H2O2
55 56 57 58
 
Scheme 10: Synthesis of 2-hydroxyterephthalates by [4+2] annulations.  
 
The syntheses of 3-hydroxyphthalates depend mainly on the annulations of symmetrical 
dialkyl acetylenedicarboxylates, which provide two vicinal ester moieties in the aromatic ring.  
Chan et al. and Langer et al.  reported [4+2] cycloadditions of the dialkylacetylene 
dicarboxylates 59 (Scheme 11) with substituted butadienes 60 to give the hydroxyphthalates 
61 [94]. 
 
The Diels-Alder [4+2] cycloadditions of dialkyl acetylenedicarboxylates 59 with substituted 
and condensed furans were extensively studied [95]. These annulations could be represented 
in general formula shown in scheme 11. Similar to this, dialkyl acetylenedicarboxylates 59 
underwent cyclizations to form 3-hydroxyphthalates, with substituted 3-hydroxy-2-pyrones, 
substituted furanones [96] and (trialkylsilyl)vinylketenes [97]. 
Transition metal complexes of vinylketenes undergo annulations to form substituted 
hydroxyphthalates. Vinylketene complex 62 underwent cyclization (Scheme 11) with 59 and 
formed phthalate 63 [98]. 3-Hydroxyphthalates were also prepared by dötz annulation [99]. 
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OMe
OSiMe3SAr
R2
60
1) neat, -78 to 20 °C
20h
2) NH4Cl, H2O
OH
ArS
R2
O
OR
O
OR
61
R2: H, alkyl
CO2RRO2C R: alkyl
59
O
O
CO2RRO2C
OH O
OR
O
OR
+ + +
Ph OEt
.
O
Fe(CO)3
OH O
OR
O
OR
EtO
Ph
63
THF, reflux
62
 
Scheme 11: Diversity-oriented synthesis of 3-hydroxyphthalates. 
 
 
1.3.2 4-Nitro- and 4-aminophenols: 
4-Nitro- and 4-aminophenols are of a great interest in synthetic and pharmaceutical organic 
chemistry, due to their wide spectrum of biological activities and occurrence in the core 
structure of many natural products [75a].  
4-Nitrophenols are important building blocks in synthetic organic chemistry, routinely they 
serve as precursors for the corresponding aminoarenes [100]. They show antifungal [101a], 
antiandrogenetic [101b], vasodilative [101c], estrogenic [101d] and HIV-1 integrase inhibition 
[101e] activities (Fig. 5). 
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OH
Cl
NO2
Antifungal agent
OH
OH
NO2
CO2HO
HO
HO
OH
OH
NO2
CO2HO
HO
HO NO2
HIV-1 integrase inhibitiors
 
Figure 5: Biologically active nitrophenols.  
 
Classical methods, which start with an existing arene, for the synthesis of 4-nitrophenols 
involve: catalytic hydroxylation of nitroaryl halides [102], nucleophilic hydroxylation of 
aromatic nitro compounds [103], oxidation of the corresponding p-nitrosophenol [104] and 
nitration of phenols using different nitrating agents [105]. 
These methods are accompanied by severe drawbacks. For example, the oxidation of 
nitrosophenol by using nitric acid results in the evolutoin of toxic nitrogen oxides [99]. The 
nitration of phenols suffers from the low regioselectivity, overnitration and the oxidation of 
the substrates. Several side-reactions are possible for functionalized substrates, due to the 
harsh reaction conditions and steric effects.  
“Acyclic approaches”, which overcome these drawbacks, involve: the base mediated 
condensations of nitromethane (64) (Eq. 13) with 4H-pyran-4-ones 65, which gave 4-
nitrophenols 66 [106]. Base mediated cyclocondensations of acetone derivatives with 2-
nitromalonaldehyde and 3-nitrochromone also gave substituted nitrophenol [107].  
 
O
O
+MeNO2
t-BuOK, MeNO2, r.t.
NO2
HO
Eq 13
64 65 66
R1 R2
R3
R1, R2: alkyl
R3: acyl
R2
R1
R3
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Ariga et al. [108] reported the base-mediated cyclization of β-nitroenamine 67 with ketones 
68 to give nitrophenols 69 (Eq. 14) 
.  
Eq 14+
O
O2N H
t-BuHN
O
R2R1 KOH, EtOH
NO2
OH
R1R2
R1: alkyl, phenyl
R2: alkyl, phenyl
67 68 69
 
 
Danishefsky´s diene 70 was cyclized (Eq. 15) with β-sulfinylnitroethylenes 71 in Diels-Alder 
fashion to give compounds 72 [109]. 
 
Eq 15
OH
NO2
O
S
O2N
OMe
Me3SiO
+
PhCH3, 110 °C, 3 h
7270 71
R
R: alkyl, H
R
 
 
Davies et al. reported the synthesis of anilines by addition of ketones to vinamidinium salts.  
Although they obtained mixtures of anilines and nitrophenols, they isolated 4-nitrophenols in 
good yields in some cases. For example, methyl acetoacetate (73) was reacted with the salt 74 
(Eq. 16) to give the nitrophenol 75 in 63% yield [110].  
 
O O
O + N
NO2
N
PF6
OH
NO2
O
OMe
t-BuOK, THF, r.t.
63 %
73 74 75
Eq 16
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Tebby and co-workers reported the synthesis of nitrophenols by cyclotrimerization of 
nitroketenes [111]. 
Nitro- and aminophenols were also prepared by [3+3] cyclization reactions (Scheme 12). 
Dienes 22 reacted with the nitro substituted 3-silyloxy-2-en-1-one 76 and afforded 
nitrophenols 77, subsequent reduction gave aminophenols 78 [112]. 
R1: H, alkyl
OR1
OSiMe3Me3SiO
OMe3SiO
OOH
OR1
TiCl4
CH2Cl2
_ 78 to 20 °C,
14h
+
NO2
NO2
R2
R2
76
22
77
OOH
OR1
NH2
R2
R2: alkyl
78
Pd/C
 
Scheme 12: Synthesis of nitro and aminophenols by [3+3] cyclizations and subsequent reduction. 
 
Anilines are important intermediates in synthetic organic chemistry and in industrial 
applications, like the manufacture of agrochemicals, dyes, pharmaceuticals, and other 
industrial products [113].  
An important class of anilines are fuctionalized 4-aminophenols. A wide range of 
pharmacological activities have been reported for functionalized 4-aminophenols. For 
example, N-(4-hydroxyphenyl)acetamide (paracetamolR) (Fig. 6) is well described as 
analgesic and antipyretic agent [114]. Antimicrobial and antituberculosis activity and several 
other pharmacological properties have been reported for N-(4-ethoxyphenyl)acetamide 
(PhenacetinR) [115] (Fig. 6). 
HN O
OH
Paracetamol R
HN O
O
Phenacetin R  
Figure 6: Biologically active aminophenols. 
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Even simple natural products, such as 3,4-dihydroxy-6-aminobenzoic acid [116a], 2-(3-amino-
2,4-dibromo-6-hydroxyphenyl)acetic acid [116b], and 2-amino-4,5-dimethoxybenzoic acid 
[116c], are of considerable pharmacological relevance. More complex natural products 
include, for example, popolohuanone D [117], or 3-hydroxy-N-(2-hydroxy-4,5-dimethoxy-
phenyl)succinamic acid [118]. In addition, the 2-acyl-4-aminophenol substructure is 
incorporated in a number of polycyclic natural products, such as uncialamycin or alpkinidine 
[119].  
Routinely, amino arenes are prepared by reduction of the corresponding nitro precursors. 
Extensive research was done in this context, various reductions, reducing agents and catalytic 
systems were reported [120].  
Reduction of aryl 4-azidophenols was also reported to give 4-aminophenols [121]. Direct 
hydroxylation of aniline also gave 4-aminophenol [122]. Recently catalytic C-N bond 
formation to produce aminoarenes has attracted a great interest and was applied for the 
synthesis of aminophenol derivatives [123].  
The direct hydroxylation suffers from serious regioisomerization problems. Functionalized 
azidoarenes could be explosive and difficult to prepare. The syntheses of highly functionalized 
or sterically encumbered starting haloarenes can be a difficult and tedious task. 
An “acyclic approach” for the direct synthesis of functionalized 4-aminophenols involves 
Diels-Alder annulation of Danishefsky’s diene 70 (Eq. 17) with 79 to give aminophenols 80. 
Actually, this process consists of many steps [124].  
 
N
O
O
Ar
+
O
Me3SiO
OH
NH2
Ar
1: PhCH3, ref lux b-HCl-THF, r.t.
2: NaOH-THF, r.t.
3: HCl, ref lux
4: NaOH
7079 80
Eq 17
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1.3.3 Diaryl selenides: 
Earlier it was considered, that selenium compounds are only toxic and have no biological 
value. Nowadays selenium is considered as micronutrient, whose absence causes skeletal and 
cardiac dysfunction [125]. It is also important for the immune system and for cellular defense 
against oxidative damage, thus its compounds could be possible candidates to play an 
important role as anticancer agents [126].  
Organoselenium compounds have been tested as antibacterial, antiviral, antifungal, 
antiparasitic, anti-inflammatory, antihistamine and anticancer agents [127]. 
Among organoselenium compounds, diaryl selenides have interesting biological and 
pharmaceutical activities. They have attracted considerable interest because of their potential 
as anticancer and antioxidant agents [128]. Diaryl selenides 81, 82, 83 (Fig. 7) were reported 
to have antitumor activities [129]. 
 
Se
H
N
H
N
Se
XX
82 X: CN
83 X: NO281  
Figure 7: Biologically active diaryl selenides.  
 
In addition, diaryl selenides play an important role in synthetic organic chemistry as key 
intermediates for the synthesis of a wide range of biologically and pharmacologically active 
selenium compounds, such as selenonium salts, selenoxides, selenimines and selenide 
dihalides [130].  
Classically, general methods for the synthesis of diaryl selenides rely on the electrophilic 
substitution by ArSeX (X= Hal, CN, SeAr) using aryllithium, aryl Grignard reagents, 
diarylmercurials [131], anilines and phenols [132], or nucleophilic reactions of ArSe- with aryl 
diazonium salts [133]. The reaction of halobenzenes with phenylselenol (PhSeH) or benzene 
selenolate anion (PhSeNa) or diphenyl diselenide (PhSeSePh) in the presence of a transition 
metal catalyst, such as Pd [134], Ni [135], Cu-salt [136] have also been reported. Recently, 
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diaryl selenides have been prepared by cross coupling reaction of aryl iodides and PhSeSnBu3 
using palladium-based catalysts [137]. In addition, the p-toluenesulfonic acid or ammonium 
peroxosulfate mediated reaction of arenes with diphenyl diselenides were reported to give 
diaryl selenides [138], while triarylbismuth reacts with diaryldiselenides to form the 
corresponding diarylselenium compounds [139].  
Symmetrical salicylate-derived diaryl-selenides are known and have been prepared by reaction 
of salicylates 84 with SeOCl2 (85) (Scheme 12) and subsequent reduction with zinc to give 
diaryl selenides 87 [140].  
 
OH O
OR + SeOCl2
OH O
OR
SeCl
Cl
OH
O
OR- H2O
Zn
OH O
OR
Se
OH
O
OR
84 85
86
87  
Scheme 13: Synthesis of symmetrical salicylate-derived diaryl selenides. 
 
Barton and coworkers have reported an isolated example of the formation of an 
unsymmetrical salicylate-derived diaryl-selenide 91 as a side-product (Eq. 18) during their 
research in the synthesis of tetracycline using benzeneselenic anhydride 89 [141]. 
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Se
O
O
Se
O
+
OH
OH O
OMe
CH2Cl2/ r. t. OH
OH O
OMe
Se
O O
OMe
OH
OH
+
88 89 90
91
Eq 18
 
 
However, these methods suffer many serious disadvantages; for example, methods that use 
starting selenolates involve usage of an excess of these precursors that make the purification 
of the final products difficult task. To produce the selenolates, excessive amounts of reducing 
agent are required. Selenols are foul-smelling reagents. Regioselectivity problems are also 
encountered. 
 
An “acyclic approach” for the synthesis of diaryl selenides involves the Diels-Alder 
annulation of DMADC (92) with the substituted diene 93 to give diaryl selenide 94 (Eq. 19) 
[142]. 
O
OMe
O
MeO
Cl
Cl
Se
O
OMe
O
OMe
Se
Cl
+ Eq 19
92 93 94
 
 
Diels-Alder [4+2] cycloaddition of diene 95 with 1-(phenylseleno)-2-(p-
tolouenesulfonyl)ethyne (96) (Eq. 20) afforded compound 97 in 80% [143]. 
+ Se S
O
O
S
O
O
Se
PhCH3, 60 °C, 15 h
OAc
Eq 20
95 96 97
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Phenyl naphthyl selenide 99 was prepared by electrophilic cyclization of benzeneselenyl 
bromide (97) (Eq. 21) with alkyne 98 [144]. 
Eq 21SeBr
+
OH
SeNaHCO3, MeCN, r.t
97 98 99  
 
Substituted phenyl naphthyl selenides 101 were also prepared by treatment of 
methylenecyclopropanes 100 with trifluoromethanesulfonic acid (Eq. 22) [145]. 
Eq 22
PhSe
OH
Ar
TfOH (30 mol%)
CH2Cl2, rt, 1.5 h
R1
R1 100
Ar
R1
SePh
R1
101
R1: H, alkyl, Halogen
 
 
Another method for the synthesis of phenyl naphthyl selenides 104 relies on radical ring-
opening-intramolecular cyclization (Eq. 23) of 2-(arylmethylene)cyclopropylaldehydes 102 
using the free radical initiator ammonium persulfate and the selenium source N-
(phenylseleno)phthalimide 103 [146]. 
Ar1
O
H
N Se
Ar2
O
O
102 103
+
(NH4)2S2O8
DMSO, 70°C
OH
Se
Ar2
104
Eq 23
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Part 2: Results and discussions: 
 
2.1 Diversity-oriented synthesis of 1-hydroxy-2,4-benzodioates by regioselective [3+3] 
cyclocondensations of 1,3-bis(silyloxy)-1,3-butadienes with 3-alkoxy- and 3-silyloxy-2-
alkoxycarbonyl-2-en-1-ones: 
In recognition of their importance in different fields of chemistry, my efforts were directed 
toward the investigation of a suitable and reliable method for the synthesis of 1-hydroxy-2,4-
benzodioates. 
2.1.1 Target, problems to solve and strategy: 
Most of the reported methods for the synthesis of 1-hydroxy-2,4-benzodioates, which adopt 
the “acyclic approach”, lack generality of starting materials. I investigated the validity of 
[3+3] cyclocondensations of 1,3-bis(silyloxy)-1,3-butadienes with 1,3-dielectrophiles for a 
regioselective and one step construction of highly functionalized 1-hydroxy-2,4-benzodioates 
under mild conditions. 
My strategy depends on the [3+3] cyclization of functionalized 1,3-bis(silyloxy)-1,3-
butadienes with the two substituted 1,3-dielectrophiles: 3-silyloxy-2-en-1-ones and 3-alkoxy-
2-en-1-ones. A retrosynthesis of the target molecules could be represented as in (Scheme 14).  
OR1
OSiMe3Me3SiO
R3
OMe3SiO
OOH
OR1
R3 +
R2R
2
R3
R3
O OR4
O OR4
OR1
OSiMe3Me3SiO
+
R2
OR5 O
R3
OH O
OR1
R2
R3
OH O
OR1
R2
or
R3
O OR4 O OR4
O OR4  
Scheme 14: Retrosynthesis of 1-hydroxy-2,4-benzodioates. 
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2.1.2 Synthesis of substituted 1-hydroxy-3,5-dimethyl-2,4-benzodioates by [3+3] 
cyclocondensation of 1,3-bis(silyloxy)-1,3-butadienes with 2-ethoxycarbonyl-3-silyloxy-2-
en-1-one: 
Langer et al. have reported [147a] preliminary results of the synthesis of 1-hydroxy-3,5-
dimethyl-2,4-benzodioates by TiCl4-mediated [3+3] cyclizations of 1,3-bis(silyloxy)-1,3-
butadienes with 3-silyloxy-2-en-1-ones derived from (symmetrical) ethyl 2-
acetylacetoacetate. My target was to extend the preparative scope of this reaction. 
The triethylamine-mediated silylation (Eq. 24) of commercially available ethyl 2-
acetylacetoacetate (105) with trimethylchlorosilane at room temperature afforded the 2-
ethoxycarbonyl-3-silyloxy-2-en-1-one 106 in 87% yield.   
106
Me
OMe3SiO
20 °C, 14 h.r.
CO2Et
105
Me
Me3SiCl
Me
OO
CO2Et
Me
NEt3
CH2Cl2
Eq 24
 
 
The TiCl4-mediated formal [3+3] cyclizations of β-ketoester-derived 1,3-bis(silyloxy)-1,3-
butadienes 22a,e,g,j,m,n,o,q-u,v with 3-silyloxy-2-en-1-one 106 afforded the 1-hydroxy-2,4-
benzodioates 107a-m (Eq. 25, Table 2) in moderate to good yields. 
The best yields were obtained when the reactions were done in concentrated solutions (2 ml of 
CH2Cl2/1mmol of 106) with equivalent ratio of the reactants (106/22/ TiCl4) (1.0/1.1/1.1). 
The reactions were done in completely dry argon atmosphere at -78 oC using iso-propanol-
liquid nitrogen bath and allowed to warm to room temperature during 14 hours. 
OSiMe3Me3SiO
OR1
R2 OH
OR1
O
MeMe
R2
CO2Et
Me Me
Me3SiO O
CO2Et
+
22a,e,g,j,m,n,o,q-u,v
106
107a-m
TiCl4
CH2Cl2
_ 78 to 20 °C
14 h
Eq 25
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Compounds 107a-m (Table 2) are 1-hydroxy-2,4-benzodioates with the same substituent on 
C3 and C5, thus the syntheses of compounds 107a-m bear no issue of regioselectivity. The 
cyclization of the 1,3-bis(silyloxy)-1,3-butadienes 22q,r,s with 106 afforded the 1-
hydroxydimethyl-2,4-benzodioates 107i,j,k, respectively. These isophthalates can be 
considered also as highly substituted biaryls. Compounds 107h,l,m could be considered as 
highly functionalized diaryl ethers. 
Functionalized diaryl ethers [21] and biaryls [22] have important biological relevance and 
occur in many natural products.  
OH
OR1
O
MeMe
R2
CO2Et  
107a-m 
Table 2: Products and yields 107a-m. 
22 107 R1 R2 % (107)a 
a a Me H 30b 
e b Et Me 48b 
g c Et Et 49b 
j d Me n-Hex 35 
m e Me n-Non 40 
n f Me n-Dec 41 
o g Me OMe 65b 
v h Et OPh 48 
q i Me 4-MeC6H4 38 
r j Me 4-ClC6H4 37 
s k Me 4-(MeO)C6H4 34 
t l Et O(2-MeC6H4) 42 
u m Et O(3-MeC6H4) 51 
              a Yields of isolated products, b ref. 147a 
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When the side-chain substituted 1,3-bis(silyloxy)-1,3-butadienes 22 were used, the yields 
increased (albeit not significantly in some cases). The butadiene 22o gave the best yield 
[147a]. The lowest yield was observed when 22a was reacted. My trials to improve the yield, 
unfortunately, failed. No clear trend for the variation of the yields was observed.  
 
2.1.3 Synthesis of functionalized 1-hydroxy-2,4-benzodioates by [3+3] cyclocondensation 
of 1,3-bis(silyloxy)-1,3-butadienes with 3-alkoxy- 2-en-1-ones: 
The second protocol of the strategy relies on the use of unsymmetrical 3-alkoxy- 2-en-1-ones, 
rather than 3-silyoxy-2-en-1-ones for the [3+3] cyclization reactions with 1,3-bis(silyloxy)-
1,3-butadienes. This provides another route for the synthesis of the target molecules. 
2-Alkoxycarbonyl-3-methoxy-2-en-1-ones 109a-d were prepared, following known 
procedures [148, 149], by reflux of β-ketoesters 108a-d in a mixture of trialkyl orthoformate 
and acetic anhydride (Scheme 15, Table 3). The syntheses of 109a,c,d were reported [149]. 
The enones 109a-d were obtained as mixtures of E/Z isomers. 
The TiCl4-mediated formal [3+3] cyclizations of 1,3-bis(silyloxy)-1,3-butadienes 
22a,b,d,g,h,j-o,q,r with 3-alkoxy-2-en-1-ones 109a-d afforded the 1-hydroxy-2,4-
benzodioates 110a-ae (Scheme 15, Table 5) in 43-60% yields. The other regioisomers were 
not detected. 
 
Ac2O, ref lux, 2 h
108a-d
HC(OR5)3
109a-d
R3
OR5O
CO2R4
R3
O
CO2R4
OR1
OSiMe3Me3SiO
110a-ae
OOH
OR1
R3
TiCl4
CH2Cl2
_ 78 to 20 °C
14 h
R2
R2
+
22a,b,d,g,h,j-o,q,r
O OR4
OOH
OR1
R2
O OR4
R3
not formed
Scheme 15: Synthesis of 1-hydroxyl-2,4-benzodioates 110a-ae. 
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109a-d
O
R5O
O
OR4R3
 
Table 3: Compounds 109a-d and their yields. 
 
 
 
 
 
 
a Yields of isolated products, for the reported compounds see ref. [149] 
 
2.1.3.1 Optimization of reaction conditions: 
The best conditions were obtained when the reaction was carried out using an equivalent ratio 
(1.0/ 1.1/ 1.1) of (109a/ 22d / TiCl4), in concentrated solution (2 ml of CH2Cl2/ 1 mmol of 
109a), at -78 oC followed by slow warming to room temperature during 14 hours. Different 
parameters were varied to get the optimized conditions (Table 4). 
 
In trial 1 the decrease of the amount 22d led to a decrease of the yield. When the amounts of 
the diene 22d and 109d were increased (trials 2 and 4 respectively), the yields of the isolated 
product decreased. This might be a result of the increase of their concentration, which 
enhances their TiCl4-mediated dimerization and polymerization under the same reaction 
conditions. 
When the reaction was done at 0 oC sudden increase of the heat and decomposition were 
observed (trial 5). Employing other Lewis acids gave complex mixtures which could not be 
isolated by normal column chromatography (trials 8, 9, 10).  
 
Yields decreased when the reaction was carried out in more dilute solution (trials 11-13), up 
to the level that no product was detected when (30 ml/ 109a) of solvent was used. 
 
 
108, 109 R3 R4 R5 % (109)a 
a Me Me  Me 82 
b Et Me  Me 84 
c    n-Pr     Me         Me 83 
d     Ph      Et Et 81 
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Table 4: Optimization of reaction parameters of the product 110b. 
trial [109a]a L.A. b 109a/22d/L.A. T. (oC) h.r.c % (110b)a 
1 2 TiCl4 1.0/1.0/1.0 -78-r.t. 14  28 
2 2 TiCl4 1.0/2.0/1.0 -78-r.t. 14  31 
3 2 TiCl4 1.0/1.0/2.0 -78-r.t. 14  20 
4 2 TiCl4 2.0/1.0/1.0 -78-r.t. 14  33 
5 2 TiCl4 1.0/1.1/1.1 0-r.t. 14  0 
6 2 TiCl4 1.0/1.1/1.1 -78-r.t. 14  57 
7 2 TiCl4 1.0/1.1/1.1 -78-r.t. 4  18 
8 2 SnCl4 1.0/1.1/1.1 -78-r.t. 14  u. p . d 
9 2 BF3.Et2O 1.0/1.1/1.1 -78-r.t. 14  u. p . d 
10 2 TMSOTf 1.0/1.1/1.1 -78-r.t. 14  u. p . d 
11 3 TiCl4 1.0/1.1/1.1 -78-r.t. 14  34 
12 6 TiCl4 1.0/1.1/1.1 -78-r.t. 14  21 
13 10 TiCl4 1.0/1.1/1.1 -78-r.t. 14  7 
14 30 TiCl4 1.0/1.1/1.1 -78-r.t. 14  0 
a ml of CH2Cl2/ mmol of 109a, b Lewis acid, c time in hours 14 hours= overnight, d unidentified products 
(formation of complex mixture) 
 
2.1.3.2 Preparative scope: 
Compounds 110a-ae (Table 5) are 1-hydroxy-3-substituted-2,4-benzodioates having no 
substituent on C5. These compounds are unknown to date. Compounds 110j,k,u and 
110ad,ae are considered as highly substituted biaryls and could be synthesized by either: 
functionalization of the side chain of the diene 22 or by functionalization of enones 109. This 
indicates that the variation of both the masked dianions 22 and the dielectrophiles 109 is 
possible and lead to these functionalized isophthalates.  
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110a-ae
OOH
OR1
R3
R2
O OR4
 
Table 5: Products and yields of 110a-ae. 
22 109 110 R1 R2 R3 R4 % (110)a 
a a a Me H Me Me 43 
d a b Me Me Me Me 57 
g a c Et Et Me Me 50 
h a d Me n-Bu Me Me 52 
j a e Me n-Hex Me Me 55 
k a f Me n-Hept Me Me 51 
l a g Me n-Oct Me Me 48 
m a h Me n-Non Me Me 52 
b a i (CH2)2OMe H Me Me 48 
q a j Me 4-MeC6H4 Me Me 53 
r a k Me 4-ClC6H4 Me Me 48 
o a l Me OMe Me Me 52 
d b m Me Me Et Me 52 
g b n Et Et Et Me 50 
h b o Me n-Bu Et Me 52 
j b p Me n-Hex Et Me 52 
k b q Me n-Hept Et Me 51 
l b r Me n-Oct Et Me 50 
m b s Me n-Non Et Me 51 
n b t Me n-Dec Et Me 49 
q b u Me 4-MeC6H4 Et Me 51 
d c v Me Me n-Pr Me 51 
g c w Et Et n-Pr Me 53 
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h c x Me n-Bu n-Pr Me 51 
j c y Me n-Hex n-Pr Me 45 
k c z Me n-Hept n-Pr Me 46 
l c aa Me n-Oct n-Pr Me 45 
m c ab Me n-Non n-Pr Me 50 
n c ac Me n-Dec n-Pr Me 55 
d d ad Me Me Ph Et 58 
g d ae Et Et Ph Et 60 
              a Yields of isolated products 
 
When R3 was a phenyl group (110ad and ae) the yields increased. The Yields of products 
110b-h are slightly higher than the yield of 110a. This could be attributed to the inductive 
donating effect of the alkyl group which enhances the nucleophilicity of the C4 carbon. No 
clear systematic trend in the yields was noticed. No clear relation was noticed when R2 were 
the same and R3 changed. 
 
2.1.3.3 Structural proof: 
For compound 110a (Fig. 8) the aromatic protons resonate as doublets at δ = 6.78 ppm and δ 
= 7.76 ppm with coupling constants 3J = 8.7 Hz and 3J = 8.9 Hz, respectively. These large 
coupling constants indicate that they are ortho to each other.  
 
 
 
 
 
Figure 8: Ortho coupling of 110a and 110i.  
 
The same was observed for 110i: the two aromatic protons resonate at δ = 6.78 ppm and δ 
=7.78 ppm as doublets with coupling constants 3J = 8.7 Hz and 3J = 9.0 Hz. 
110a
CH3
OH O
OCH3
O OCH3
CH3
OH O
O(CH2)2OCH3
O OCH3
110i
H
H
H
H
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For other compounds, the elucidation of the structure and the confirmation of the 
regioselectivity were difficult and had to rely on 2D NMR spectroscopy. 
1H,1H NOE experiments were done for compounds 110p and 110y. For 110p, the benzylic 
protons (at carbon 1) of the hexyl side chain appear as a triplet at δ = 2.53 ppm and correlate 
with the aromatic proton which appears as a singlet at δ = 7.61 ppm (Fig. 9 and 10). Also, a 
NOE correlation was observed between this aromatic proton and the protons at carbon 2. 
CH2CH3
OH O
OCH3
O OCH3
H
12
3
 
Figure 9: 1H,1H NOE correlations of 110p. 
Figure 10: 1H,1H NOE Spectrum of 110p. 
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In 110y, a NOE correlation was observed between the benzylic protons which resonate as a 
triplet at δ = 3.03 ppm and the methyl protons of the propyl side chain which appear at δ = 
0.90 ppm. It is useful to assign both benzylic protons groups (PhCH2) (Fig. 11). On the other 
hand, a NOE correlation was observed between the aromatic proton which resonates at δ = 
7.61 ppm and the benzylic protons of carbon 1 which resonate at δ = 2.53 ppm.  
OH O
OCH3
O OCH3
H
2
1
 
Figure 11: 1H,1H NOE correlations of 110y. 
 
More downfield shifts for aromatic protons in compounds 110j,k,u (Fig. 13) were noticed. It 
might be that these aromatic protons are affected by the anisotropic effect of the aromatic ring 
on the carbon atom C5 of these phenols.   
 
CH3
OH
110j
O
OCH3
O OCH3
H3C
CH3
OH O
OCH3
O OCH3
Cl
110k
CH2CH3
OH O
OCH3
O OCH3
H3C
110u  
Figure 12: Compounds 110j,k,u. 
 
The regioselectivity observed here can be explained by steric and electronic factors (see 
section 1.2.4 and 1.2.1). 
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2.1.3.4 X-ray analysis: 
The structures of both 110b and 110k were confirmed by X-ray crystal structure analyses. 
 
Figure 13: ORTEP plot of one of the two molecules 110b in the asymmetric unit and 110k (50% level). 
These X-ray structures (Fig. 13) were another proof of the suggested regioselectivity. In both 
compounds the O-H group is involved in intramolecular hydrogen bonding. In addition, it is 
involved in intermolecular hydrogen bonding (Fig. 14) in 110k. The torsion angle between the 
two aromatic planes in 110k was calculated to be 39.960 (7).  
Hydrogen bonding properties: bond lengths between donors and acceptors and the angles are 
listed for compounds 110b and 110k in Tables 6 and 7 respectively.  
Table 6:  Hydrogen bonds for 110b [Å and °]. 
D-H...A d(D-H) d(H...A) d(D...A) <(DHA) 
O(3B)-H(3B)...O(1B) 0.94(2) 1.76(2) 2.6124(16) 149.6(19) 
O(3A)-H(3A)...O(1A) 0.96(3) 1.69(3) 2.5772(16) 151(2) 
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Figure 14: Inter -and intra-molecular hydrogen bonding in 110k. 
 
Table 7: Hydrogen bonds for 110K [Å and °]. 
D-H...A d(D-H) d(H...A) d(D...A) <(DHA) 
O(3)-H(3O)...O(1) 0.89(4) 1.76(4) 2.508(3) 140(3) 
O(3)-H(3O)...O(1)#1 0.89(4) 2.25(3) 2.913(3) 130(3) 
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2.2 Competing regiodirecting effects of ester and aryl groups in [3+3] 
cyclocondensations of 1,3-bis(trimethylsilyloxy)-1,3-butadienes. Regioselective synthesis 
of 3-hydroxy-phthalates and 2-hydroxy-terephthalates: 
 
The divergent use of 3-hydroxy-phthalates and 2-hydroxy-terephthalates in various fields of 
chemistry raises the need to find reliable methods for their synthesis. 
 
2.2.1 Target, problems to solve and strategy: 
Few strategies that adopt the “acyclic approach” for the synthesis 3-hydroxy-phthalates and 
2-hydroxy-terephthalates are reported in literature (see section 1.3.1). However, these 
methods have many drawbacks such as lack of generality of the starting materials.  
I investigated the possibility of synthesis of these arenes by the use of [3+3] 
cyclocondensations of 1,3-bis(silyloxy)-1,3-butadienes with 1,3-dielectrophiles. This strategy 
would offer a direct, regioselective and one step construction of substituted 3-hydroxy-
phthalates and 2-hydroxy-terephthalates under mild conditions. 
My strategy relies on the [3+3] cyclization of functionalized 1,3-bis(silyloxy)-1,3-butadienes 
with two types of 1,3-dielectrophiles: 3-silyloxy-2-en-1-ones and 3-alkoxy-2-en-1-ones, a 
schematic presentation for this strategy is shown in Scheme 16. In the cyclizations with 
unsymmetrical 3-silyloxy-2-en-1-ones, two regioisomers could be predicted, the same is for 
unsymmetrical 3-alkoxy-2-en-1-ones.   
OR1
OSiMe3Me3SiOOOH
OR1
+
R2R
2
R4
+
OR5 O
OH O
OR1
R2
OH O
OR1
R2
O
OR3
O
OR3
R4
R4 O
OR3
OOH
OR1
R2
or
R4
O
R3O
OSiMe3O
R4
O
OR3
or
O
R3O
R4
OR1
OSiMe3Me3SiO
R2
 
Scheme 16: Retrosynthesis of 3-hydroxy-phthalates and 2-hydroxy-terephthalates. 
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2.2.2 Synthesis of substituted 3-hydroxyphthalates by [3+3] cyclocondensation of 1,3-
bis(silyloxy)-1,3-butadienes with unsymmetrical 3-(silyloxy)-2-en-1-ones derived from 
acetylpyruvates: 
Langer et al. reported [147a] preliminary results related to the synthesis of 3-hydroxy-5-
methylphthalates based on regioselective chelation-controlled cyclizations of 1,3-
bis(silyloxy)-1,3-butadienes with 4-silyloxy-2-oxo-3-butenoates, derived from 
acetylpyruvates. Herein, I report a full and detailed account related to this scope. 
 
4-Silyloxy-2-oxo-3-butenoates 112a,b were prepared in 84% and 81% yields, respectively, by 
triethylamine-mediated silylation (Eq. 26) of the commercially available acetylpyruvates 
111a,b,  which exist mainly in their enol form 111/a,b [150]. 
 
112a,b20 °C, 14 h111a,b
Me3SiCl
NEt3
CH2Cl2
Me
O OSiMe3
O
OR
Me
O
O
OR
O
Eq 26Me
O
O
OR
OH
111a,b
 
 
The TiCl4-mediated formal [3+3] cyclizations (Eq. 27, Table 8) of 1,3-bis(silyloxy)-1,3-
butadienes 22a,e,g,j,m,n,o,s,v with 4-silyloxy-2-oxo-3-butenoates 112a,b  afforded the 3-
hydroxy-5-methylphthalates 113a-i, in good yields. No other regioisomers were detected. 
 
Me
O OSiMe3
O
OR
OH
OR1
O
Me
R2
O
OR
22a,e,g,j,m,n,o,s,v
112a,b
113a-i
+
OR1
OSiMe3Me3SiO
R2
TiCl4
CH2Cl2
_ 78 to 20 °C
14 h
Eq 27
OH
OR1
O
R2
Me
O
RO
not formed
 
 
The best yields were obtained when the equivalent ratio of reactants was (112/22/ TiCl4) 
(1.0/1.1/1.1), when the reactions were done in a concentrated solution (2 ml of CH2Cl2/1 
mmol of 112) under inert atmosphere of argon gas at -78oC using iso-propanol-liquid nitrogen 
bath and when the reactions were allowed to warm to room temperature during 14 hours. 
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2.2.2.1 Preparative scope: 
Compounds 113a-i (Table 8) are C6 unsubstituted 3-hydroxy-phthalates. Compound 113h 
can be considered as a highly functionalized biaryl, while compound 113i is a functionalized 
diaryl ether.  
The yields of 113a,c were improved from 17%, 22%, respectively [147a] to 43% and 42%. 
The previous low yields could be due to practical problems or due to the quality of the starting 
materials, such as the use of old diene or wet solvent or reaction atmosphere. 
 
 
 
 
Table 8: Products and yields of 113a-i. 
112 22 113 R R1 R2  % (113)a 
a a a Me Me H 43b 
a e b Me Et Me 32 
a g c Me Et Et 42b 
b j d Et Me n-Hex 37 
b m e Et Me n-Non 42 
b n f Et Me n-Dec 42 
a o g Me Me OMe 45b 
b s h Et Me 4-(MeO)C6H4 39 
b v i Et Et OPh 40 
b w j Et Et Cl 0 
                     a Yields of isolated products, b ref. 147a 
 
 
OH
OR1
O
Me
R2
O
OR
113a-i
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The highest yield was obtained when 22o was used. No clear systematic trend for the yields 
was observed. When the diene 22w was used no aromatic compound was isolated. This could 
be due to the electron withdrawing inductive effect of the chlorine atom, which decreases the 
nucleophilicity of the terminal carbon atom. 
2.2.2.2 Structural proof: 
The (PhCH3) protons in compound 113h (Fig. 15) are more downfield shifted than the other 
derivatives, they resonate at δ = 2.51 ppm. This could be due to the anisotropic effect of the 
neighboring aromatic ring. 
 
 
 
 
Figure 15: The phthalate 113h. 
 
1H,1H NOE experiments were done for compounds 113b and 113h  in my recent work, it was 
also done for 113c as well [147] (Fig. 16). These experiments confirmed the suggested 
regioselectivity. Both PhCH3 proton groups in 113b, which resonate at  = 2.26 ppm and 2.39 
ppm, correlate with each other (Fig. 16). In addition, there is a NOE correlation between the 
aromatic proton which resonates at  = 6.94 ppm and the methyl group appears as a singlet at 
 = 2.39 ppm. 
 
OH O
OCH2CH3
H3C
O
OCH3H3C
H
OH O
OCH2CH3
H3CH2C
O
OCH3H3C
H
OH O
OCH3
O
OCH2CH3
H3C
H3CO
H
 
Figure 16: 1H,1H NOE correlations of 113b, 113c and 113h. 
The regioselectivity might be explained by TiCl4-assisted migration of the TMS group of 112 
(Scheme 17) and formation of intermediate A as a result of the chelation of TiCl4 with the 
neighbouring oxygen atoms.  
OH O
OCH3
O
OCH2CH3
H3C
H3CO
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The reaction of 1,3-bis(silyloxy)-1,3-butadienes with 3-silyloxy-2-en-1-ones usually proceeds 
by attack of the terminal carbon atom of the diene onto the double bond of the 3-silyloxy-2-
en-1-one in a conjugate addition fashion intermediate B. The -donating effect of the silyloxy 
group increases the electron density (and thus decreases the electrophilicity) of the carbonyl 
group of the enone moiety. Therefore, conjugate addition is observed. 
112a,b
Me
O OSiMe3
O
OR
A
Me3SiClOMe3SiO
TiCl4
O
Me3SiO
O
OR1
TiCl3
Me3SiO
B
TiCl4
O
OMe
O
OR
Me Me
22
 
 
Scheme 17: Me3Si migration promoted by TiCl4 chelation ring formation in the cyclization of 112. 
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2.2.3 Synthesis of substituted 2-hydroxy-terephthalates by [3+3] cyclocondensation of 
1,3-Bis(silyloxy)-1,3-butadienes with unsymmetrical 3-(silyloxy)-2-en-1-ones derived 
from benzoylpyruvates: 
In continuation of the cyclization of unsymmetrical 3-(silyloxy)-2-en-1-ones derived from 
acetylpyruvates, I studied also the cyclizations of 3-(silyloxy)-2-en-1-ones derived from 
benzoylpyruvates.  
 
The reaction of various substituted acetophenones 114a-d with diethyl oxalate (115) (Scheme 
18, Table 9), in the presence of sodium hydride (60% in oil), afforded the 2,4-diketoesters 
116a–d [151] in excellent yields, which were by triethylamine-mediated silylation converted 
to the corresponding 3-silyloxy-2-en-1-ones 117a-d.  
 
 
Scheme 18: Synthesis of the enones 117a-d. 
 
Table 9: Products 116 and 117.  
114, 116, 117 R % (116)a % (117)a 
a H 94 89 
b Me 95 84 
c NO2 92 94 
d Br 95 91 
                                            a Yields of isolated products. 
OH
O
OEt
O
R
114a-d
20 °C, 14 h
Me3SiCl
NEt3
CH2Cl2
R
O EtO
O
O
OEt
NaH, PhCH3
ref lux 2 h
116a-d
O
O
OEt
O
R
Me3SiO
O
OEt
O
R
117a-d
115
116a-d
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The TiCl4-mediated formal [3+3] cyclization (Eq. 28, Table 10) of 1,3-bis(silyloxy)-1,3-
butadienes 22a,d,f,h,j,k with the 3-(silyloxy)-2-en-1-ones 117a-d, derived from 
benzoylpyruvates, afforded the 6-aryl-2-hydroxy-terephthalates 118a-n. 
 
Me3SiO
O
OEt
O
R
117a-d
OH
OR1
O
R2
+
OSiMe3Me3SiO
R2
R
O
EtO
OR1
118a-n
TiCl4
CH2Cl2
_ 78 to 20 °C
14 h
22a,d,f,h,j,k
Eq 28
OH
OR1
O
R2
R
O
OEt
not formed
 
The cyclizations were done using optimized parameters: the equivalent ratio of reactants was 
(117/22/ TiCl4) (1.0/1.1/1.1). The reactions were done under inert atmosphere in concentrated 
solutions (2 ml of extra dry CH2Cl2/1 mmol of 117).  
Compounds 118a-n (Table 10) are 6-aryl-2-hydroxy-terephthalates having no substituent on 
C5. These compounds could be also considered as substituted biaryls. Compounds 118h,i are 
nitro-substituted biaryls, which can be intermediates for amino-substituted biaryls. Both 
classes of compounds have wide applications in medicinal and pharmaceutical chemistry 
[152]. 
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OH
OR1
O
R2
R
O
EtO
118a-n  
Table 10: Products 118a-n.  
22 117 118 R R1 R2 % (118)a 
a a a H Me H 43 
d a b H Me Me 49 
f a c H Me Et 50 
h a d H Me n-Bu 46 
a b e Me Me H 44 
d b f Me Me Me 46 
f b g Me Me Et 46 
d c h NO2 Me Me 66 
f c i NO2 Me Et 67 
a d j Br Me H 53 
d d k Br Me Me 55 
f d l Br Me Et 59 
j d m Br Me n-Hex 50 
k d n Br Me n-Hept 50 
p a o H Me OPh 0 
w c p NO2 Et Cl 0 
                                                            a Yields of isolated products. 
 
The yields varied according to the electron withdrawing inductive effect of the substituent 
located the 6-aryl moieties.  Generally, the yields increased as the withdrawing inductive 
effect of this substituent increased NO2 > Br > H > Me. The latter increase the electrophilicity 
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of the carbonyl. Trials to cyclise both dienes 22p and 22w failed, even with Ar-NO2 
substituted enones. 
2.2.3.1 Structural proof: 
1H,1H NOE experiments were done for compound 118e (Fig. 17). It was found that the PhCH3 
protons, which resonate as a singlet at δ = 2.33 ppm, correlate with the aromatic protons 
which appear as a multiplet in the range δ =7.09 - 7.13 ppm (Fig. 18). Thus, it was useful to 
assign the aromatic protons of the toulene ring. The aromatic protons, which appear as 
multiplet at δ =7.04 - 7.08 ppm, correlate with only one aromatic proton of the phenol ring 
which resonate as a doublet at δ =7.39 ppm. A correlation, which supposed to be observed in 
the hypothetic isomer of 118e with the other doublet at δ =7.55 ppm, was not observed. This 
observation cancelled the possibility of the hypothetic regioisomer of 118e. Moreover, the 
coupling constants observed for the phenol protons (1.6 and 1.7 Hz) indicate meta couplings. 
OH
OCH3
O
O
H3CH2CO
CH3
118e
H
H
 
Figure 17: 1H,1H NOE correlations of 118e.  
 
Similarly, coupling constants observed for the phenol protons for compounds 118a and 118j 
(1.7 and 1.8 Hz) indicate meta couplings. 
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Figure 18: 1H,1H NOE spectrum of 118e. 
 
The signals (1H NMR) of the methyl group of the CO2Me moiety of terephthalates 118 (δ = 
3.36 – 3.47 ppm) are generally slightly shifted upfield compared to the corresponding signals 
of isophthalates 107, 110 and 113. This can be explained by the fact that the CO2Me groups of 
terephthalates 118 are located in the anisotropic cone (Fig. 19) of the neighboring aryl group.  
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OH
O
O
R1
O
EtO
R2
CH3
 
Figure 19: Location of the CO2Me group in the anisotropic cone of the neighboring aryl group of 118a-n. 
The regioselectivity observed in the [3+3] cyclizations of  3-(silyloxy)-2-en-1-ones 117a-d, 
derived from benzoylpyruvates, is different form that observed acetylpyruvates 112a,b. The 
aryl group of 118a-n is located in ortho-position to the ester group, while the methyl group of 
113a-i is located para to the ester group.  
Chan and Brownbridge reported [14a] that the reaction of 22a with 4-phenyl-4-
(trimethylsilyloxy)but-3-en-2-one 120, prepared from benzoylacetone (119) (Scheme 19), 
afforded methyl 6-phenyl-4-methylsalicylate 122 (the phenyl group of which is located ortho 
to the ester group).  
This result was explained by TiCl4-mediated isomerization of the TMS group of 4-phenyl-4-
(trimethylsilyloxy)but-3-en-2-one 120 to give 1-phenyl-3-(trimethylsilyloxy)but-2-en-1-one 
121 (or its titanium-complex) and subsequent conjugate addition of the terminal carbon atom 
of 22a onto the enone.  
Similarly, it is expected that 117a-d underwent this isomerisation, followed by conjugate 
addition of the terminal carbon atom of dienes 22.  
TMSO O
22a, TiCl4, CH2Cl2
_ 78 to 20 °C
12 h
120
OH O
OMe
O OTMS
121
122
OH O
119
20 °C, 14 h
Me3SiCl
NEt3
CH2Cl2
 
Scheme 19: TiCl4-mediated isomerization of the TMS group in 4-phenyl-4-(trimethylsilyloxy)but-3-en-2-
ones. 
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This might be explained by an energetically favourable interaction of Ti(IV) with the 
neighbouring phenyl group. The regioselective formation of 118a-n shows that this effect 
successfully competes with the chelation discussed above for the synthesis of products 113a-i. 
The tendency of the aryl group to be located in ortho-position to the ester group is obviously 
higher than the tendency of the pyruvate-derived ester group to be located ortho to the diene-
derived ester group. 
2.2.3.2 X-ray analysis: 
Another proof of the regioselectivity came from the X-ray crystal structure analyses (Fig. 20 
and 21) of compounds 118h, 118m, respectively.  
 
 
 
 
 
 
 
 
 
 
 
Figure 20: ORTEP plot of 118h (50% level). 
 
 
 
 
Results and discussions 
 
54 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 21: ORTEP plot 118m (50% level). 
 
In both compounds, the OH group is involved in intramolecular hydrogen bonding (Tables 11 
and 12). In 118h, the torsion angle between the two aromatic planes is 60.17 (3)0 and between 
the NO2 group and the phenyl group the torsion angle is 9.96 (12)0. This indicates that the 
nitro group is almost in the plane of the aromatic ring. In compound 118m, the torsion angle 
between the two aromatic planes is 54.66 (6)0. 
Table 11: Hydrogen bonds for 118h [Å and °]. 
D-H...A d(D-H) d(H...A) d(D...A) <(DHA) 
O5—H5···O3 0.90 (2) 1.74 (2) 2.5610 (12) 150.5 (17) 
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Table 12: Hydrogen bonds for 118m [Å and °]. 
D-H...A d(D-H) d(H...A) d(D...A) <(DHA) 
O(3)-H(3O)...O(1) 0.77(3) 1.85(3) 2.541(2) 151(3) 
 
 
2.2.4 Synthesis of substituted 2-hydroxy-terephthalates and 3-hydroxyphthalates by 
[3+3] cyclocondensation of 1,3-bis(silyloxy)-1,3-butadienes with substituted 4-ethoxy-2-
oxo-3-butenoates: 
The protocol then was extended toward the utilization of 4-alkoxy-, rather than 4-silyloxy-2-
oxo-3-butenoates in the formal [3+3] cyclization reactions with 1,3-bis(silyloxy)-1,3-
butadienes. This provides another method for the synthesis of the target molecules. 
The treatment of the enol ethers 123a-c with methyl 2-chloro-2-oxoacetate (124) afforded, 
following a known procedure [153], the substituted 4-ethoxy-2-oxo-3-butenoates 125a-c (Eq. 
29, Table 13), which were isolated as mixtures of E/Z isomers. The synthesis of the derivative 
125a has been previously reported [153]. 
OEt O
R O
OMe
125a-c
0°C, 2-4 hCl
O
O
OMe
+
123a-c
OEt
R
124
Eq 29
 
 
Table 13: Products and yields 125a-c.  
123,124 R % (124)a 
a H 82 
b Me 97 
c Et 95 
                                                                                         a Yields of isolated products 
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The TiCl4-mediated formal [3+3] cyclizations of 1,3-bis(silyloxy)-1,3-butadiene 22a with 4-
ethoxy-2-oxo-3-butenoates 125a-c gave 2-hydroxyterephthalates 126a-c (Eq. 30, Table 14). 
The formation of the other regioisomers was not observed. The reaction proceeds by attack of 
the terminal carbon atom of the diene 22a onto the carbonyl group and subsequent cyclization 
followed by aromatization.  
 
Eq 30
OSiMe3
OMeMe3SiO
22a
+
TiCl4
CH2Cl2
_ 78 to 20 °C
12 h
OEtO
RO
MeO
125a-c
OH O
OMe
RO
MeO
126a,b,c
OH O
OMe
R O
OMe
not formed
 
 
In contrast, TiCl4-mediated [3+3] cyclizations of 1,3-bis(silyloxy)-1,3-butadienes 22d,g,h,i,l, 
which have a substituent at C4, with 4-ethoxy-2-oxo-3-butenoate 125a-c gave 3-
hydroxyphthalates 127a-g (Eq. 31, Table 15). The products were formed with very good 
regioselectivity. The formation of the other regioisomers, 2-hydroxyterephthalates, was not 
observed.  
 
TiCl4
CH2Cl2
_ 78 to 20 °C
12 h
not formed
OR1
OSiMe3Me3SiO
22d,g,h,i,l
+
R2
OEt O
R O
OMe
125a-c
OH O
OR1
R2
R O
OMe
127a-g
Eq 31
OH O
OR1
R2
RO
MeO
 
 
Compounds 126a-c (Table 14) are 2-hydroxyterephthalates having no substituent located at 
C3 and C6. Compounds 127a-g (Table 15) are substituted 3-hydroxyphthalates having no 
substituents at C5.  Both categories of molecules are considered as functionalized salicylates.  
 
Results and discussions 
 
57 
 
OH O
OMe
RO
MeO
126a-c  
Table 14: Products and yields 126a-c.  
125,126 R % (126)a 
a H 40 
b Me 45 
c Et 47 
                                                                                           a Yields of isolated products 
 
 
 
 
 
 
Table 15: Products and yields of 127a-g. 
22 125 127 R R1 R2 % (127)a 
d a a H Me Me 42 
g a b H Et Et 45 
h a c H Me n-Bu 43 
l a d H Me n-Oct 45 
d b e Me Me Me 45 
i b f Me Me n-Pent 46 
d c g Et Me Me 48 
                                                                   a Yields of isolated products 
 
OH O
OR1
R2
R O
OMe
127a-g
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2.2.4.1 Structural proof: 
The terephthalate 126a was previously prepared by anodic monohydroxylation of dimethyl 
terephthalate in 47% yield [81]. the obtained spectroscopic data are in full agreement with 
those reported.  The comparison of these data with those reported for 126a [81] and for its 
phthalate regioisomer, reported also in the literature [96d], confirmed the structure for 126a.  
The structure of terephthalate 126b was confirmed by the two singlets observed at δ = 7.41 
ppm and 7.62 ppm (Fig. 22), the same also was noticed for 126c. The phthalate regioisomers 
of 126b [154] and 126c [95e] are known and their spectroscopic data are, as expected, 
different from terephthalates 126b and 126c. 
The regioselectivity noticed for compounds 126a-c could be explained by the higher 
electrophilicity of the carbonyl group located next to the ester group, which also forms a 
chelate with TiCl4.  
The change of the regioselectivity in the formation of compounds 127a-g might be explained 
by steric reasons (interaction of substituent R2 with the ester group of the enone). 
Compound 127e was previously reported and its spectroscopic data are in agreement with the 
obtained data [96f].  
 
3-Hydroxyphthalates 127a-g show a singlet at approx. 7.10 ppm which can be assigned to 
proton H-5 located meta to the ester group. In contrast, the signals of protons located ortho to 
an ester group are generally shifted more downfield. 
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Figure 22: 1H NMR spectrum (300 MHz, CDCl3) of 126b. 
 
1H,1H NOE experiments were  performed for compounds 127g and 127e. For 127g, it was 
observed that the aromatic proton, which resonates at δ = 7.13 ppm as a singlet, correlates 
with the PhCH3 protons (Fig. 23 and 24), which resonate at δ = 2.19 ppm as a singlet. In 
addition it correlates with both groups of protons of the ethyl side chain PhCH2CH3.  
OH O
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H3C
O
OCH3
CH3CH2
H
OH O
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OCH3
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Figure 23: 1H,1H NOE correlations of 127g and 127e. 
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Figure 24: 1H,1H NOE Spectrum of 127g. 
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2.3 Regioselective synthesis of functionalized 4-nitro- and 4-aminophenols based on 
formal [3+3] cyclocondensations of 3-ethoxy-2-nitro-2-en-1-ones with 1,3-bis(silyloxy)-
1,3-butadienes: 
 
The great importance of 4-nitro- and 4-aminophenols in pharmaceutical and natural product 
chemistry has attracted my attention to find a new synthetic method for their regioselective 
and reliable synthesis. 
 
2.3.1 Target, problems to solve and strategy: 
Hefner et al. have reported [3+3] cyclocondensation of symmetrical nitro substitited 3-
silyloxy-2-en-1-one with 1,3-bis(silyloxy)-1,3-butadienes [112] to give nitrophenols followed 
by reduction to get 4-aminophenols. The scope of the reaction was limited to symmetrical 
substrates. My task was to develop a more versatile protocol. 
My approach is based on the cyclization of unsymmetrical 3-alkoxy-2-nitro-2-en-1-ones with 
1,3-bis(silyloxy)-1,3-butadienes (Scheme 20) to give functionalized 4-nitrophenols under 
mild conditions, followed by the catalytic reduction of these nitrophenols to get 4-
aminophenols. 
 
 
 
 
 
Scheme 20: Retrosynthesis of 4-nitro- and 4-aminophenols. 
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2.3.2 Regioselective synthesis of functionalized 4-nitro- and 4-aminophenols by formal 
[3+3] cyclocondensations of 1,3-bis(silyloxy)-1,3-butadienes with 3-ethoxy-2-nitro-2-en-
1-ones and subsequent catalytic hydrogenation: 
Aryl phenolates 129a-c were previously reported [155] and were synthesized from the 
corresponding aroyl chlorides 128a-c [156].  
The base mediated reactions of 129a-c with nitromethane [157] gave the -
nitroacetophenones 130a-c, (Scheme 21, Table 16), which have also been earlier reported 
[157,158].  
The reflux of 130a-c in a mixture of triethyl orthoformate and acetic anhydride afforded the 3-
ethoxy-2-nitro-2-en-1-ones 131a-c as mixtures of E/Z regioisomers (Scheme 21, Table 16). 
 
O
ArPhO
O
ArCl
Ar
O2N
O
OEt
Ar
O
O2N
PhOH
60 °C
128a-c 129a-c 130a-c 131a-c
CH3NO2
t-BuOK, 12 h
DMSO, 0-10 °C
AC2O, HC(OEt)3
120 °C, 6 h
 
Scheme 21: Synthesis of 3-alkoxy-2-nitro-2-en-1-ones 131a-c. 
 
Table 16: Products and yields of 131a-c. 
129,130, 131 Ar %(131)a 
a Ph 81 
b 2-MeC6H4 81 
c 2-ClC6H4 82 
                                                                               a Yields of isolated products 
 
The TiCl4-mediated formal [3+3]cyclizations of 1,3-bis(silyloxy)-1,3-butadienes 22a,d,g,h,l 
with 3-ethoxy-2-nitro-2-en-1-ones 131a-c (Scheme 22, Table 17) gave 4-nitrophenols 132a-i  
in good to very good yields. The other regioisomers were not formed. 
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The hydrogenation of the nitrophenols 132a-i, catalyzed by Pd/C (10 mol%)  (Scheme 22, 
Table 17), afforded the corresponding aminophenols 133a-i in excellent yields. 
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TiCl4
CH2Cl2
_ 78 to 20 °C
14 h
H2, Pd/C (10 mol%)
20°C, 48 h
OOH
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R2
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Ar
 
Scheme 22: Synthesis of 4-nitro- and 4-aminophenols 132a-i, 133a-i. 
 
 
Compounds 132a-i are 4-nitrophenols. They can be also considered as functionalized biaryls. 
Furthermore, they are nitro-biaryls, which were reported to possess a wide spectrum of 
pharmaceutical applications [107]. Compounds 133a-i are the corresponding amino 
derivatives of 132a-i. These compounds could be starting substrates for many synthetic 
targets. The synthesis of 3-alkyl-4-nitro and 3-alkyl-4-aminophenols is now under 
investigation.  
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Table 17: Products and yields of 132a-i and 133a-i. 
 
 
 
 
 
 
 
 
 
 
 
 
                      a Yields of isolated products. 
 
Generally, the yields increased when a C4-substituted diene was used.  No regular effect on 
the yield was observed with variation of the aryl group. Excellent yields of the aminophenols 
were obtained. 
 
2.3.2.1 Structural proof: 
1H,1H NOE experiments were done for compounds 132b and 132d. For 132d, it was observed 
that the aromatic proton, which resonates at δ = 7.68 ppm as a singlet, correlates with the 
PhCH2 protons (Fig. 25 and 26) which resonate at δ = 2.64 ppm as a triplet. In addition, it 
correlates with CH2 protons of the butyl side chain PhCH2CH2.  
 
131 22 132, 133 Ar R1 R2 % (132)a % (133)a 
a a a Ph Me H 56 86 
a d b Ph Me Me 57 85 
a g c Ph Et Et 65 96 
a h d Ph Me n-Bu 58 91 
a l e Ph Me n-Oct 62 90 
b a f 2-MeC6H4 Me H 68 90 
b d g 2-MeC6H4 Me Me 72 89 
c a h 2-ClC6H4 Me H 56 88 
c d i 2-ClC6H4 Me Me 70 89 
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Figure 25: 1H, 1H NOE correlations of 132b and 132d. 
 
It was noticed from 1H NMR spectroscopy that the OH groups in compounds 132a-i resonate 
in the range (δ = 11.07-11.79) ppm, while for compounds 133a-i they appear in the range of  
δ = 9.98-10.42 ppm. This difference could be attributed to the electron withdrawing nature of 
the nitro group, the donating effect of the amino group as well as the presence of the 
intermolecular hydrogen bonding.  The NH2 protons appear as broad singlets in the range of δ 
= 3.02-3.09 ppm. Generally, OCH3 groups in compounds 133a-i are slightly more downfield 
shifted than those of the corresponding amino derivatives.  
In the 13C NMR spectra, the carbon of the C-OH group in compounds 132a-i appear in the 
range of δ = 162.0-164.4 ppm, while for compounds 133a-i, they appear between δ = 152.8-
154.7 ppm.  
The aromatic protons of the phenol rings of 132a resonate at δ = 7.02 and 7.82 ppm as 
doublets with coupling constants 3J = 9.0 Hz and 3J = 8.9 Hz which are assigned for ortho-
coupling. The same was noticed for both 132f and 132h. 
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Figure 26: 1H,1H NOE Spectrum of 132d. 
 
The regioselectivity observed here resulted from the initial addition of the C4 nucleophilic 
center of the diene to the conjugate position of the enone. 
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2.3.2.2 X-ray analysis: 
Another proof of the regioselectivity came from the X-ray crystal structure analyses (Fig. 27) 
of compounds 132i.  
The reported bond lengths NO are: d(N-O) =1.45 oA and d(N=O) =1.17 oA [159], for 
compound 132i the bond lengths are: d (O(4)-N(1)) = 1.2255(17) oA and d ((5)-N(1)) = 
1.2211(19) oA, which lies between the values for the single and double bond. This is due to 
the partial double bond character of NO in NO2.  
 
The O-H group in compound 132i is involved in both inter- and intramolecular hydrogen 
bonding (Fig. 28, Table 18).  
 
 
 
 
 
 
 
 
 
 
 
Figure 27: ORTEP plot of 132i and (50% level). 
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Figure 28: Inter -and intra-molecular hydrogen bonding in 132i. 
 
Table 18:  Hydrogen bonds for 132i [Å and °]. 
        D-H...A d(D-H) d(H...A) d(D...A) <(DHA) 
 O(3)-H(3O)...O(1) 0.91(3) 1.81(3) 2.6299(18) 150(3) 
 O(3)-H(3O)...O(1)#1 0.91(3) 2.60(3) 3.2021(17) 125(2) 
 
 
There are four symmetry independent molecules in the asymmetric unit of 133a (Fig. 29, 30 
and 31) which form a very special network of hydrogen bonds.  
The molecules can be distinguished by the help of the angles between their aromatic rings or 
the dihedral angle of the respective atoms (Table 19). 
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Figure 29: ORTEP plot of molecule A (1 of the four symmetry independent molecules) in 133a. 
 
 
Figure 30: Crystal structure of 133a (view almost along the b- and screw axis, molecules A: green, B: blue, C: 
red, D: yellow). 
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Table 19: Differences between the four symmetry independent molecules in 133a with estimated standard 
deviations in parentheses. 
Molecule Angle between aromatic rings Dihedral angle 
A(green) 76.45(0.09) C1A-C6A-C9A-C10A: 73.27(0.26) 
B(blue) 58.55(0.09) C15B-C20B-C23B-C24B: 57.49(0.24) 
C(red) 66.93(0.07) C29C-C34C-C37C-C42C: -64.03(0.23) 
D(yellow) 68.92(0.08) C43D-C48D-C51D-C52D: 67.95(0.24) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 31: ORTEP plot of the asymmetric unit of 133a. 
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Although there is a total of 12 different bond lengths for the hydrogen bonds, there are only 
five different symmetry operators for generating equivalent atoms in neighboring molecules.  
 
This means that there are some common patterns of hydrogen bond types (Table 20). All four 
molecules form rows of hydrogen bonded molecules along the b-axis via the hydrogen atoms 
of the amino groups as donor and the carbonyl oxygen atoms of the next molecule as 
acceptor.  
 
The OH-protons point in any case to the nitrogen of the amino group of a neighbor molecule. 
This is done in pairs, i.e. the OH group in an A molecule points to the N-atom in molecule B 
(the symmetry code being x+1, y-1, z), the OH in B to a nitrogen in a neighboring molecule A 
with symmetry code -x+1, y-1/2, -z+1/2 thus forming tubes of hydrogen bonded molecules 
around a screw axis. In a similar manner C and D type molecules are arranged about another 
screw axis. However, since there is an inter-molecular hydrogen bond between H12D of the 
OH group in molecule D and the nitrogen N3C in molecule C of the same asymmetric unit, 
only three symmetry operators ($1, $3 and $4) are needed here.    
  
Unfortunately the position of the OH protons could not be elucidated from the difference map. 
Therefore in this case there is no estimated standard deviation for the distances D-H, H…A 
and the angle DHA. On the other hand all hydrogen atoms of the four amino groups could be 
taken from the difference map.   
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Table 20: Distances (Å) and angles (deg) for the hydrogen bonds in 133a with estimated standard deviations 
in parentheses. 
Involved atoms D-H H…A D…A Angle DHA 
O3A-H3A...N2B_$1a 0.82 2.05 2.865(2) 169.8 
N1A-H1NA...O1A_$2 0.91(3) 2.20(3) 2.844(3) 127(2) 
N1A-H2NA...O3A_$2 0.89(3) 2.32(3) 3.167(2) 159(3) 
O6B-H6B...N1A_$3 0.82 2.02 2.840(2) 175.1 
N2B-H2NB...O4B_$2 0.84(3) 2.47(3) 3.068(3) 129(2) 
N2B-H1NB...O6B_$2 0.89(3) 2.22(3) 3.095(2) 168(3) 
O9C-H9C...N4D_$4 0.82 2.06 2.877(2) 171.2 
N3C-H2NC...O9C_$5 0.91(3) 2.30(3) 3.170(2) 160(2) 
N3C-H1NC...O7C_$5 0.88(3) 2.17(3) 2.807(2) 129(2) 
O12D-H12D...N3C 0.82 2.01 2.828(2) 174.6 
N4D-H2ND...O12D_$5 0.87(3) 2.30(3) 3.163(2) 168(3) 
N4D-H1ND...O10D_$5 0.81(3) 2.46(3) 2.976(2) 122(2) 
aThe symmetry codes can be seen from (Table 21) 
 
 
Table 21: Operators and symmetry codes for generating equivalent atoms or molecules. 
Operator symmetry code 
$1 x+1, y-1, z 
$2 x, y+1, z 
$3 -x+1, y-1/2, -z+1/2 
$4 -x+1, y+3/2, -z+1/2 
$5 x, y-1, z 
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2.4 Synthesis of functionalized diaryl selenides by the first [3+3] cyclocondensations of 
1,3-bis(silyloxy)-1,3-butadienes with organoselenium compounds: 
 
Diaryl selenides play an important role in pharmaceutical chemistry; this was reviewed 
[127b]. Finding reliable methods for the direct synthesis of highly functionalized diaryl 
selenides is a demanding task.   
 
2.4.1 Target, problems to solve and strategy: 
The few reported methods for the synthesis of diaryl selenides starting with “acyclic 
precursors” suffer from the fact that the availability of these starting precursors is a tedious 
task and their substitution pattern is limited.  
 
My strategy to overcome the previous drawbacks rely on the construction of these 
functionalized arenes by [3+3] cyclization reactions (Scheme 23) of 1,3-bis(silyloxy)-1,3-
butadienes with phenylselanyl substituted 3-silyloxy-2-en-1-ones and 3-alkoxy-2-en-1-ones.  
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Scheme 23: Retrosynthesis of diaryl selenides. 
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2.4.2 Synthesis of functionalized diaryl selenides by [3+3] cyclocondensations of 1,3-
bis(silyloxy)-1,3-butadienes with symmetrical 3-silyloxy-2-phenylselanyl-2-en-1-ones: 
 
The sulfuric acid catalyzed reaction of diketones 134a,b with selenium dioxide and diphenyl 
diselenide (Scheme 24) afforded the phenylselanyl-substituted 1,3-diketones 135a,b in 
relatively good yields.  
The synthesis of 135a has been previously reported [160]. The base mediated silylation  of 
135a,b (Scheme 24) using chlorotrimethylsilane as a silylating agent afforded the novel 
phenylselanyl substituted 3-silyloxy-3-en-1-ones 136a,b in high yields. 
 
R
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SePh
RR
OO
R R
OMe3SiO
SePh
R
134a,b 135a (R = Me): 52%
135b (R = Et) : 47%
PhSeSePh
SeO2
H2SO4 (cat.)
CH2Cl2
10 to 20 °C
Me3SiCl
C6H4, NEt3
20 °C
136a (R = Me): 90%
136b (R = Et) : 91%  
 
Scheme 24: Synthesis of 3-silyloxy-2-phenylselanyl-2-en-1-ones. 
 
The formal [3+3] cyclizations of 1,3-bis(silyloxy)-1,3-butadienes 22a,b,d,f,h,j,k,l with 
symmetrical 3-silyloxy-2-phenylselenayl-2-en-1-ones 136a,b, mediated by TiCl4 (Eq. 32, 
Table 20), afforded the diaryl selenides 137a-j in good to very good yields.  
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These cyclizations were done using the equivalent ratio of reactants (136/22/ TiCl4) 
(1.0/1.1/1.1), in concentrated solutions (2 ml of extra dry CH2Cl2/1  mmol of 136). 
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Compounds 137a-j could be considered as unsymmetrical diaryl selenides. These 4-
(phenylselanyl)phenols have the same substituents at C3 and C5.  
 
OOH
OR1
R
Se
R2
R
137-j  
Table 22: Products and yields of 137a-j. 
136 22 137 R R2 R1 %(137)a 
a a a Me H Me 59 
a b b Me H CH2CH2OCH3 57 
a d c Me Me Me 68 
a f d Me Et Me 70 
a h e Me n-But Me 69 
a j f Me n-Hex Me 62 
a k g Me n-Hep Me 62 
a l h Me n-Oct Me 59 
b a i Et. H Me 56 
b b j Et. H CH2CH2OCH3 55 
b c k Et H CH2C6H5 0 
a w l Me Cl Et 0 
b o m Et OMe Me 0 
                        a Yields of isolated products 
 
 
Generally, when C4-substituted dienes were used, the yields increased. No regular 
dependence of the yield on the side chain length of the diene was noticed. Trials to cyclize the 
dienes 22c,w,o  failed and the starting precursors were recovered. Yields also were relatively 
low when 136b was used as dielectrophile. This could be due to steric factors. 
No issue of regioselectivity is encountered here. 
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My attempts to prepare unsymmetrical 3-alkoxy-2-phenylselanyl-2-en-1-ones, unfortunately, 
failed. 
 
2. 4.2.1 X-ray analysis: 
The structure of 137b was confirmed by X-ray crystal structure analyses (Fig. 32, Table 23). 
The OH group is involved in intramolecular hydrogen bonding. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 32: ORTEP plot of 137b and (50% level). 
 
The angle C16A—O4A—C17A was found to be 113.1 (7) o, while its for C7—Se1—C1 
100.73 (10)o. The dihedral angle (C7—Se1—C1—C6) is 100.4 (2) °. 
 
Table 23: Hydrogen bonds for 137b [Å and °]. 
 
D-H...A d(D-H) d(H...A) d(D...A) <(DHA) 
 O(1)-H(1)...O(2) 0.87 (4) 1.69(4) 2.536 (3) 165 (3) 
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Part 3: Experimental part: 
 
3.1 General: Equipment, chemicals and work techniques:  
 
3.1.11H NMR spectroscopy:  
Bruker: AM 250, Avance 250, AC 250 (250 MHz); ARX 300, Avance 300 (300 MHz); 
Varian VXR 500 S, Avance 500 (500 MHz); δ = 0.00 ppm for Tetramethylsilane; δ = 2.04 
ppm for Acetone d-6; δ = 7.26 ppm for Deuterochloroform (CDCl3) and δ = 2.50 ppm for 
DMSO- d6; Multiplicities are given as follows: s = singlet, d = doublet, t = triplet, q = quartet,  
m = multiplet, br = broad signals. More complex coupling patterns are represented by 
combinations of the respective symbols. For example, td indicates a triplet of doublets with 
the larger coupling constant associated with the first symbol (here: triplet).  Spectra were 
evaluated according to first order rule. All coupling constants are indicated as (J). 
3.1.2 13C NMR spectroscopy:  
Bruker: AM 250, Avance 250, AC 250 (62.9 MHz); ARX 300, Avance 300 (75 MHz); Varian 
VXR 500 S, Avance 500 (125 MHz); δ = 128.00 ppm for Acetone d-6; δ = 77.00 ppm for 
CDCl3, δ = 39.7 ppm for DMSO- d6. The multiplicity of the carbon atoms was determined by 
the DEPT 135 and APT technique (APT = Attached Proton Test) and quoted as CH3, CH2, 
CH and C for primary, secondary, tertiary and quaternary carbon atoms. Characterization of 
the signal fragmentations: quart = quartet the multiplicity of the signals was determined by the 
DEPT recording technology and/or the APT recording technology. 
3.1.3 Mass spectrometry (MS):  
AMD MS40, Varian MAT CH 7, MAT 731 (EI, 70 eV), Intecta AMD 402 (EI, 70 eV and 
CI), Finnigan MAT 95 (CI, 200 eV).  
3.1.4 High resolution mass spectroscopy:  
Finnigan MAT 95 or Varian MAT 311;  Bruker  FTCIR, AMD 402 (AMD Intectra). 
3.1.5 Infrared spectroscopy (IR):  
Bruker IFS 66 (FT IR), Nicolet 205 FT IR; Nicolet Protege 460, Nicolet 360 Smart Orbit 
(ATR); KBr, KAP, Nujol, and ATR; Abbreviations for signal allocations: w = weak, m = 
medium, s = strong, br = broad. 
3.1.6 Elementary analysis:  
LECO CHNS-932, Thermoquest Flash EA 1112. 
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3.1.7 X-ray crystal structure analysis:  
Bruker X8Apex Diffractometer with CCD-Kamera (Mo-Ka und Graphit Monochromator, 
λ = 0.71073 Å). The space group is determined by the XPREP program and the structures 
were solved via the SHELX-97 program package. Refinements were carried out according to 
the minimum square error method.  
3.1.8 Melting points:  
Micro heating table HMK 67/1825 Kuestner (Büchi Apparatus), Leitz Labolux 12 Pol with 
heating table Mettler FP 90. Melting points are uncorrected.  
3.1.9 Column chromatography:  
Chromatography was performed over Merck silica gel 60 (0,063 -0,200 mm, 70 - 230 mesh) 
as normal and/or over mesh silica gel 60 (0,040 - 0,063 mm, 200 -400 mesh) as Flash 
Chromatography. All solvent were distilled before use. 
3.1.10 Thin layer chromatography (TLC): 
Merck Kieselgel 60 F254 on aluminium foil from Macherey-Nagel. Detection was carried out 
under UV light at 254 nm and 365 nm. As colourizing reagent the following mixtures were 
used: 1-2/100 p-Anisaldehyde or vanillin, 10/100 glacial acetic acid, 5/100 sulphuric acid, 83-
84/100 methanol.  
3.2 Chemicals and work techniques: 
All solvents for using were distilled by standard methods. All reactions were carried out under 
an inert atmosphere, oxygen and humidity exclusion. Schlenk techniques were applied. All of 
the chemicals are standard, commercially available from Merck®, Aldrich®, Arcos® and 
others. The order of the characterized connections effected numerically, but does not 
correspond to the order in the main part of the dissertation. 
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3.3 Procedures:  
3.3.1 General procedure for the [3+3] cyclocondensations of 1,3-bis(silyloxy)-1,3-
butadienes with dielectrophiles; synthesis of 107a-m, 110a-ae, 113a-i, 118a-n, 126a-c, 
127a-g, 132a-i and 137a-j: 
To a CH2Cl2 solution (2 mL / 1.0 mmol of the dielectrophile) of the dielectrophile (1.0 equiv.) 
was added 22 (1.1 equiv.) and, subsequently, TiCl4 (1.1equiv.) at 	78 °C. The temperature of 
the solution was allowed to warm to 20 °C during 14 h with stirring. To the solution was 
added hydrochloric acid (10%, 20 mL) and the organic and the aqueous layer were separated. 
The later was extracted with CH2Cl2 (3 x 20 mL). The combined organic layers were dried 
(Na2SO4), filtered and the filtrate was concentrated in vacuo. The residue was purifed by 
chromatography (silica gel, n-heptane / EtOAc) to give product the products.  
 
3.3.2 General procedure for the synthesis of 1-hydroxy2,4-benzodioates 109b,c:  
β-Ketoester was added to a mixture of  triethyl orthoformate and acetic anhydride and the 
mixture was heated under reflux for 2 hours. The mixture was purified by distillation to give 
109b,c  
3.3.3 General procedure for the synthesis of alkyl 4-ethoxy-2-oxo-3-butbutenoates 125a-
c: 
To alkyl vinyl ether 123a-c (2.0 equiv.) is dropwise added during 20 minutes methyl 
chlorooxoacetate (1.0 equiv.) under Argon at 0 °C. The mixture was stirred for at 0 °C for 3 h. 
The temperature was allowed to warm to 20 °C during 15 h with stirring. The mixture was 
distilled in vacuo, to give 125a-c. The synthesis of 125a has been previously reported [153]. 
3.3.4 General procedure for the synthesis of 3-ethoxy-2-nitro-1-phenylprop-2-en-1-ones 
131a-c:  
To a solution of 130a-c in acetic anhydride (2.0 equiv / 1.0 equiv of 130a-c) was added 
triethyl orthoformiate (1.2 equiv). The solution was stirred at 120 °C for 6 h. The solvent was 
concentrated in vacuo and the residue was purified by chromatography (silica gel, heptanes / 
EtOAc) to give 131a-c.  
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3.3.5 General procedure for the synthesis of 4-aminophenols 133a-i: 
To a methanol suspension (25 mL/1 mmol of 132a-i) of 132a-i (1.0 equiv.) or an ethanol 
suspension of 132c (1.0 equiv.) was added Pd/C (10 mol-%, 0.1 equiv.). The mixture was set 
under a hydrogen atmosphere. After stirring for 48 h at 20 °C, the reaction mixture was 
filtered (Celite) and the filtrate was concentrated in vacuo. The residue was purified by 
chromatography (silica gel, heptanes/EtOAc = 2:1). 
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3.4 Spectroscopic data of the synthesized compounds: 
 
1-Ethyl 3-methyl 5-hexyl-4-hydroxy-2,6-imethylisophthalate (107d): 
Starting with 106 (0.489 g, 2.0 mmol) and 22j (0.758 g, 2.2 mmol), 107d was isolated after 
chromatography (silica gel, heptanes/EtOAc) as a colourless viscous oil (0.236 g, 35%).        
1H NMR (250 MHz, CDCl3):  = 0.81 (t(br), 3J = 7.4 Hz, 3 
H, CH3), 1.19 − 1.25 (m, 8 H, 4 CH2), 1.31 (t, 3J = 7.6 Hz, 3 
H, OCH2CH3), 2.16 (s, 3 H, PhCH3), 2.34 (s, 3 H, PhCH3), 
2.59 (t, 3J = 7.4 Hz, 2 H, PhCH2), 3.88 (s, 3 H, OCH3), 4.32 
(q, 3J = 7.6 Hz, 2 H, OCH2CH3), 11.40 (s, 1 H, OH). 13C 
NMR (75 MHz, CDCl3):  = 15.2, 15.3, 18.0, 21.0 (CH3), 
23.7, 27.3, 29.7, 32.4, 34.4 (CH2), 53.6 (OCH3), 62.3 (OCH2CH3), 111.1, 129.3, 130.0, 135.1, 
140.0 (CAr), 161.9 (COH), 171.8, 173.5 (CO). IR (neat, cm-1): ν̃ = 2962 (m), 1723 (m), 1663 
(m), 1439 (m), 1394 (m), 1229 (s), 1194 (s), 1151 (s), 1101 (m), 1033 (m), 844 (w), 723 (w). 
GC-MS (EI, 70 eV): m/z (%) = 336 ([M+], 49), 289 (100), 276 (87), 259 (19), 234 (54), 206 
(31), 187 (43), 178 (13), 159 (6), 91 (9), 77 (8), 43 (7). HRMS (EI): Calcd. for C19H28O5: 
336.19313; found: 336.19263. 
1-Ethyl 3-methyl 4-hydroxy-2,6-dimethyl-5-nonylisophthalate (107e):  
Starting with 106 (0.489 g, 2.0 mmol) and 22m (0.851 g, 2.2 mmol), 107e was isolated after 
chromatography (silica gel, n-heptane/EtOAc) as a yellowish oil (0.302 g, 40%).  
1H NMR (250 MHz, CDCl3): δ = 0.80 (t, 3J = 7.3 Hz, 3 H, 
(CH2)8CH3), 1.19 - 1.24 (m, 14 H, 7 CH2), 1.31 (t, 3J = 7.3 
Hz, 3 H, OCH2CH3), 2.15 (s, 3 H, PhCH3), 2.34 (s, 3 H, 
PhCH3), 2.57 (t, 3J = 6.7 Hz, 2 H, PhCH2), 3.87 (s, 3 H, 
OCH3), 4.30 (q, 3J = 7.1 Hz, 2 H, OCH2CH3), 11.48 (s, 1 H, 
OH). 13C NMR (CDCl3, 75 MHz):  = 14.0, 14.1, 16.8, 20.0 
(CH3), 22.6, 26.1, 28.8, 29.3, 29.5, 29.6, 29.9, 31.8 (CH2), 52.2 (OCH3), 61.3 (OCH2), 109.9 
(CCOOCH3), 128.1 (COOC2H5), 128.8, 133.8, 138.8 (CAr), 160.7 (COH), 170.6, 172.3 (CO). 
IR (neat, cm-1): ν̃ = 2953 (w), 2922 (m), 2852 (w), 1725 (m), 1657 (m), 1598 (w), 1572 (w), 
1439 (m), 1411 (w), 1362 (m), 1328 (m), 1267 (m), 1217 (s), 1192 (m), 1155 (m), 1123 (m), 
1094 (w), 1073 (w), 1033 (m), 972 (w), 858 (w), 809 (m), 756 (w), 684 (w), 662 (w), 580 (w), 
541 (w). GC-MS (EI, 70 eV): m/z (%) = 378 ([M]+, 52), 333 (20), 332 (118), 331 (100), 329 
OH O
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O OCH2CH3
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(17), 318 (29), 301 (10), 275 (14), 235 (10), 234 (60), 233 (38), 206 (41), 187 (24). HRMS 
(EI): Calcd. for C22H34O5 ([M]+): 378.240088; found: 378.239837. 
 
1-Ethyl 3-methyl 5-decyl-4-hydroxy-2,6-dimethylisophthalate (107f): 
Starting with 106 (0.489 g, 2.0 mmol) and 22n (0.882 g, 2.2 mmol), 107f was isolated after 
chromatography (silica gel, n-heptane/EtOAc) as a yellowish oil (0.321 g, 41%). 
 1H NMR (250 MHz, CDCl3) : δ = 0.80 (t, 3J = 7.3 Hz, 3 H, 
(CH2)9CH3), 1.13 - 1.23 (m, 16 H, 8 CH2), 1.30 (t, 3J = 7.3 
Hz, 3 H, OCH2CH3), 2.15 (s, 3 H, PhCH3), 2.33 (s, 3 H, 
PhCH3), 2.57 (t, 3J = 6.7 Hz, 2 H, PhCH2), 3.87 (s, 3 H, 
OCH3),  4.30 (q, 3J = 7.2 Hz, 2 H, OCH2CH3), 11.47 (s, 1 H, 
OH). 13C NMR (CDCl3, 75 MHz):  = 14.0, 14.1, 16.8, 20.0 
(CH3), 22.6, 26.1, 28.8, 29.3, 29.5, 29.6, 29.6, 29.9, 31.8 (CH2), 52.2 (OCH3), 61.3 (OCH2), 
109.9 (CCOOCH3), 128.1 (COOC2H5), 128.8, 133.8, 138.9 (CAr), 160.7 (COH), 170.6 172.3 
(CO). IR (neat, cm-1): ν̃ = 2953 (w), 2922 (m), 2852 (w), 1725 (m), 1657 (m), 1597 (w), 1572 
(w), 1439 (m), 1409 (w), 1362 (m), 1328 (m), 1264 (m), 1216 (s), 1191 (m), 1155 (m), 1123 
(m), 1093 (w), 1070 (w), 1033 (m), 959 (w), 858 (w), 808 (m), 761 (w), 721(w), 685 (w), 662 
(w), 580 (w), 539 (w). GC-MS (EI, 70 eV): m/z (%) = 392 ([M]+, 42), 347 (23), 346 (24), 345 
(100), 343 (22), 332 (17), 315 (10), 275 (13), 261 (10), 235 (10), 234 (51), 233 (38), 206 (40), 
177 (11), 43 (13). HRMS (EI): Calcd. for C23H36O5 ([M]+): 392.25573; found: 392.255696. 
 
Diethyl 4-hydroxy-2,6-dimethyl-5-phenoxyisophthalate (107h): 
Starting with 106 (0.489 g, 2.0 mmol) and 22v (0.807 g, 2.2 mmol), 107h was isolated after 
chromatography (silica gel, n-heptane/EtOAc) as a reddish viscous oil (0.344 g, 48%). 
 1H NMR (250 MHz, CDCl3):  = 1.31 (t, 3J = 7.4 Hz, 3 H, 
OCH2CH3), 1.34 (t, 3J = 7.6 Hz, 3 H, OCH2CH3), 2.07 (s, 3 
H, PhCH3), 2.42 (s, 3 H, PhCH3), 4.33 (q, 3J = 7.3 Hz, 2 H, 
OCH2CH3), 4.37 (q, 3J = 7.4 Hz, 2 H, OCH2CH3), 6.76 (d, 
3J = 7.4 Hz, 2 H, CHAr), 6.89 (m, 1 H, CHAr), 6.94 (m, 2 H, 
CHAr), 11.27 (s, 1 H, OH). 13C NMR (62 MHz, CDCl3):  = 
12.7 , 13.1 19.0, 19.2 (CH3), 60.1, 61.1 (OCH2CH3), 110.6 (CCOOC2H5), 113.6 (2 CHAr), 
115.2 (CHAr), 128.7 (CCOOC2H5), 130.7 (2 CHAr), 130.9, 132.6, 137.9, 154.9 (CAr), 156.5 
(COH), 168.2, 169.9 (CO).IR (neat, cm-1): ν̃ = 2979 (w), 1722 (s), 1658 (m), 1489 (m), 1367 
(m), 1261 (m), 1215 (s), 1046 (s), 749 (s), 688 (m).GC-MS (EI, 70 eV): m/z (%) = 358 ([M+], 
OH O
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O OCH2CH3
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63), 312 (64), 283 (100), 267 (21), 240 (12), 211 (6), 181 (5), 161 (11), 105 (61), 77 (22). 
HRMS (EI): Calcd. for C20H22O6: 358.14109; found: 358.14174. 
 
3-Ethyl 5-methyl 6-hydroxy-2,4,4'-trimethylbiphenyl-3,5-dicarboxylate (107i):  
Starting with 106 (0.489 g, 2.0 mmol) and 22q (0.771 g, 2.2 mmol), 107i was isolated after 
chromatography (silica gel, n-heptane/EtOAc) as a yellowish 
oil (0.260 g, 38%).  
1H NMR (250 MHz, CDCl3): δ = 1.24 (t, 3J = 7.0 Hz, 3 H, 
OCH2CH3), 1.90 (s, 3 H, PhCH3), 2.27 (s, 3 H, PhCH3), 2.36 
(s, 3 H, PhCH3), 3.83 (s, 3 H, OCH3), 4.26 (q, 3J = 7.0 Hz, 2 
H, OCH2CH3), 6.94 - 6.97 (m, 2 H, CHAr), 7.02 - 7.08 (m, 2 
H, CHAr), 11.18 (s, 1 H, OH). 13C NMR (CDCl3, 75 MHz):  
= 14.1, 18.2, 20.1, 21.2 (CH3), 52.3 (OCH3), 61.2 (OCH2), 110.6 (CCOOCH3), 128.8 (CAr), 
129.0 (CCOOC2H5), 129.2 (2 CHAr), 129.7 (2 CHAr), 133.0 (CAr), 135.8, 137.0, 139.5 (CAr), 
160.1 (COH), 170.1, 171.9 (CO). IR (neat, cm-1): ν̃ = 2954 (w), 2929 (w), 2871 (w), 1721 
(m), 1658 (m), 1598 (w), 1568 (w), 1513 (w), 1438 (m), 1363 (w), 1330 (m), 1213 (s), 1203 
(s), 1098 (m), 1075 (w), 1035 (m), 958 (w), 923 (w), 842 (w), 821 (w), 809 (m), 760 (w), 729 
(w), 710 (w), 686 (w), 666 (w), 611 (w), 580 (w), 539 (w). GC-MS (EI, 70 eV): m/z (%) = 
342 ([M]+, 50), 310 (100), 297 (17), 282 (22), 265 (13), 253 (12),  236 (11),  209 (16), 165 
(14), 119 (5), 43 (5). HRMS (EI): Calcd. for C20H22O5 ([M]+): 342.14618; found: 342.146101. 
 
3-Ethyl 5-methyl 4'-chloro-6-hydroxy-2,4-dimethyl-biphenyl-3,5-dicarboxylate (107j): 
Starting with 106 (0.489 g, 2.0 mmol) and 22r (0.816 g, 2.2 mmol), 107j was isolated after 
chromatography (silica gel, n-heptane/EtOAc) as a yellowish 
oil (0.270 g, 37%).  
1H NMR (250 MHz, CDCl3): δ = 1.16 (t, 3J = 6.9 Hz, 3 H, 
OCH2CH3), 1.78 (s, 3 H, PhCH3), 2.27 (s, 3 H, PhCH3),  3.74 
(s, 3 H, OCH3), 4.16 (q, 3J = 6.9 Hz, 2 H, OCH2CH3), 6.89 - 
6.93 (m, 2 H, 2 CHAr), 7.02 - 7.08 (m, 2 H, 2 CHAr), 11.26 
(S, 1 H, OH). 13C NMR (CDCl3, 75 MHz):  = 15.1, 19.1, 
21.2 (CH3), 53.3 (OCH3), 62.2 (OCH2), 111.5 (CCOOCH3), 128.7 (CAr), 129.6 (2 CHAr), 
129.9 (CCOOC2H5), 132.2 (2 CHAr), 134.3, 135.5, 137.4, 140.3 (CAr), 160.0 (COH), 170.8, 
172.8 (CO). IR (neat, cm-1): ν̃ = 2954 (w), 2930 (w), 2871 (w), 1722 (m), 1658 (m), 1604 (w), 
1591 (w), 1571 (w), 1491 (w), 1438 (m), 1408 (w), 1363 (w), 1329 (m), 1204 (s), 1100 (m), 
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1086 (m), 1034 (m), 1014 (m), 985 (w), 957 (w), 831 (m), 809 (m), 758 (w), 689 (w), 665 
(w), 612 (w), 579 (w). GC-MS (EI, 70 eV): m/z (%) = 364 ([M+], 37Cl, 12), 362 ([M+], 35Cl, 
39), 332 (37Cl, 29), 331 (23), 330 (35Cl, 100), 317 (15), 302 (18), 285 (12), 274 (8), 165 (14), 
128 (6), 86 (9),  43 (5). HRMS (EI): Calcd. for C19H19ClO5 ([M]+, 35Cl): 362.09155; found: 
362.090638. 
 
3-Ethyl 5-methyl 6-hydroxy-4'-methoxy-2,4-dimethyl-biphenyl-3,5-dicarboxylate (107k): 
Starting with 106 (0.489 g, 2.0 mmol) and 22s (0.807 g, 2.2 mmol), 107k was isolated after 
chromatography (silica gel, n-heptane/EtOAc) as a yellowish oil (0.245 g, 34%).  
1H NMR (250 MHz, CDCl3): δ = 1.32 (t, 3J = 7.1 Hz, 3 H, 
OCH2CH3), 1.96 (s, 3 H, PhCH3), 2.42 (s, 3 H, PhCH3), 
3.77 (s, 3 H, OCH3), 3.89 (s, 3 H, OCH3), 4.32 (q, 3J = 6.9 
Hz, 2 H, OCH2CH3), 6.88 - 6.93 (m, 2 H, 2 CHAr), 7.02 - 
7.08 (m, 2 H, 2 CHAr), 11.26 (s, 1 H, OH). 13C NMR 
(CDCl3, 75 MHz):  = 14.2, 18.2, 20.1 (CH3), 52.3, 55.3 
(OCH3), 61.2 (OCH2), 110.6 (CCOOCH3), 113.9 (2 CHAr), 128.1 (CAr), 128.7 (CCOOC2H5), 
128.9 (CAr), 130.9 (2 CHAr), 135.8, 139.7 (CAr), 158.8 (CAr), 160.2 (COH), 170.2, 171.9 (CO). 
IR (neat, cm-1): ν̃ = 3033 (w), 2995 (w), 2953 (w), 2906 (w), 2835 (w), 1719 (m), 1656 (w), 
1608 (w), 1509 (s), 1439 (m), 1364 (w), 1331 (m), 1300 (w), 1242 (s), 1207 (s), 1174 (s), 
1100 (m), 1073 (w), 1030 (s), 985 (w), 956 (w), 830 (m), 810 (m), 764 (w), 686 (w), 637 (w), 
581 (w), 555 (w), 526 (m). GC-MS (EI, 70 eV): m/z (%) = 358 ([M]+, 5), 326 (10), 270 (21), 
121 (100), 78 (6). HRMS (EI): Calcd. for C20H22O6 ([M]+): 358.14109; found: 358.140227. 
 
Diethyl 4-hydroxy-2,6-dimethyl-5-(2-tolyloxy)isophthalate (107l):  
Starting with 106 (0.489 g, 2.0 mmol) and 22t (0.837 g, 2.2 mmol), 107l was isolated after 
chromatography (silica gel, n-heptane/EtOAc) as a reddish viscous oil (0.312 g, 42%).  
1H NMR (250 MHz, CDCl3):  = 1.32 (t, 3J = 7.2 Hz, 3 H, 
OCH2CH3), 1.35 (t, 3J = 7.4 Hz, 3 H, OCH2CH3), 2.05 (s, 3 
H, PhCH3), 2.24 (s, 3 H, PhCH3), 2.43 (s, 3 H, PhCH3), 
4.35 (q, 3J = 7.4 Hz, 2 H, OCH2CH3), 4.38 (q, 3J = 7.6 Hz, 
2 H, OCH2CH3), 6.54 (s, 1 H, CHAr), 6.56 (m, 2 H, 2 
CHAr), 6.75 (d, 3J = 7.5 Hz, 1 H, CHAr), 11.20 (s, 1 H, 
OH). 13C NMR (62 MHz, CDCl3):  = 15.6, 16.0, 16.1, 
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21.9, 23.3 (CH3), 63.2, 64.0 (CH2), 113.1 (CHAr), 114.2 (CAr), 117.1, 124.7, 130.5 (CHAr), 
131.3 135.4, 136.8, 140. 9, 141.6 (CAr), 157.8 (COH), 159.4 (CAr), 171.1, 172.8 (CO). 
IR (neat, cm-1): ν̃ = 2979 (m), 1723 (s), 1658 (s), 1586 (m), 1444 (s), 1367 (m), 1321 (s), 1218 
(s), 1139 (s), 1032 (s), 939 (m), 771 (m), 686 (m).  MS (EI, 70 eV): m/z (%) = 372 ([M+], 33), 
326 (49), 297 (84), 281 (12), 254 (13), 225 (4), 119 (100). HRMS (EI): Calcd. for C21H24O6: 
372.15673; found: 372.15665. 
 
Diethyl 4-hydroxy-2,6-dimethyl-5-(3-tolyloxy)isophthalate (107m):  
Starting with 106 (0.489 g, 2.0 mmol) and 22u (0.837 g, 2.2 mmol), 107m was isolated after 
chromatography (silica gel, n-heptane/EtOAc) as a reddish viscous oil (0.382 g, 51%). 
 1H NMR (250 MHz, CDCl3):  = 1.31 (t, 3J = 7.4 Hz, 3 
H, OCH2CH3), 1.35 (t, 3J = 7.6 Hz, 3 H, OCH2CH3), 
2.07 (s, 3 H, PhCH3), 2.22 (s, 3 H, PhCH3), 2.42 (s, 3 H, 
PhCH3), 4.36 (q, 3J = 7.2 Hz, 2 H, OCH2CH3), 4.38 (q, 
3J = 7.6 Hz, 2 H, OCH2CH3), 6.56 (m, 2 H, 2 CHAr), 
6.72 (d, 3J = 7.6 Hz, 1 H, CHAr), 7.06 (m, 1 H, CHAr), 
11.25 (s, 1 H, OH). 13C NMR (62 MHz, CDCl3):  = 13.7, 14.1, 14.2, 20.0, 21.4 (CH3), 61.4, 
61.8 (CH2), 111.5 (CHAr), 112.3 (CAr), 115.3, 122.8 (CHAr), 128.6 (CAr), 129.2 (CHAr), 133.5, 
135.0, 139.0, 139.7 (CAr), 155.9 (COH), 157.5 (CAr), 169.3, 170.9 (CO). IR (neat, cm-1): ν̃ = 
1660 (s), 1619 (m), 1452 (s), 1343 (s), 1219 (m), 1136 (s), 966 (m), 882 (m), 694 (m). MS 
(EI, 70 eV): m/z (%) = 372 ([M+], 28), 326 (52), 297 (66), 254 (28), 119 (100). HRMS (EI): 
Calcd. for C21H24O6: 372.15673; found: 372.15665. 
 
Methyl 2-(methoxymethylene)-3-oxopentanoate (109b):  
Methyl 3-oxopentanoate (1.3 ml, 10 mmol), was reacted with a mixture of triethyl 
orthoformate (2.5 mL) and acetic anhydride (2.5 mL). Distillation gave 109b as a brownish 
oil (1.44 g, 84%, mixture of geometric isomers, only NMR data of the major isomer are 
listed). 
 1H NMR (250 MHz, CDCl3): δ = 0.94 (t, 3J =7.2 Hz, 3 H, CH3), 
2.61 (q, 3J =7.3 Hz, 2 H, CH2), 3.60 (s, 3 H, OMe), 3.66 (s, 3H, 
OMe), 7.79 (s, 1 H, CHolf).13C NMR (CDCl3, 75 MHz): δ = 8.2 
(CH3), 35.8 (CH2), 54.4, 62.0 (OCH3), 112.1 (C), 165.1 (CHolf), 
171.9 (CO), 203.9 (CO). IR (neat, cm-1): ν̃ = 2355 (w), 2249 (w), 
2125 (w), 2003 (w), 1961 (w), 1711 (w), 1629 (w), 1450 (w), 1283 (w) 1126 (w), 1052 (s), 
H3CH2C
O O
OCH3
H3CO
Chemical Formula: C8H12O4
Exact Mass: 172,07
OH O
H3C CH3
O OCH2CH3
OCH2CH3
O
H3C
Chemical Formula: C21H24O6
Exact Mass: 372,16
Experimental part 
 
86 
 
1024 (s), 1005 (s), 819 (m), 757 (m), 622 (m). GC-MS (EI, 70 eV): m/z (%) = 172([M]+, 40), 
143 (81), 85 (18), 75 (100), 59 (11), 57 (13), 55 (11), 54 (16), 53 (13), 29 (20). HRMS (EI): 
Calcd. for C8H12O4: 172.07301; found: 172.072814. 
Methyl 2-(methoxymethylene)-3-oxohexanoate (109c):  
Methyl 3-oxohexanoate (1.4 ml, 9.9 mmol) was reacted with a mixture of triethyl 
orthoformate (2.5 mL) and acetic anhydride (2.5 mL). Distillation gave 109c as a brownish oil 
(1.53 g, 83%, mixture of geometric isomers, only NMR data of the major isomer are listed). 
 1H NMR (250 MHz, CDCl3): δ = 0.85 (t, 3J =7.2 Hz, 3 H, 
CH3), 1.43 - 1.50 (m, 2 H, CH2), 2.62 (t, 3J =7.2 Hz, 2 H, CH2), 
3.63 (s, 3 H, OMe), 3.67 (s, 3 H, OMe), 7.79 (s, 1 H, CHolf).13C 
NMR (CDCl3, 75 MHz): δ = 13.3 (CH3), 17.4, 44.3 (CH2), 54.1, 
61.3 (OCH3), 112.5 (C), 165.2 (CHolf), 171.0, 201.7 (CO). IR 
(neat, cm-1): ν̃ = 3437 (w), 2960 (w), 2250 (w), 2124 (w), 1711 (w), 1630 (w), 1439 (w), 1378 
(w), 1274 (w), 1129 (w), 1052 (s), 1024 (s), 1004 (s), 820 (m), 757 (m), 622 (m). GC-MS (EI, 
70 eV): m/z (%) = 186([M]+, 3), 155 (22), 143 (93), 85 (16), 75 (100), 59 (10), 55(13), 54 
(15), 43 (16), 41 (15). HRMS (EI): Calcd. for C9H14O4: 186.08866; found: 186.088376. 
 
Dimethyl 4-hydroxy-2-methylisophthalate (110a):  
Starting with 109a (0.237 g, 1.5 mmol) and 22a (0.430 g, 1.65 mmol), 110a was isolated after 
chromatography (silica gel, heptanes/EtOAc) as a yellowish solid (0.144 g, 43%), m.p. = 88 - 
90 °C. 
 1H NMR (250 MHz, CDCl3): δ = 2.63 (s, 3 H, PhCH3), 3.79 (s, 
3 H, OCH3), 3.91 (s, 3 H, OCH3), 6.78 (d, 3J = 8.7 Hz, 1 H, 
CHAr), 7.76 (d, 3J = 8.9 Hz, 1 H, CHAr), 10.98 (s, 1 H, OH). 13C 
NMR (CDCl3, 75 MHz):  = 20.0 (CH3), 52.0, 52.5 (OCH3), 
114.5 (CCOOCH3), 115.2 (CHAr), 123.9 (CCOOCH3), 135.8 
(CHAr), 143.6 (CAr), 163.9 (COH), 168.0, 171.7 (CO). IR (KBr, 
cm-1): ν̃ = 3339 (w), 2989 (w), 2959 (w), 2924 (w), 2853 (w), 1715 (m), 1688 (m), 1651 (m), 
1583 (m), 1537 (m), 1430 (m), 1386 (m), 1321 (m), 1243 (m), 1195 (s), 1151 (s), 1050 (m), 
1018 (m), 960 (m), 944 (m), 858 (m), 797 (s), 754 (m), 707 (s), 652 (m), 560 (m). GC-MS 
(EI, 70 eV): m/z (%) = 224 ([M]+, 31), 193 (30), 192 (100), 161 (56), 160 (26), 149 (13), 133 
(12), 132 (12), 105 (10), 77 (15), 51 (11). HRMS (EI): Calcd. for C11H12O5 ([M]+): 
224.06792; found: 224.067341. 
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Dimethyl 4-hydroxy-2,5-dimethylisophthalate (110b):  
Starting with 109a (0.237 g, 1.5 mmol) and 22d (0.453 g, 1.65 mmol), 110b was isolated after 
chromatography (silica gel, heptanes/EtOAc) as a white solid (0.205 g, 57%), m.p. = 110 - 
112°C.  
1H NMR (250 MHz, CDCl3): δ = 2.15 (s, 3 H, PhCH3), 2.60 (s, 
3 H, PhCH3), 3.78 (s, 3 H, OCH3), 3.90 (s, 3 H, OCH3), 7.75 (s, 
1 H, CHAr), 11.22 (s, 1 H, OH). 13C NMR (CDCl3, 75 MHz):  
= 15.7, 19.8 (CH3), 51.9, 52.4 (OCH3), 113.7 (CCOOCH3), 
123.0 (CAr), 124.0 (CCOOCH3), 136.3 (CHAr), 140.6 (CAr), 
162.4 (COH) 168.2, 172.1 (CO). IR (KBr, cm-1): ν̃ = 3349 (w), 
2992 (w), 2953 (w), 2931 (w), 2853 (w), 1716 (m), 1693 (m), 1667 (m), 1579 (m), 1537 (m), 
1434 (m), 1384 (w), 1330 (m), 1229 (m), 1190 (s), 1144 (s), 1049 (m), 1013 (m), 959 (m), 
855 (m), 796 (s), 745 (m), 702 (m), 651 (m), 606 (m). GC-MS (EI, 70 eV): m/z (%) = 238 
([M]+, 33), 207 (33), 206 (100), 178 (65), 175 (31), 163 (26), 91 (16), 65 (12).  HRMS (EI): 
Calcd. for C12H14O5 ([M]+): 238.08358; found: 238.083755. 
 
3-Ethyl 1-methyl 5-ethyl-4-hydroxy-2-methylisophthalate (110c):  
Starting with 109a   (0.237 g, 1.5 mmol) and 22g (0.499 g, 1.65 mmol), 110c was isolated 
after chromatography (silica gel, heptanes/EtOAc) as a yellowish oil (0.200 g, 50%). 
 1H NMR (250 MHz, CDCl3): δ = 1.05 (t, 3J = 7.5 Hz, 3 H, 
CH2CH3), 1.27 (t, 3J = 6.7 Hz, 3 H, OCH2CH3), 2.48 (q, 3J 
= 7.3 Hz, 2 H, CH2CH3), 2.52 (s, 3 H, PhCH3), 3.71 (s, 3 H, 
OCH3), 4.30 (q, 3J = 7.0 Hz, 2 H, OCH2CH3), 7.55 (s, 1 H, 
CHAr), 11.21 (s, 1 H, OH). 13C NMR (CDCl3, 75 MHz):  = 
13.5, 14.1, 19.9 (CH3), 23.1 (CH2), 52.0 (OCH3), 62.2 
(OCH2), 114.3 (CCOOC2H5), 123.4 (CCOOCH3), 129.8 (CAr), 134.9 (CHAr), 140.8 (CAr), 
162.5 (COH), 168.5, 171.9 (CO).  IR (neat, cm-1): ν̃  = 2967 (w), 2874 (w), 1718 (m), 1655 
(m), 1580 (w), 1429 (m), 1396 (w), 1372 (m),  1326 (m), 1261 (m), 1227 (s), 1199 (s), 1154 
(s), 1095 (w), 1043 (m), 1019 (m), 959 (w), 844 (w), 809 (m), 780 (m), 743 (w), 650 (m), 535 
(w). GC-MS (EI, 70 eV): m/z (%) = 266 ([M]+, 25), 221 (17), 220 (63), 193 (12), 192 (100), 
189 (15), 177 (10), 77 (11), 29 (7). HRMS (EI): Calcd. for C14H18O5 ([M]+): 266.11488; 
found: 266.115159. 
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Dimethyl 5-butyl-4-hydroxy-2-methylisophthalate (110d):  
Starting with 109a (0.237 g, 1.5 mmol) and 22h (0.522 g, 1.65 mmol), 110d was isolated after 
chromatography (silica gel, heptanes/EtOAc) as a yellowish oil (0.218 g, 52%).  
1H NMR (250 MHz, CDCl3): δ = 0.85 (t, 3J = 7.5 Hz, 3 H, 
CH3), 1.25 – 1.35 (m, 2 H, CH2), 1.48 – 1.53 (m, 2 H, CH2), 
2.54 (t, 3J = 7.5 Hz, 2 H, PhCH2), 2.58 (s, 3 H, PhCH3), 3.79 
(s, 3 H, OCH3), 3.90 (s, 3 H, OCH3), 7.62 (s, 1 H, CHAr), 
11.21 (s, 1 H, OH). 13C NMR (CDCl3, 75 MHz):  = 12.9, 
18.9 (CH3), 21.5, 28.9, 30.4 (CH2), 50.9, 51.5 (OCH3), 113.0 
(CCOOCH3), 122.1 (CAr), 127.6 (CCOOCH3), 134.8 (CHAr), 139.6 (CAr), 161.1 (COH), 
167.4, 171.2 (CO).  IR (neat, cm-1): ν̃  = 3024 (w), 2989 (w), 2957 (w), 2932 (w), 2865 (w), 
1713 (s), 1659 (m), 1608 (w), 1579 (w), 1431 (s), 1377 (w), 1337 (m), 1259 (m), 1228 (s), 
1199 (s), 1152 (s), 1049 (m), 994 (m), 962 (m), 894 (m), 872 (w), 808 (m), 767 (m), 653 (m), 
544 (w). GC-MS (EI, 70 eV): m/z (%) = 280 ([M]+, 34), 249 (20), 248 (19), 231 (15), 220 
(39), 219 (18), 217 (14), 207 (12), 206 (100), 205 (23), 189 (19), 178 (40), 173 (34), 91 (10), 
77 (11). HRMS (EI): Calcd. for C15H20O5 ([M]+): 280.13053; found: 280.130756. 
 
Dimethyl 5-hexyl-4-hydroxy-2-methylisophthalate (110e): 
Starting with 109a (0.237 g, 1.5 mmol) and 22J (0.569 g, 1.65 mmol), 110e was isolated after 
chromatography (silica gel, heptanes/EtOAc) as a light yellowish oil (0.254 g, 55%).  
1H NMR (250 MHz, CDCl3): δ = 0.72 (t, 3J = 7.5 Hz, 3 H, 
CH3), 1.11 – 1.20 (m, 6 H, 3 CH2), 1.40 – 1.47 (m, 2 H, CH2), 
2.44 (t, 3J = 7.5 Hz, 2 H, PhCH2), 2.51 (s, 3 H, PhCH3), 3.71 
(s, 3 H, OCH3), 3.82 (s, 3 H, OCH3), 7.54 (s, 1 H, CHAr), 
11.13 (s, 1 H, OH). 13C NMR (CDCl3, 75 MHz):  = 14.0, 
19.8 (CH3), 22.6, 29.1, 29.2, 29.7, 31.7 (CH2), 51.9, 52.4 
(OCH3), 113.9 (CCOOCH3), 123.1 (CAr), 128.7 (CCOOCH3), 135.7 (CHAr), 140.5 (CAr), 
162.0 (COH), 168.3, 172.2 (CO). IR (neat, cm-1): ν̃  = 2952 (w), 2926 (w), 2856 (w), 1719 
(m), 1659 (m), 1608 (w), 1580 (w), 1432 (m), 1335 (m), 1227 (s), 1194 (s), 1150 (s), 1045 
(m), 990 (m), 961 (w), 886 (w), 808 (m), 779 (m), 725 (w), 651 (m), 555 (w). GC-MS (EI, 70 
eV): m/z (%) = 308 ([M]+, 37), 277 (23), 276 (20), 259 (16), 248 (40), 247 (31), 245 (11), 233 
(13), 220 (10), 219 (17), 217 (14), 207 (16), 206 (100), 205 (33), 178 (35), 173 (42), 91 (10), 
77 (10), 43 (8).   HRMS (EI): Calcd. for C17H24O5 ([M]+): 308.16183; found: 308.161283. 
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Dimethyl 5-hexyl-4-hydroxy-2-methylisophthalate (110f):  
Starting with 109a (0.237 g, 1.5 mmol) and 22k (0.592 g, 1.65 mmol), 110f was isolated after 
chromatography (silica gel, heptanes/EtOAc) as a light yellowish oil (0.246 g, 51%). 
 1H NMR (250 MHz, CDCl3): δ = 0.78 (t, 3J = 7.5 Hz, 3 H, 
CH3), 1.18 – 1.22 (m, 8 H, 4 CH2), 1.48 – 1.54 (m, 2 H, CH2), 
2.53 (t, 3J = 7.5 Hz, 2 H, PhCH2), 2.58 (s, 3 H, PhCH3), 3.79 
(s, 3 H, OCH3), 3.89 (s, 3 H, OCH3), 7.62 (s, 1 H, CHAr), 
11.22 (s, 1 H, OH). 13C NMR (CDCl3, 75 MHz):  = 13.0, 
18.8 (CH3), 21.6, 27.7, 27.8, 28.2, 28.7, 30.8 (CH2), 50.9, 51.4 
(OCH3), 112.9 (CCOOCH3), 122.1 (CAr), 127.6 (CCOOCH3), 134.7 (CHAr), 139.6 (CAr), 
161.1 (COH), 167.4, 171.4 (CO). IR (neat, cm-1): ν̃  = 3400 (w), 2952 (w), 2923 (w), 2853 
(w), 1720 (m), 1659 (m), 1610 (w), 1579 (w), 1433 (m), 1379 (w), 1336 (m), 1228 (s), 1195 
(s), 1152 (s), 1046 (m), 997 (w), 889 (w), 809 (m), 779 (m), 723 (w), 651 (m), 553 (w). GC-
MS (EI, 70 eV): m/z (%) = 322 ([M]+, 33), 291 (23), 290 (19), 273 (14), 262 (32), 247 (29), 
233 (11), 231 (14), 219 (17), 207 (17), 206 (100), 205 (33), 178 (33), 173 (40), 91 (10), 77 
(9), 43 (10), 29 (8). HRMS (EI): Calcd. for C18H26O5 ([M]+): 322.17748; found: 322.177264. 
 
Dimethyl  4-hydroxy-2-methyl-5-octylisophthalate (110g): 
Starting with 109a (0.237 g, 1.5 mmol) and 22l (0.615 g, 1.65 mmol), 110g was isolated after 
chromatography (silica gel, heptanes/EtOAc) as a light yellowish oil (0.241 g, 48%).  
1H NMR (250 MHz, CDCl3): δ = 0.80 (t, 3J = 7.5 Hz, 3 H, 
CH3), 1.15 – 1.23 (m, 10 H, 5 CH2), 1.51 – 1.53 (m, 2 H, 
CH2), 2.54 (t, 3J = 7.7 Hz, 2 H, PhCH2), 2.59 (s, 3 H, 
PhCH3), 3.80 (s, 3 H, OCH3), 3.90 (s, 3 H, OCH3), 7.62 (s, 1 
H, CHAr), 11.21 (s, 1 H, OH). 13C NMR (CDCl3, 75 MHz):  
= 14.0, 19.8 (CH3), 22.6, 29.2, 29.4, 29.5, 29.6, 29.7, 31.8 
(CH2), 51.9, 52.4 (OCH3), 113.9 (CCOOCH3), 123.1 (CAr), 128.8 (CCOOCH3), 135.7 (CHAr), 
140.6 (CAr), 162.0 (COH), 168.4, 172.1 (CO). IR (neat, cm-1): ν̃  = 2952 (w), 2924 (w), 2853 
(w), 1720 (m), 1699 (m), 1605 (w), 1552 (w), 1434 (m), 1377 (w), 1336 (m), 1229 (s), 1202 
(s), 1153 (s), 1045 (m), 996 (w), 911 (w), 809 (m), 759 (m), 700 (m), 652 (w), 566 (w). GC-
MS (EI, 70 eV): m/z (%) = 336 ([M]+, 35), 305 (20), 304 (14), 287 (13), 276 (32), 247 (34), 
245 (17), 233 (12), 219 (18), 207 (15), 206 (100), 205 (30), 178 (33), 173 (39), 91 (11), 43 
(10), 41 (10), 29 (7).  HRMS (EI): Calcd. for C19H28O5 ([M]+): 336.19313; found: 
336.193115. 
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Dimethyl 4-hydroxy-2-methyl-5-nonylbenzene-1,3-dioate (110h):  
Starting with 109a (0.237 g, 1.5 mmol) and 22m (0.638 g, 1.65 mmol), 110h was isolated 
after chromatography (silica gel, heptanes/EtOAc) as a white solid (0.273 g, 52%), m.p. 56 - 
57 °C. 
1H NMR (250 MHz, CDCl3): δ = 0.80 (t, 3J = 7.3 Hz, 3 H, 
CH3), 1.19 – 1.26 (m, 12 H, 6 CH2), 1.47 – 1.55 (m, 2 H, 
CH2), 2.54 (t, 3J = 7.2 Hz, 2 H, PhCH2), 2.59 (s, 3 H, PhCH3), 
3.80 (s, 3 H, OCH3), 3.90 (s, 3 H, OCH3), 7.62 (s, 1 H, CHAr), 
11.20 (s, 1 H, OH). 13C NMR (CDCl3, 75 MHz):  = 13.1, 
18.8 (CH3), 21.6, 28.2, 28.3, 28.4, 28.5, 28.7, 29.9, 30.9 
(CH2), 50.9, 51.4 (OCH3), 112.9 (CCOOCH3), 122.1 (CCOOCH3), 127.6 (CAr), 134.7 (CHAr), 
139.6 (CAr), 161.0 (COH), 167.3, 171.2 (CO). IR (KBr, cm-1): ν̃  = 3000 (w), 2954 (m), 2914 
(m), 2851 (m), 1709 (m), 1665 (m), 1607 (w), 1579 (m), 1471 (m), 1437 (w), 1426 (w), 1382 
(w), 1335 (m), 1252 (w), 1229 (s), 1210 (s), 1194 (s), 1149 (s), 1045 (m), 1003 (m), 986 (m), 
972 (m), 961 (m), 920 (m), 887 (s), 802 (m), 791 (m), 781 (m), 743 (m), 714 (m), 659 (m), 
610 (m), 561 (w). GC-MS (EI, 70 eV): m/z (%) =  350 ([M+],  34),   319 (20), 290 (24), 259 
(15), 247 (27), 233 (10), 219 (15), 206 (100), 192 (9), 173 (39), 163 (7), 147 (6), 119 (3), 91 
(7), 77 (7), 55 (4), 41 (10). HRMS (EI): Calcd. for C20H30O5  ([M]+): 350.20878; found: 
350.208651. 
 
3-(2-Methoxyethyl) 1-methyl 4-hydroxy-2-methylbenzene-1,3-dioate (110i):  
Starting with 109a (0.237 g, 1.5 mmol) and 22b (0.502 g, 1.65 mmol), 110i was isolated after 
chromatography (silica gel, heptanes/EtOAc) as a yellowish oil (0.193 g, 48%).  
1H NMR (250 MHz, CDCl3): δ = 2.66 (s, 3 H, PhCH3), 3.36 
(s, 3 H, OCH3), 3.66 (t, 3J = 4.9 Hz, 2 H,OCH2CH2OCH3 ), 
3.80 (s, 3 H, OCH3), 4.47 (t, 3J = 4.7 Hz, 2 H, 
OCH2CH2OCH3), 6.78 (d, 3J = 8.7 Hz, 1 H, CHAr),  7.78 (d, 
3J = 9.0 Hz, 1 H, CHAr), 10.51 (s, 1 H, OH). 13C NMR 
(CDCl3, 75 MHz):  = 20.6 (CH3), 52.7, 59.6 (OCH3), 65.2, 
70.5 (OCH2), 115.9 (CHAr), 116.0 (CAr), 124.7 (CCOOCH3), 136.5 (CHAr), 144.3 (CAr), 164.0 
(COH), 168.6, 171.1 (CO). IR (KBr, cm-1): ν̃  = 3281 (w), 2951 (w), 2924 (w), 2851 (w), 
1716 (m), 1661 (w), 1588 (m), 1470 (w), 1434 (w), 1378 (w), 1315 (w), 1224 (m), 1200 (m), 
1048 (s), 1028 (s), 955 (m), 868 (m), 834 (m), 804 (m), 783 (m), 709 (m), 653 (m), 608 (m), 
543 (m). GC-MS (EI, 70 eV): m/z (%) = 268 ([M+], 17),   237 (8), 192 (100), 161 (32), 133 
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(5), 105 (6), 77 (7), 59 (11), 45 (5). HRMS (EI): Calcd. for C13H16O6 ([M]+): 268.09414; 
found: 268.094150. 
 
Dimethyl 2-hydroxy-4,4'-dimethylbiphenyl-3,5-dicarboxylate (110j): 
Starting with 109a (0.237 g, 1.5 mmol) and 22q (0.578 g, 1.65 mmol), 110j was isolated after 
chromatography (silica gel, heptanes/EtOAc) as a yellowish solid (0.250 g, 53 %), m.p. = 83 - 
85 °C.  
1H NMR (250 MHz, CDCl3): δ = 2.32 (s, 3 H, PhCH3), 2.65 
(s, 3 H, PhCH3), 3.80 (s, 3 H, OCH3), 3.93 (s, 3 H, OCH3), 
7.15 – 7.19 (m, 2 H, 2 CHAr), 7.34 – 7.37 (m, 2 H, 2 CHAr), 
7.83 (s, 1 H, CHAr), 11.04 (s, 1 H, OH). 13C NMR (CDCl3, 
75 MHz):  = 18.9, 20.2 (CH3), 51.0, 51.6 (OCH3), 114.3 
(CCOOCH3), 122.6 (CCOOCH3), 126.9 (CAr), 128.0 (2 
CHAr), 128.2 (2 CHAr), 132.6 (CAr), 135.4 (CHAr), 136.4, 141.0 (CAr), 159.5 (COH), 167.0, 
171.0 (CO). IR (KBr, cm-1): ν̃  = 3027 (w), 3012 (w), 2953 (w), 2924 (w), 2853 (w), 1771 
(w), 1718 (m), 1684 (w), 1663 (m), 1653 (m), 1636 (w), 1616 (w), 1608 (w), 1576 (w), 1558 
(w), 1540 (w), 1533 (w), 1516 (w), 1507 (w), 1497 (w), 1489 (w), 1472 (w), 1456 (w), 1436 
(m), 1399 (w), 1338 (m), 1240 (m), 1209 (m), 1103 (w), 1052 (w), 1028 (w), 958 (w), 910 
(w), 822 (w), 783 (w), 733 (m), 668 (w), 650 (w), 617 (w), 608 (w),  567 (w), 541 (w). GC-
MS (EI, 70 eV): m/z (%) =  314 ([M+],  42),   282 (100), 267 (5), 251 (14), 239 (16), 222 (13), 
195 (14), 165 (13), 152 (12), 132 (12), 119 (29), 105 (18), 91 (19), 69 (22), 57 (29), 43 (20). 
HRMS (EI): Calcd. for C18H18O5  ([M]+): 314.11488; found: 314.114827. 
 
Dimethyl 4'-chloro-2-hydroxy-4-methylbiphenyl-3,5-dicarboxylate (110k):  
Starting with 109a (0.237 g, 1.5 mmol) and 22r (0.612 g, 1.65 mmol), 110k was isolated after 
chromatography (silica gel, heptanes/EtOAc) as a brownish 
crystals (0.241 g, 48%), m.p. = 160 - 161 °C.  
1H NMR (250 MHz, CDCl3): δ = 2.65 (s, 3 H, PhCH3), 3.80 
(s, 3 H, OCH3), 3.93 (s, 3 H, OCH3), 7.28 – 7.33 (m, 2 H, 2 
CHAr), 7.38 – 7.43 (m, 2 H, 2 CHAr), 7.81 (s, 1 H, CHAr), 
11.36 (s, 1 H, OH). 13C NMR (CDCl3, 75 MHz):  = 19.1 
(CH3), 51.1, 51.7 (OCH3), 114.0 (CCOOCH3), 122.9 (CCOOCH3), 125.6 (CAr), 127.4 (2 
CHAr), 129.6 (2 CHAr), 132.6, 134.0 (CAr), 135.4 (CHAr), 141.8 (CAr), 159.7 (COH), 166.8, 
171.0 (CO). IR (KBr, cm-1): ν̃  = 3000 (w), 2951 (w), 1716 (m), 1662 (m), 1603 (m), 1579 
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(m), 1562 (w), 1492 (m), 1439 (m), 1425 (m), 1389 (m), 1375 (m), 1323 (m), 1301 (m), 1239 
(m), 1194 (s), 1171 (s), 1105 (m), 1085 (m), 1051 (m), 1025 (m), 1010 (m), 949 (m), 926 (m), 
876 (m), 825 (m), 806 (m), 782 (m), 771 (m), 746 (m), 719 (m), 675 (m), 650 (m), 629 (m), 
613 (m), 540 (m). GC-MS (EI, 70 eV): m/z (%) = 336 ([M+], 37Cl, 6), 334 ([M+], 35Cl, 17), 
302 (100), 296 (20), 270 (12), 242 (7), 215 (4), 152 (11), 125 (8), 104 (6), 86 (10), 43 (9). 
HRMS (EI): Calcd. for C17H15O5Cl  ([M]+): 334.06025; found: 334.059873. 
 
Dimethyl  4-hydroxy-5-methoxy-2-methylbenzene-1,3-dioate (110l):  
Starting with 109a (0.237 g, 1.5 mmol) and 22o (0.360 g, 1.7 mmol), 110l was isolated after 
chromatography (silica gel, heptanes/EtOAc) as a yellowish oil (0.198 g, 52%). 
1H NMR (250 MHz, CDCl3): δ = 2.45 (s, 3 H, PhCH3), 3.76 (s, 
3 H, OCH3), 3.79 (s, 3 H, OCH3), 3.86 (s, 3 H, OCH3), 7.32 (s, 
1 H, CHAr), 9.41 (s, 1 H, OH). 13C NMR (CDCl3, 75 MHz):  = 
18.7 (CH3), 52.0, 52.6, 56.2 (OCH3), 115.5 (CHAr), 117.6 
(CCOOCH3), 122.3 (CCOOCH3), 133.4, 145.3 (CAr), 151.6 
(COH), 167.7, 170.4 (CO). IR (KBr, cm-1): ν̃  = 3400 (w), 3001 
(w), 2951 (w), 2842 (w), 1713 (m), 1662 (m), 1610 (w), 1587 (m), 1492 (m), 1433 (m), 1385 
(w), 1357 (m), 1305 (m), 1282 (m), 1200 (s), 1167 (s), 1082 (s), 1048 (m), 1029 (s), 959 (m), 
914 (w), 886 (m), 858 (w), 806 (w), 780 (m), 730 (m), 688 (w), 671 (w), 647 (w), 621 (w), 
592 (w), 553 (w). GC-MS (EI, 70 eV): m/z (%) = 254 ([M+], 38), 222 (100), 207 (4), 194 (53), 
179 (20), 163 (11), 147 (18), 136 (15), 119 (5), 107 (3), 92 (7), 77 (10), 64 (5), 53 (5), 39 (5). 
HRMS (EI): Calcd. for C12H14O6 ([M]+): 254.07849; found: 254.078254. 
 
Dimethyl  2-ethyl-4-hydroxy-5-methylisophthalate (110m): 
 Starting with 109b (0.258 g, 1.5 mmol) and 22d (0.453 g, 1.65 mmol), 110m was isolated 
after chromatography (silica gel, heptanes/EtOAc) as a light 
yellowish oil (0.196 g, 52%).  
1H NMR (250 MHz, CDCl3): δ = 1.14 (t, 3J = 7.7 Hz, 3 H, 
CH2CH3), 2.21 (s, 3 H, PhCH3), 3.09 (q, 3J = 7.1 Hz, 2 H, 
CH2CH3), 3.79 (s, 3 H, OCH3), 3.91 (s, 3 H, OCH3), 7.63 (s, 1 
H, CHAr), 11.14 (s, 1 H, OH). 13C NMR (CDCl3, 75 MHz):  = 
14.8, 15.0 (CH3), 24.2 (CH2), 50.9, 51.5 (OCH3), 112.2 (CCOOCH3), 121.5 (CAr), 123.4 
(CCOOCH3), 136.0 (CHAr), 145.6 (CAr), 161.4 (COH), 167.3, 171.2 (CO).  
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IR (neat, cm-1): ν̃  = 2952 (w), 2930 (w), 2854 (w), 1719 (m), 1658 (m), 1610 (w), 1578 (w), 
1432 (m), 1380 (w), 1333 (m), 1300 (m), 1277 (m), 1225 (s), 1192 (s), 1149 (s), 1071 (m), 
1017 (m), 983 (m), 886 (w), 813 (m), 776 (m), 732 (m), 675 (m), 644 (m). GC-MS (EI, 70 
eV): m/z (%) = 252 ([M]+, 32), 221 (27), 220 (100), 189 (24), 177 (11), 170 (12), 161 (11), 
160 (19), 133 (9), 132 (10), 103 (9), 77 (14). HRMS (EI): Calcd. for C13H16O5 ([M]+): 
252.09923; found: 252.099203. 
 
3-Ethyl 1-methyl 2,5-diethyl-4-hydroxyisophthalate (110n): 
Starting with 109b (0.258 g, 1.5 mmol) and 22g (0.499 g, 1.65 mmol), 110n was isolated after 
chromatography (silica gel, heptanes/EtOAc) as a light yellowish oil (0.210 g, 50%).  
1H NMR (250 MHz, CDCl3): δ = 1.11 - 1.19 (m, 6 H, 2 CH3 
), 1.37 (t, 3J = 7.4 Hz, 3 H, OCH2CH3), 2.58 (q, 3J = 7.4 Hz, 2 
H, PhCH2), 3.11 (q, 3J = 7.5 Hz, 2 H, PhCH2), 3.79 (s, 3 H, 
OCH3), 4.39 (q, 3J = 7.4 Hz, 2 H, OCH2CH3), 7.63 (s, 1 H, 
CHAr), 11.22 (s, 1 H, OH). 13C NMR (CDCl3, 75 MHz):  = 
13.4, 13.9, 15.2 (CH3), 21.9, 23.9, 50.9 (CH2), 61.1 (OCH2), 
112.4 (CCOOC2H5), 121.6 (CCOOCH3), 129.0 (CAr), 134.0 (CHAr), 145.3 (CAr), 161.0 
(COH), 167.3, 170.6 (CO). IR (neat, cm-1): ν̃  = 2968 (w), 2935 (w), 2875 (w), 1722 (m), 
1657 (m), 1608 (w), 1578 (w), 1429 (w), 1373 (w), 1323 (w), 1274 (m), 1229 (m), 1200 (m), 
1156 (w), 1093 (w), 1061 (w), 1021 (w), 979 (w), 909 (w), 847 (w), 818 (w), 733 (m), 648 
(w). GC-MS (EI, 70 eV): m/z (%) = 280 ([M]+, 36), 249 (11), 235 (23), 234 (100), 206 (17), 
203 (20), 191 (16), 175 (11), 174 (37), 147 (15), 146 (16), 91 (13), 77 (10). HRMS (EI): 
Calcd. for C15H20O5 ([M]+): 280.13053; found: 280.130632. 
 
Dimethyl 5-butyl-2-ethyl-4-hydroxyisophthalate (110o):  
Starting with 109b (0.258 g, 1.5 mmol) and 22h (0.522 g, 1.65 mmol), 110o was isolated after 
chromatography (silica gel, heptanes/EtOAc) as a yellowish oil (0.229 g, 52%).  
1H NMR (250 MHz, CDCl3): δ = 0.86 (t, 3J = 7.4 Hz, 3 H, 
(CH2)3CH3), 1.14 (t, 3J = 7.4 Hz, 3 H, CH2CH3), 1.25 – 1.34 
(m, 2 H, CH2), 1.45 – 1.54 (m, 2 H, CH2), 2.55 (t, 3J = 7.6 
Hz, 2 H, PhCH2), 3.08 (q, 3J = 7.4 Hz, 2 H, PhCH2), 3.78 (s, 
3 H, OCH3), 3.91 (s, 3 H, OCH3), 7.62 (s, 1 H, CHAr), 11.08 
(s, 1 H, OH). 13C NMR (CDCl3, 75 MHz):  = 13.9, 16.0 
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(CH3), 22.6, 25.1, 29.6, 31.4 (CH2), 51.9, 52.5 (OCH3), 113.4 (CCOOCH3), 122.6 (CAr), 
128.8 (CCOOCH3), 135.9 (CHAr), 146.4 (CAr), 162.0 (COH), 168.2, 172.1 (CO).  
IR (neat, cm-1): ν̃  = 2954 (w), 2930 (w), 2873 (w), 2256 (w), 1721 (m), 1662 (m), 1606 (w), 
1579 (w), 1434 (m), 1337 (w), 1276 (m), 1228 (m), 1202 (m), 1153 (w), 1068 (w), 986 (w), 
908 (m), 816 (w), 732 (s), 648 (w). GC-MS (EI, 70 eV): m/z (%) = 294 ([M]+, 47), 263 (27), 
262 (41), 247 (12), 245 (23), 233 (18), 231 (20), 221 (14), 220 (100), 219 (26), 203 (55), 192 
(13), 187 (28), 160 (15), 159 (11), 131 (11), 103 (12), 91 (13), 77 (14). HRMS (EI): Calcd. for 
C16H22O5 ([M]+): 294.14618; found: 294.146337. 
 
Dimethyl 2-ethyl-5-hexyl-4-hydroxyisophthalate (110p): 
Starting with 109b (0.258 g, 1.5 mmol) and 22j (0.569 g, 1.65 mmol), 110p was isolated after 
chromatography (silica gel, heptanes/EtOAc) as a light yellowish oil (0.251 g, 52%).  
1H NMR (250 MHz, CDCl3): δ = 0.79 (t, 3J = 7.6 Hz, 3 H, 
CH3), 1.13 (t, 3J = 7.4 Hz, 3 H, CH2CH3), 1.21 – 1.29 (m, 6 H, 
3 CH2), 1.46 – 1.53 (m, 2 H, CH2), 2.53 (t, 3J = 7.6 Hz, 2 H, 
PhCH2), 2.99 (q, 3J = 7.3 Hz, 2 H, PhCH2), 3.78 (s, 3 H, 
OCH3), 3.90 (s, 3 H, OCH3), 7.61 (s, 1 H, CHAr), 11.08 (s, 1 
H, OH). 13C NMR (CDCl3, 75 MHz):  = 14.0, 16.0, (CH3), 
22.6, 25.0, 29.1, 29.2, 29.8, 31.7 (CH2), 51.9, 52.5 (OCH3), 113.3 (CCOOCH3), 122.6 (CAr), 
128.8 (CCOOCH3), 135.9 (CHAr), 146.4 (CAr), 161.9 (COH), 168.2, 172.1 (CO). IR (neat, cm-
1): ν̃  = 2953 (w), 2927 (w), 2856 (w), 2255 (w), 1719 (m), 1660 (m), 1606 (w), 1578 (w), 
1433 (m), 1334 (m), 1272 (m), 1227 (s), 1200 (s), 1151 (m), 1087 (w), 1068 (w), 1047 (w), 
992 (w), 906 (s), 816 (w), 729 (s), 648 (m). GC-MS (EI, 70 eV): m/z (%) = 323 (10), 322 
([M]+, 50), 291 (28), 290 (38), 273 (25), 262 (11), 261 (43), 259 (16), 247 (11), 234 (11), 233 
(21), 231 (49), 221 (16), 220 (100), 219 (31), 205 (10), 192 (14), 187 (31), 160 (15), 131 (11), 
103 (11), 91 (12), 77 (11). HRMS (EI): Calcd. for C18H26O5 ([M]+): 322.17748; found: 
322.177229. 
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Dimethyl  2-ethyl-5-heptyl-4-hydroxyisophthalate (110q):  
Starting with 109b (0.258 g, 1.5 mmol) and 22k (0.592 g, 1.65 mmol), 110q was isolated 
after chromatography (silica gel, heptanes/EtOAc) as a yellowish oil (0.257 g, 51%). 
 1H NMR (250 MHz, CDCl3): δ = 0.81 (t, 3J = 7.6 Hz, 3 H, 
CH3), 1.14 (t, 3J = 7.6 Hz, 3 H, CH2CH3), 1.20 – 1.27 (m, 8 H, 
4 CH2), 1.49 – 1.54 (m, 2 H, CH2), 2.53 (t, 3J = 7.6 Hz, 2 H, 
PhCH2), 3.08 (q, 3J = 7.4 Hz, 2 H, PhCH2), 3.79 (s, 3 H, 
OCH3), 3.91 (s, 3 H, OCH3), 7.62 (s, 1 H, CHAr), 11.08 (s, 1 
H, OH). 13C NMR (CDCl3, 75 MHz):  = 14.1, 16.0, (CH3), 
22.6, 25.1, 29.1, 29.2, 29.4, 29.8, 31.8 (CH2), 51.9, 52.5 (OCH3), 113.2 (CCOOCH3), 122.7 
(CAr), 129.0 (CCOOCH3), 136.2 (CHAr), 146.6 (CAr), 162.3 (COH), 168.4, 172.2 (CO).  
IR (neat, cm-1): ν̃  = 2953 (w), 2927 (m), 2855 (w), 2258 (w), 1722 (m), 1662 (m), 1606 (w), 
1579 (w), 1434 (m), 1335 (w), 1275 (m), 1228 (m), 1202 (m), 1152 (w), 1069 (w), 990 (w), 
908 (m), 816 (w), 733 (m), 648 (w). GC-MS (EI, 70 eV): m/z (%) = 337 (10), 336 ([M]+, 45), 
305 (26), 304 (35), 287 (24), 275 (10), 273 (15), 262 (10), 261 (41), 247 (11), 246 (49), 234 
(10), 233 (20), 221 (18), 220 (100), 205 (10), 192 (15), 161 (10), 160 (13), 159 (11), 131 (11), 
103 (10), 91 (11), 43 (10). HRMS (EI): Calcd. for C19H28O5 ([M]+): 336.19313; found: 
336.193054. 
 
Dimethyl 2-ethyl-4-hydroxy-5-octylisophthalate (110r): 
Starting with 109b (0.258 g, 1.5 mmol) and 22l (0.615 g, 1.65 mmol), 110r was isolated after 
chromatography (silica gel, heptanes/EtOAc) as a light yellow oil (0.263 g, 50%). 
1H NMR (250 MHz, CDCl3): δ = 0.79 (t, 3J = 7.5 Hz, 3 H, 
CH3), 1.13 (t, 3J = 7.6 Hz, 3 H, CH2CH3), 1.22 – 1.36 (m, 10 
H, 5 CH2), 1.47 – 1.56 (m, 2 H, CH2), 2.52 (t, 3J = 7.6 Hz, 2 
H, PhCH2), 3.06 (q, 3J = 7.5 Hz, 2 H, PhCH2), 3.79 (s, 3 H, 
OCH3), 3.90 (s, 3 H, OCH3), 7.62 (s, 1 H, CHAr), 11.07 (s, 1 
H, OH). 13C NMR (CDCl3, 75 MHz):  = 13.7, 15.9, (CH3), 
22.1, 25.1, 28.9, 29.0, 29.2, 29.3, 29.8, 31.6 (CH2), 51.6, 52.4 (OCH3), 112.8 (CCOOCH3), 
121.7 (CAr), 128.7 (CCOOCH3), 135.9 (CHAr), 146.1 (CAr), 161.9 (COH), 167.7, 171.9 (CO). 
IR (neat, cm-1): ν̃  = 2954 (w), 2925 (m), 2854 (w), 2255 (w), 1745 (w), 1711 (w), 1658 (m), 
1604 (w), 1569 (w), 1462 (w), 1329 (w), 1231 (w), 1153 (w), 908 (m), 845 (w), 734 (s), 649 
(w). GC-MS (EI, 70 eV): m/z (%) =  350 (10), 318 (12), 228 (28), 220 (20), 155 (10), 130 
(10), 129 (44), 116 (100), 111 (11), 101 (10), 98 (11), 97 (15), 95 (12), 85 (21), 83 (16), 81 
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(17), 71 (30), 69 (40), 57 (43), 55 (26), 43 (32), 41 (19). HRMS (ESI, [M-H)-]): Calcd. for 
C20H29O5: 349.20205; found: 349.20192. 
 
Dimethyl 2-ethyl-4-hydroxy-5-nonylbenzene-1,3-dioate (110s): 
Starting with 109b (0.258 g, 1.5 mmol) and 22m (0.638 g, 1.65 mmol), 110s was isolated 
after chromatography (silica gel, heptanes/EtOAc) as a light yellow oil (0.278 g, 51%).  
1H NMR (250 MHz, CDCl3): δ = 0.81 (t, 3J = 6.5 Hz, 3 H, 
CH3), 1.14 (t, 3J = 7.0 Hz, 3 H, CH3), 1.18 – 1.25 (m, 12 H, 6 
CH2), 1.49 – 1.54 (m, 2 H, CH2), 2.54 (t, 3J = 7.0 Hz, 2 H, 
PhCH2), 3.08 (q, 3J = 7.5 Hz, 2 H, PhCH2), 3.80 (s, 3 H, 
OCH3), 3.91 (s, 3 H, OCH3), 7.62 (s, 1 H, CHAr), 11.08 (s, 1 
H, OH). 13C NMR (CDCl3, 75 MHz):  = 13.2, 15.1 (CH3), 
21.7, 24.1, 26.4, 28.2, 28.3, 28.5, 28.8, 30.3, 30.8 (CH2), 50.9, 51.5 (OCH3), 112.3 
(CCOOCH3), 121.6 (CCOOCH3), 127.8 (CAr), 135.0 (CHAr), 145.5 (CAr), 161.0 (COH), 
167.4, 171.1 (CO). IR (KBr, cm-1): ν̃  = 2925 (s), 2854 (m), 1749 (w), 1717 (m), 1662 (m), 
1617 (w), 1577 (w), 1559 (w), 1540 (w), 1507 (w), 1456 (w), 1436 (m), 1331 (w), 1273 (w), 
1229 (m), 1203 (m), 1153 (w), 1070 (w), 994 (w), 909 (m), 817 (w), 734 (m), 668 (w), 649 
(w). GC-(EI, 70 eV): m/z (%) = 364 ([M+], 47), 332 (49), 315 (19), 273 (41), 242 (21), 220 
(100), 187 (21), 160 (9), 129 (26), 116 (54), 97 (12), 85 (7), 69 (11), 57 (14), 43 (16). HRMS 
(EI): Calcd. for C21H32O5 ([M]+): 364.22443; found: 364.223933. 
 
Dimethyl 5-decyl-2-ethyl-4-hydroxybenzene-1,3-dioate (110t):  
Starting with 109b (0.258 g, 1.5 mmol) and 22n (0.661 g, 1.65 mmol), 110t was isolated after 
chromatography (silica gel, heptanes/EtOAc) as a light yellow oil (0.278 g, 49%).  
1H NMR (250 MHz, CDCl3): δ = 0.80 (t, 3J = 6.6 Hz, 3 H, 
CH3), 1.13 (t, 3J = 8.6 Hz, 3 H, CH3), 1.16 – 1.24 (m, 14 H, 7 
CH2), 1.46 – 1.54 (m, 2 H, CH2), 2.53 (t, 3J = 7.6 Hz, 2 H, 
PhCH2), 3.08 (q, 3J = 7.4 Hz, 2 H, PhCH2), 3.79 (s, 3 H, 
OCH3), 3.91 (s, 3 H, OCH3), 7.62 (s, 1 H, CHAr), 11.08 (s, 1 
H, OH). 13C NMR (CDCl3, 75 MHz):  = 13.1, 15.3 (CH3), 
21.8, 24.2, 28.2, 28.3, 28.4, 28.5, 28.6, 28.7, 28.8, 30.9, (CH2), 50.8, 51.5 (OCH3), 112.5 
(CCOOCH3), 121.8 (CCOOCH3), 127.9 (CAr), 134.9 (CHAr), 145.5 (CAr), 161.0 (COH), 
167.4, 171.2 (CO). IR (KBr, cm-1): ν̃  = 2953 (m), 2925 (s), 2854 (m), 1723 (m), 1663 (m), 
1608 (w), 1578 (w), 1435 (m), 1336 (m), 1275 (m), 1228 (m), 1203 (m), 1153 (m), 1069 (w), 
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995 (w), 909 (m), 817 (w), 734 (m), 649 (w). GC-MS (EI, 70 eV): m/z (%) =  378 ([M+],  43),   
363 (3), 346 (48), 329 (19), 311 (11), 287 (40), 275 (9), 261 (36), 233 (19), 220 (100), 207 
(63), 187 (21), 160 (9), 115 (32), 95 (11), 73 (21), 55 (13), 43 (16). HRMS (EI): Calcd. for 
C22H34O5 ([M]+): 378.24008; found: 378.240020. 
 
Dimethyl 4-ethyl-2-hydroxy-4'-methylbiphenyl-3,5-dicarboxylate (110u): 
Starting with 109b (0.258 g, 1.5 mmol) and 22q (0.578 g, 1.65 mmol), 110u was isolated 
after chromatography (silica gel, heptanes/EtOAc) as a light red oil (0.250 g, 51%). 
1H NMR (250 MHz, CDCl3): δ = 1.19 (t, 3J = 7.5 Hz, 3 H, 
CH2CH3), 2.31 (s, 3 H, PhCH3), 3.11 (q, 3J = 7.5 Hz, 2 H, 
CH2CH3), 3.79 (s, 3 H, OCH3), 3.93 (s, 3 H, OCH3), 7.15 - 
7.19 (m, 2 H, 2 CHAr), 7.33 - 7.36 (m, 2 H, 2 CHAr), 7.82 (s, 
1 H, CHAr), 10.60 (s, 1 H, OH). 13C NMR (CDCl3, 75 MHz): 
 = 15.9, 21.2 (CH3), 25.2 (CH2), 52.0, 52.7 (OCH3), 115.2 
(CCOOCH3), 122.9 (CAr), 127.9 (CCOOCH3), 129.1 (2 
CHAr), 129.5 (2 CHAr), 133.5 (CAr), 136.5 (CHAr), 137.5, 147.5 (CAr), 160.0 (COH), 167.7, 
171.6 (CO). IR (neat, cm-1): ν̃  = 2950 (w), 2874 (w), 1719 (m), 1660 (m), 1605 (m), 1561 
(m), 1514 (w), 1431 (m), 1397 (m), 1332 (m), 1293 (m), 1231 (s), 1198 (s), 1174 (s), 1081 
(m), 1029 (m), 961 (m), 932 (m), 822 (m), 778 (m), 745 (m), 680 (w), 656 (m), 539 (m). GC-
MS (EI, 70 eV): m/z (%) = 328 ([M]+, 40), 297 (47), 296 (100), 253 (12), 165 (7). HRMS 
(EI): Calcd. for C19H20O5 ([M]+): 328.13053; found: 328.130425. 
 
Dimethyl 4-hydroxy-5-methyl-2-propylisophthalate (110v):  
Starting with 109c (0.279 g, 1.5 mmol) and 22d (0.453 g, 1.65 mmol), 110v was isolated after 
chromatography (silica gel, heptanes/EtOAc) as a light red oil (0.203 g, 51%).  
1H NMR (250 MHz, CDCl3): δ = 0.85 (t, 3J = 7.5 Hz, 3 H, 
(CH2)3CH3), 1.41 – 1.50 (m, 2 H, CH2CH2CH3), 2.10 (s, 3 H, 
PhCH3), 2.98 (t, 3J = 8.2 Hz, 2 H, CH2CH2CH3), 3.73 (s, 3 H, 
OCH3), 3.86 (s, 3 H, OCH3), 7.58 (s, 1 H, CHAr), 11.09 (s, 1 H, 
OH). 13C NMR (CDCl3, 75 MHz):  = 14.5, 15.8 (CH3), 22.3, 
33.6 (CH2), 51.9, 52.6 (OCH3), 113.2 (CCOOCH3), 122.9 
(CAr), 124.4 (CCOOCH3), 136.8 (CHAr), 145.2 (CAr), 162.4 (COH), 168.3, 172.3 (CO). IR 
(neat, cm-1): ν̃  = 2953 (w), 2927 (w), 2855 (w), 1720 (m), 1658 (m), 1609 (w), 1580 (w), 
1432 (m), 1379 (w), 1331 (m), 1265 (m), 1222 (s), 1192 (s), 1150 (s), 1063 (m), 1017 (m), 
CH2CH3
OH
Chemical Formula: C19H20O5
Exact Mass: 328,13
O
OCH3
O OCH3
H3C
CH2CH2CH3
OH
Chemical Formula: C14H18O5
Exact Mass: 266,12
O
OCH3
O OCH3
H3C
Experimental part 
 
98 
 
CH2CH2CH3
OH
Chemical Formula: C16H22O5
Exact Mass: 294,15
O
OCH2CH3
O OCH3
H3CH2C
985 (m), 912 (w), 843 (w), 813 (m), 760 (m), 731 (m), 678 (w), 647 (w). GC-MS (EI, 70 eV): 
m/z (%) = 266 ([M]+, 28), 235 (29), 234 (100), 219 (12), 203 (24), 187 (14), 178 (14), 177 (9), 
175 (11), 163 (9), 157 (8), 147 (9), 91 (10), 77 (8). HRMS (EI): Calcd. for C14H18O5 ([M]+): 
266.11488; found: 266.114914. 
 
3-Ethyl 1-methyl 5-ethyl-4-hydroxy-2-propylisophthalate (110w):  
Starting with 109c (0.279 g, 1.5 mmol) and 22g (0.499 g, 1.65 mmol), 110w was isolated 
after chromatography (silica gel, heptanes/EtOAc) as a yellowish oil (0.233 g, 53%).  
1H NMR (250 MHz, CDCl3): δ = 0.76 (t, 3J = 7.5 Hz, 3 H, 
(CH2)2CH3), 0.99 (t, 3J = 7.5 Hz, 3 H, CH2CH3), 1.23 (t, 3J = 
7.4 Hz, 3 H, OCH2CH3), 1.32 – 1.47 (m, 2 H, CH2CH2CH3), 
2.44  (q, 3J = 7.6 Hz, 2 H, PhCH2CH3), 2.91 (q, 3J = 7.4 Hz, 2 
H, PhCH2CH2), 3.65 (s, 3 H, OCH3), 4.25  (q, 3J = 7.6 Hz, 2 
H, OCH2CH3), 7.48 (s, 1 H, CHAr), 11.08 (s, 1 H, OH). 13C 
NMR (CDCl3, 75 MHz):  = 14.8, 15.3, 15.8 (CH3), 24.2, 26.5, 34.9 (CH2), 53.2 (OCH3), 
63.4 (OCH2CH3), 114.7 (CCOOCH2CH3), 124.1 (CAr), 131.3 (CCOOCH3), 136.3 (CHAr), 
146.1 (CAr), 163.4 (COH), 169.7, 173.0 (CO). IR (neat, cm-1): ν̃  = 2963 (w), 2933 (w), 2872 
(w), 2255 (w), 1716 (m), 1655 (m), 1607 (w), 1578 (w), 1428 (w), 1396 (w), 1373 (w), 1321 
(w), 1298 (w), 1263 (w), 1223 (s), 1154 (m), 1097 (w), 1054 (w), 1020 (w), 971 (w), 906 (m), 
868 (w), 845 (w), 818 (w), 729 (s), 648 (w), 581 (w). GC-MS (EI, 70 eV): m/z (%) = 294 
([M]+, 38), 263 (14), 249 (22), 248 (100), 233 (17), 230 (14), 217 (21), 215 (11), 198 (17), 
192 (48), 191 (11), 177 (12), 173 (12), 171 (13), 115 (10), 91 (13), 77 (10). HRMS (EI): 
Calcd. for C16H22O5 ([M]+): 294.14618; found: 294.146042. 
 
Dimethyl 5-butyl-4-hydroxy-2-propylisophthalate (110x): 
Starting with 109c (0.279 g, 1.5 mmol) and 22h (0.522 g, 1.65 mmol), 110x was isolated after 
chromatography (silica gel, heptanes/EtOAc) as a light yellowish oil (0.236 g, 51%).  
1H NMR (250 MHz, CDCl3): δ = 0.82 - 0.93 (m, 6 H, 2 
CH3), 1.25 – 1.35 (m, 2 H, (CH2)2CH2CH3), 1.45 – 1.55 (m, 
4 H, 2 CH2), 2.54 (t, 3J = 7.4 Hz, 2 H, PhCH2), 3.03 (t, 3J = 
7.4 Hz, 2 H, PhCH2), 3.79 (s, 3 H, OCH3), 3.91 (s, 3 H, 
OCH3), 7.61 (s, 1 H, CHAr), 11.07 (s, 1 H, OH). 13C NMR 
(CDCl3, 75 MHz):  = 13.9, 14.6 (CH3), 22.6, 25.3, 29.5, 
31.4, 33.6 (CH2), 51.9, 52.5 (OCH3), 113.4 (CCOOCH3), 122.8 (CAr), 128.7 (CCOOCH3), 
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135.9 (CHAr), 145.0 (CAr), 161.9 (COH), 168.3, 172.1 (CO). IR (neat, cm-1): ν̃  = 2955 (w), 
2930 (w), 2871 (w), 2255 (w), 1719 (m), 1661 (m), 1606 (w), 1579 (w), 1434 (m), 1335 (w), 
1297 (w), 1265 (w), 1226 (m), 1199 (m), 1153 (m), 1088 (w), 1063 (w), 999 (w), 907 (m), 
816 (w), 731 (s), 649 (w). GC-MS (EI, 70 eV): m/z (%) = 309 (10), 308 ([M]+, 54), 277 (36), 
276 (41), 259 (30), 247 (20), 245 (38), 235 (13), 234 (100), 233 (29), 219 (11), 217 (53), 216 
(19), 202 (11), 201 (17), 191 (13), 187 (10), 184 (10), 178 (22), 173 (14), 115 (16), 91 (14), 
77 (12). HRMS (EI): Calcd. for C17H24O5 ([M]+): 308.16183; found: 308.162084. 
 
Dimethyl 5-hexyl-4-hydroxy-2-propylisophthalate (110y):  
Starting with 109c (0.279 g, 1.5 mmol) and 22j (0.569 g, 1.65 mmol), 110y was isolated after 
chromatography (silica gel, heptanesEtOAc) as a yellowish oil (0.227 g, 45%).  
1H NMR (250 MHz, CDCl3): δ = 0.80 (t, 3J = 7.4 Hz, 3 H, 
(CH2)5CH3), 0.90 (t, 3J = 7.4 Hz, 3 H, (CH2)2CH3), 1.17 – 
1.32 (m, 6 H, 3 CH2), 1.43 – 1.56 (m, 4 H, 2 CH2), 2.53 (t, 
3J = 7.4 Hz, 2 H, PhCH2), 3.03 (t, 3J = 7.5 Hz, 2 H, PhCH2), 
3.78 (s, 3 H, OCH3), 3.90 (s, 3 H, OCH3), 7.61 (s, 1 H, 
CHAr), 11.07 (s, 1 H, OH). 13C NMR (CDCl3, 75 MHz):  = 
14.0, 14.6 (CH3), 22.6, 25.3, 29.1, 29.2, 29.8, 31.7, 33.6 (CH2), 51.9, 52.6 (OCH3), 113.7 
(CCOOCH3), 122.9 (CAr), 128.8 (CCOOCH3), 136.0 (CHAr), 145.0 (CAr), 162.3 (COH), 
168.4, 172.3 (CO). IR (neat, cm-1): ν̃  = 2954 (w), 2927 (m), 2857 (w), 2255 (w), 1720 (m), 
1660 (m), 1606 (w), 1579 (w), 1433 (m), 1331 (w), 1298 (w), 1261 (w), 1226 (s), 1199 (s), 
1152 (m), 1092 (w), 1062 (w), 995 (w), 972 (w), 907 (m), 816 (w), 731 (s), 649 (w). GC-MS 
(EI, 70 eV): m/z (%) = 337 (34), 336 ([M]+, 98), 306 (19), 305 (91), 304 (96), 303 (14), 289 
(21), 288 (13), 287 (75), 276 (23), 275 (89), 274 (14), 273 (76), 262 (18), 261 (37), 249 (11), 
248 (54), 247 (72), 246 (17), 245 (87), 244 (13), 235 (55), 234 (100), 233 (88), 229 (12), 219 
(22), 217 (14), 216 (32), 215 (32), 206 (11), 205 (13), 203 (18), 202 (23), 201 (44), 192 (13), 
191 (24), 189 (11), 187 (14), 184 (14), 178 (37), 175 (18), 174 (12), 173 (22), 159 (11), 157 
(14), 147 (12), 146 (10), 145 (13), 115 (12), 91 (12). HRMS (EI): Calcd. for C19H28O5 ([M]+): 
336.19313; found: 336.192594. 
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Dimethyl 5-heptyl-4-hydroxy-2-propylisophthalate (110z):  
Starting with 109c (0.279 g, 1.5 mmol) and 22k (0.592 g, 1.65 mmol), 110z was isolated after 
chromatography (silica gel, heptanes/EtOAc) as a yellowish oil (0.242 g, 46%).  
1H NMR (250 MHz, CDCl3): δ = 0.79 (t, 3J = 7.6 Hz, 3 H, 
(CH2)6CH3), 0.91 (t, 3J = 7.5 Hz, 3 H, (CH2)2CH3), 1.13 – 
1.30 (m, 8 H, 4 CH2), 1.45 – 1.58 (m, 4 H, 2 CH2), 2.54 (t, 
3J = 7.6 Hz, 2 H, PhCH2), 3.03 (t, 3J = 7.5 Hz, 2 H, 
PhCH2), 3.79 (s, 3 H, OCH3), 3.91 (s, 3 H, OCH3), 7.61 (s, 
1 H, CHAr), 11.07 (s, 1 H, OH). 13C NMR (CDCl3, 75 
MHz):  = 14.0, 14.6 (CH3), 22.7, 25.4, 29.1, 29.5, 29.6, 29.8, 31.8, 33.6 (CH2), 51.9, 52.5 
(OCH3), 113.6 (CCOOCH3), 122.8 (CAr), 128.8 (CCOOCH3), 135.8 (CHAr), 145.0 (CAr), 
162.1 (COH), 168.4, 172.2 (CO). IR (neat, cm-1): ν̃  = 2954 (w), 2926 (m), 2855 (w), 1720 
(m), 1661 (m), 1607 (w), 1578 (w), 1434 (m), 1329 (w), 1298 (w), 1262 (w), 1226 (s), 1199 
(m), 1152 (w), 1093 (w), 1063 (w), 994 (w), 908 (w), 816 (w), 732 (s), 649 (w). GC-MS (EI, 
70 eV): m/z (%) = 351 (13), 350 ([M]+, 56), 319 (41), 318 (43), 301 (34), 289 (10), 287 (36), 
276 (12), 275 (50), 262 (10), 261 (12), 259 (43), 248 (11), 247 (25), 235 (17), 234 (100), 233 
(44), 219 (11), 216 (12), 203 (11), 202 (12), 201 (21), 191 (14), 178 (22), 173 (14), 145 (10). 
HRMS (EI): Calcd. for C20H30O5 ([M]+): 350.20878; found: 350.208521. 
 
Dimethyl 4-hydroxy-5-octyl-2-propylisophthalate (110aa):  
Starting with 109c (0.279 g, 1.5 mmol) and 22l (0.615 g, 1.65 mmol), 110aa was isolated 
after chromatography (silica gel, heptanes/EtOAc) as a 
yellowish oil (0.246 g, 45%). 
 1H NMR (250 MHz, CDCl3): δ = 0.80 (t, 3J = 7.4 Hz, 3 H, 
(CH2)7CH3), 0.90 (t, 3J = 7.6 Hz, 3 H, (CH2)2CH3), 1.17 – 
1.30 (m, 10 H, 5 CH2), 1.46 – 1.57 (m, 4 H, 2 CH2), 2.53 (t, 
3J = 7.6 Hz, 2 H, PhCH2), 3.03 (t, 3J = 7.5 Hz, 2 H, PhCH2), 
3.79 (s, 3 H, OCH3), 3.90 (s, 3 H, OCH3), 7.61 (s, 1 H, 
CHAr), 11.07 (s, 1 H, OH). 13C NMR (CDCl3, 75 MHz):  = 14.0, 14.6 (CH3), 22.6, 25.3, 
29.1, 29.2, 29.4, 29.5, 29.8, 31.8, 33.6 (CH2), 51.8, 52.5 (OCH3), 113.7 (CCOOCH3), 123.1 
(CAr), 129.0 (CCOOCH3), 136.1 (CHAr), 145.4 (CAr), 162.1 (COH), 168.2, 172.2 (CO). IR 
(neat, cm-1): ν̃  = 2954 (w), 2926 (m), 2855 (w), 2256 (w), 1721 (w), 1662 (m), 1606 (w), 
1579 (w), 1434 (m), 1331 (w), 1298 (w), 1262 (w), 1227 (m), 1200 (m), 1152 (w), 1094 (w), 
1062 (w), 995 (w), 908 (m), 817 (w), 733 (s), 649 (w). GC-MS (EI, 70 eV): m/z (%) = 364 
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([M]+, 47), 333 (42), 332 (73), 315 (28), 301 (33), 289 (11), 276 (21), 275 (74), 273 (53), 261 
(13), 248 (17), 247 (32), 235 (26), 234 (100), 233 (69), 228 (16), 219 (14), 217 (11), 216 (22), 
215 (10), 203 (13), 202 (16), 201 (32), 191 (14), 185 (11), 184 (11), 179 (11), 178 (25), 175 
(14), 173 (17), 158 (10), 157 (12), 155 (13), 147 (10), 145 (10), 130 (11), 129 (45), 117 (13), 
116 (85), 115 (11), 101 (10), 98 (11), 91 (11), 85 (19), 83 (12), 81 (10), 71 (30), 69 (25), 57 
(42), 55 (23). HRMS (EI): Calcd. for C21H32O5 ([M]+): 364.22443; found: 364.224478. 
 
Dimethyl 4-hydroxy-5-nonyl-2-propylbenzene-1,3-dioate (110ab): 
Starting with 109c (0.279 g, 1.5 mmol) and 22m (0.638 g, 1.65 mmol), 110ab was isolated 
after chromatography (silica gel, heptanes/EtOAc) as a yellowish oil (0.284 g, 50%).  
1H NMR (250 MHz, CDCl3): δ = 0.80 (t, 3J = 6.4 Hz, 3 H, 
(CH2)8CH3), 0.91 (t, 3J = 7.5 Hz, 3 H, (CH2)2CH3), 1.15 – 
1.26 (m, 14 H, 7 CH2), 1.52 – 1.54 (m, 2 H, CH2), 2.54 (t, 3J 
= 7.5 Hz, 2 H, PhCH2), 3.00 – 3.06 (m, 2 H, PhCH2), 3.79 
(s, 3 H, OCH3), 3.91 (s, 3 H, OCH3), 7.61 (s, 1 H, CHAr), 
11.07 (s, 1 H, OH). 13C NMR (CDCl3, 75 MHz):  = 13.0, 
13.9 (CH3), 21.9, 24.4, 26.1, 28.2, 28.3, 28.5, 28.8, 30.3, 30.9 32.6 (CH2), 50.9, 51.5 (OCH3), 
112.6 (CCOOCH3), 121.9 (CCOOCH3), 127.9 (CAr), 135.1 (CHAr), 144.2 (CAr), 161.2 (COH), 
167.6, 171.2 (CO). IR (KBr, cm-1): ν̃  = 2954 (m), 2925 (s), 2854 (m), 1722 (m), 1662 (m), 
1608 (w), 1578 (w), 1435 (m), 1330 (w), 1299 (w), 1262 (m), 1227 (s), 1200 (m), 1153 (m), 
1094 (w), 1063 (w), 995 (w), 908 (m), 817 (w), 733 (s), 650 (w). GC-MS (EI, 70 eV): m/z (%) 
=  378 ([M+],  50),   368 (5), 346 (57), 329 (21), 275 (40), 242 (22), 234 (100), 201 (17), 178 
(18), 158 (12), 129 (37), 116 (78), 97 (16), 85 (12), 69 (17), 57 (23), 43 (21). HRMS (EI): 
Calcd. for C22H34O5 ([M]+): 378.24008; found: 378.239947. 
 
Dimethyl 5-decyl-4-hydroxy-2-propylbenzene-1,3-dioate (110ac):  
Starting with 109c (0.279 g, 1.5 mmol) and 22n (0.661 g, 1.65 mmol), 110ac was isolated 
after chromatography (silica gel, heptanes/EtOAc) as a yellowish oil (0.323 g, 55%).  
1H NMR (250 MHz, CDCl3): δ = 0.80 (t, 3J = 6.5 Hz, 3 H, 
(CH2)9CH3), 0.91 (t, 3J = 7.2 Hz, 3 H, (CH2)2CH3), 1.16 – 
1.26 (m, 16 H, 8 CH2), 1.49 – 1.54 (m, 2 H, CH2), 2.53 (t, 3J 
= 7.7 Hz, 2 H, PhCH2), 3.01 – 3.06 (m, 2 H, PhCH2), 3.79 
(s, 3 H, OCH3), 3.91 (s, 3 H, OCH3), 7.61 (s, 1 H, CHAr), 
11.07 (s, 1 H, OH). 13C NMR (CDCl3, 75 MHz):  = 13.9, 
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14.7 (CH3), 22.7, 25.2, 29.2, 29.3, 29.4, 29.5, 29.6, 29.7, 29.8, 31.9, 33.8 (CH2), 51.9, 52.7 
(OCH3), 113.3 (CCOOCH3), 122.9 (CCOOCH3), 128.8 (CAr), 136.0 (CHAr), 145.1 (CAr), 
162.0 (COH), 168.4, 172.2 (CO). IR (KBr, cm-1): ν̃  = 2954 (m), 2955 (m), 2854 (m), 1723 
(m), 1662 (m), 1606 (w), 1579 (w), 1434 (m), 1331 (w), 1298 (w), 1261 (w), 1227 (m), 1200 
(m), 1152 (w), 1095 (w), 1061 (w), 996 (w), 908 (w), 817 (w), 734 (m), 650 (w). GC-MS (EI, 
70 eV): m/z (%) =  392 ([M+],  50),   360 (43), 343 (20), 301 (30), 275 (31), 247 (20), 234 
(100), 219 (8), 201 (15), 178 (18), 145 (7), 116 (12), 91 (5), 69 (4), 55 (7), 43 (11). HRMS 
(EI): Calcd. for C23H36O5  ([M]+): 392.25573; found: 392.255638. 
 
6-Ethyl 2-methyl 3-hydroxy-4-methylbiphenyl-2,6-dicarboxylate (110ad):  
Starting with 109d (0.372 g, 1.5 mmol) and 22d (0.453 g, 1.65 mmol), 110ad was isolated 
after chromatography (silica gel, heptanes/EtOAc) as a yellowish oil (0.272 g, 58%).  
1H NMR (300 MHz, CDCl3): δ = 1.17 (t, 3J = 7.0 Hz, 3 H, 
OCH2CH3), 2.24 (s, 3 H, PhCH3), 3.89 (s, 3 H, OCH3), 4.14 (q, 
3J = 7.5 Hz, 2 H, OCH2CH3), 7.02 - 7.06  (m, 3 H, 3 CHAr), 7.33 
- 7.36 (m, 2 H, 2 CHAr), 7.88 (s, 1 H, CHAr), 11.04 (s, 1 H, OH). 
13C NMR (CDCl3, 75 MHz):  = 14.0, 15.8 (CH3), 51.9 (OCH3), 
61.4 (OCH2), 112.7 (CCOOCH3), 123.9 (CCOOC2H5), 126.0 
(CAr), 128.2 (CHAr), 128.4 (2 CHAr), 128.7 (2 CHAr), 133.7 (CHAr), 135.6, 135.9 (CAr), 167.5 
(COH), 171.4, 173.1 (CO). IR (KBr, cm-1): ν̃  = 3059 (w), 2981 (w), 2953 (w), 2905 (w), 
2872 (w), 1737 (m), 1686 (m), 1662 (m), 1597 (m), 1578 (m), 1494 (w), 1381 (w), 1366 (m), 
1264 (m), 1193 (s), 1148 (s), 1076 (m), 1022 (m), 998 (m), 942 (w), 870 (w), 814 (m), 755 
(m), 687 (s), 647 (m), 572 (m). GC-MS (EI, 70 eV): m/z (%) = 314 ([M]+, 51), 283 (20), 282 
(100), 254 (22), 253 (96), 237 (27), 210 (12), 209 (47), 208 (23), 181 (10), 153 (15), 152 (10). 
HRMS (EI): Calcd. for C18H18O5 ([M]+): 314.11488; found: 314.114952. 
 
Diethyl 4-ethyl-3-hydroxybiphenyl-2,6-dicarboxylate (110ae): 
Starting with 109d (0.372 g, 1.5 mmol) and 22g (0.499 g, 1.65 mmol), 110ae was isolated 
after chromatography (silica gel, heptanes/EtOAc) as yellowish oil (0.308 g, 60%).  
1H NMR (300 MHz, CDCl3) : δ = 0.57  (t, 3J = 7.3 Hz, 3 H, 
OCH2CH3), 0.77 (t, 3J = 7.4 Hz, 3 H, OCH2CH3) , 1.16 (t, 3J = 
7.3 Hz, 3 H, PhCH2CH3), 2.61 (q, 3J = 7.5 Hz, 2 H, 
PhCH2CH3), 3.74 – 3.85(m, 4 H, 2 OCH2CH3), 6.99 – 7.04 
(m, 2 H, 2 CHAr), 7.17 - 7.19 (m, 3 H, 3 CHAr), 7.62 (s, 1 H, 
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CHAr), 11.17 (s, 1 H, OH). 13C NMR (CDCl3, 75 MHz):  = 12.8, 13.4, 13.6 (CH3), 22.9, 
60.7, 61.3 (CH2), 113.0 (CCOOCH3), 124.5 (CCOOC2H5), 126.6 (CHAr), 127.1 (2 CHAr), 
128.3 (2 CHAr), 131.9 (CHAr), 134.4, 141.2, 142.3 (CAr), 161.5 (COH), 168.4, 171.3 (CO). IR 
(KBr, cm-1): ν̃  = 3058 (w), 2978 (w), 2935 (w), 2874 (w), 2254 (w), 1708 (m), 1657 (m), 
1602 (w), 1571 (w), 1443 (m), 1398 (w), 1367 (m), 1329 (m), 1306 (m), 1281 (m), 1265 (m), 
1214 (s), 1178 (s), 1125 (m), 1095 (w), 1066 (w), 1020 (m), 907 (m), 884 (w), 866 (w), 819 
(w), 763 (w), 728 (s), 698 (s), 669 (w), 648 (w). GC-MS (EI, 70 eV): m/z (%) = 342 ([M]+, 
35), 297 (16), 296 (51), 268 (19), 267 (100), 251 (12), 223 (36), 222 (11), 165 (13), 152 (13). 
HRMS (EI): Calcd. for C20H22O5 ([M]+) : 342.14618; found: 342.146145. 
 
2-Ethyl 1-methyl 3-hydroxy-4,5-dimethylphthalate (113b):  
Starting with 112a (0.433 g, 2.0 mmol) and 22e (0.635 g, 2.2 mmol), 113b was isolated as a 
reddish viscous oil (0.161 g, 32%).  
1H NMR (250 MHz, CDCl3):  = 1.27 (t, 3J = 7.6 Hz, 3 H, 
OCH2CH3), 2.26 (s, 3 H, PhCH3), 2.39 (s, 3 H, PhCH3), 3.85 (s, 
3H, OCH3), 4.24 (q, 3J = 7.4 Hz, 2 H, OCH2CH3), 6.94 (s, 1 H, 
CHAr), 11.54 (s, 1H, OH).13C NMR (62 MHz, CDCl3):  = 11.5, 
13.4, 21.6 (CH3), 51.3 (OCH3), 60.2 (OCH2), 112.4 (CAr), 121.4 
(CHAr), 124.0, 134.7, 136.7 (CAr), 160.3 (COH), 166.7, 171.2 (CO). IR (neat, cm-1): ν̃ = 1660 
(s), 1619 (m), 1452 (s), 1343 (s), 1219 (m), 1136 (s), 966 (m), 882 (m), 694 (m). MS (EI, 70 
eV): m/z (%) = 252 ([M+], 55), 220 (100), 207 (37), 192 (87), 175 (13), 164 (82), 147 (17), 
119 (15), 91 (25), 77 (11), 65 (18). HRMS (EI): Calcd. for C13H16O5: 252.10056; found: 
252.09998. 
1-Ethyl 2-methyl 4-hexyl-3-hydroxy-5-methylphthalate (113d):  
Starting with 112b (0.461 g, 2.0 mmol) and 22j (0.758 g, 2.2 mmol), 113d was isolated as a 
reddish viscous oil (0.238 g, 37%).  
1H NMR (250 MHz, CDCl3):  = 0.81 (t(br), 3J = 7.1 Hz, 3 
H, CH3), 1.02−1.25 (m, 8 H, CH2), 1.31 (t, 3J = 7.6 Hz, 3 H, 
OCH2CH3), 2.24 (s, 3 H, PhCH3), 2.58 (t, 3J = 7.4 Hz, 2 H, 
PhCH2), 3.81 (s, 3 H, OCH3), 4.25 (q, 3J = 7.2 Hz, 2 H, 
OCH2CH3), 6.69 (s, 1 H, CHAr), 10.84 (s, 1 H, OH).  
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13C NMR (62 MHz, CDCl3):  = 15.2, 15.4 (CH3), 23.7 (CH2), 25.1 (CH3), 28.3, 30.3, 30.1, 
32.7 (CH2), 34.4 (OCH3), 64.4 (OCH2CH3), 114.8 (CAr), 123.7 (CHAr), 130.8, 137.1, 139.1 
(CAr), 162.4 (COH), 168.4, 173.4 (CO). MS (EI, 70 eV): m/z (%) = 322 ([M+], 20), 290 (7), 
261 (11), 233 (5), 220 (100), 206 (32), 192 (32), 174 (8), 161 (6), 148 (7), 119 (8), 91 (6), 69 
(7). HRMS (EI): Calcd. for C18H26O5: 322.17747; found: 322.17730. 
1-Ethyl 2-methyl 3-hydroxy-5-methyl-4-nonylphthalate (113e):  
Starting with 112b (0.461 g, 2.0 mmol) and 22m (0.851 g, 2.2 mmol), 113e was isolated as a 
yellowish oil (0.306 g, 42%). 
1H NMR (250 MHz, CDCl3): δ = 0.81 (t, 3J = 6.3 Hz, 3 H, 
CH3), 1.16-1.19 (m, 14 H, 7CH2), 1.32 (t, 3J = 6.7 Hz, 3 H, 
OCH2CH3), 2.44 (s, 3 H, PhCH3), 2.53 (t, 3J = 7.5 Hz, 2 H, 
CH2), 3.83 (s, 3 H, OCH3), 4.29 (q, 3J = 7.5 Hz, 2 H, 
OCH2CH3), 6.12 (s, 1 H, CHAr), 11.84 (s, 1 H, OH). 13C 
NMR (CDCl3, 75 MHz):  = 13.0, 13.1, 21.6 (CH3), 22.7, 25.9, 28.5, 29.0, 29.3, 29.6, 30.8, 
31.8 (CH2), 50.7 (OCH3), 60.3 (OCH2), 112.9 (CAr), 121.4 (CHAr), 128.6, 134.8, 144.3, (CAr), 
159.9 (COH), 165.0, 171.4 (CO). IR (neat, cm-1): ν̃ = 3336 (w), 3107 (w), 2953 (w), 2919 
(m), 2848 (w), 1725 (w), 1660 (w), 1612 (m), 1493 (w), 1462 (m), 1415 (m), 1284 (m), 1259 
(m), 1201 (m), 1225 (m), 1089 (m), 1014 (m), 977 (m), 840 (w), 795 (s), 754 (m), 722 (w), 
682 (w), 622 (w), 551 (w). GC-MS (EI, 70 eV): m/z (%) = 364 ([M]+, 22), 260 (19), 259 
(100), 192 (12), 191 (34). HRMS (EI): Calcd. for C21H32O5 ([M]+): 364.22443; found: 
364.224257. 
1-Ethyl 2-methyl 4-decyl-3-hydroxy-5-methylphthalate (113f):  
Starting with 112b (0.461 g, 2.0 mmol) and 22n (0.882 g, 2.2 mmol), 113f was isolated as a 
yellowish oil (0.318 g, 42%).  
1H NMR (250 MHz, CDCl3): δ = 0.80 (t, 3J = 6.7 Hz, 3 H, 
CH3), 1.16-1.19 (m, 16 H, 8 CH2), 1.32 (t, 3J = 6.2 Hz, 3 H, 
OCH2CH3), 2.44 (s, 3 H, PhCH3), 2.76 (t, 3J = 7.2 Hz, 2 H, 
PhCH2), 3.89 (s, 3 H, OCH3), 4.29 (q, 3J = 6.2 Hz, 2 H, 
OCH2CH3), 6.94 (s, 1 H, CHAr), 11.54 (s, 1 H, OH). 13C 
NMR (CDCl3, 75 MHz):  = 13.0, 13.2, 21.6 (CH3), 22.8, 
25.9, 26.2, 28.2, 28.4, 28.5, 29.0, 30.8, 31.8 (CH2), 51.3 (OCH3), 60.2 (OCH2), 112.6 (CAr), 
121.4 (CHAr), 128.6, 134.7, 136.8 (CAr), 160.2 (COH), 166.9, 171.2 (CO).  
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IR (neat, cm-1): ν̃ = 2953 (w), 2922 (s), 2852 (m), 1724 (m), 1662 (m), 1624 (w), 1561 (w), 
1445 (m), 1395 (m), 1367 (m), 1298 (m), 1229 (s), 1193 (m), 1148 (m), 1104 (m), 1058 (m), 
1011 (m), 843 (m), 800 (m), 780 (m), 721 (w), 602 (w). GC-MS (EI, 70 eV): m/z (%) = 378 
([M]+, 21), 274 (20), 273 (100), 192 (12), 191 (32). HRMS (EI): Calcd. for C22H34O5 ([M]+): 
378.24008; found: 378.239759.  
4-Ethyl 3-methyl 2-hydroxy-4'-methoxy-6-methylbiphenyl-3,4-dicarboxylate (113h): 
Starting with 112b (0.461 g, 2.0 mmol) and 22s (0.807 g, 2.2 mmol), 113h was isolated as a 
yellowish oil (0.268 g, 39 %).  
1HNMR (250 MHz, CDCl3) : δ = 1.27 (t, 3J = 7.1 Hz, 3 
H, OCH2CH3), 2.51 (s, 3 H, PhCH3), 3.76 (s, 3 H, 
OCH3), 3.91 (s, 3 H, OCH3),  3.99 (q, 3J = 6.2 Hz, 2 H, 
OCH2CH3), 6.76 (s, 1 H, CHAr), 6.85 - 6.88 (m, 2 H, 
CHAr), 7.10 - 7.12 (m, 2 H, CHAr), 11.43 (s, 1 H, OH). 
13C NMR (CDCl3, 75 MHz):  = 12.6, 19.0 (CH3), 51.4, 
54.2 (OCH3), 60.1 (OCH2), 112.5 (CAr), 113.1 (2CHAr), 121.2 (CHAr), 127.0, 129.1 (CAr), 
129.4 (2 CHAr), 129.8, 136.2, 157.6 (CAr), 159.2 (COH), 170.4, 170.9 (CO). IR (neat, cm-1): 
ν̃ = 3034 (w), 2953 (w), 2931 (w), 2871 (w), 2836 (w), 1720 (w), 1661 (w), 1608 (m), 1510 
(m), 1438 (w), 1392 (w), 1368 (w), 1299 (w), 1243 (s), 1193 (w), 1174 (m), 1156 (m), 1109 
(w), 1078 (w), 1031 (m), 969 (w), 902 (w), 831 (m), 788 (w), 689 (w), 643 (w), 597 (w), 578 
(w). GC-MS (EI, 70 eV): m/z (%) = 344 ([M]+, 53), 313 (21), 312 (100), 283 (18), 256 (13), 
239 (8), 211 (6), 197 (5), 149 (7), 135 (10), 121 (12), 73 (12). HRMS (EI): Calcd. for 
C19H20O6 ([M]+): 344.125; found: 344.071546. 
Diethyl 3-hydroxy-5-methyl-4-phenoxyphthalate (113i):  
Starting with 112b (0.461 g, 2.0 mmol) and 22v (0.807 g, 2.2 mmol), 113i was isolated as a 
reddish viscous oil (0.275 g, 40%).  
1H NMR (250 MHz, CDCl3):  = 0.91 (t, 3J = 7.2 Hz, 3 H, 
OCH2CH3), 1.27 (t, 3J = 7.5 Hz, 3 H, OCH2CH3), 2.42 (s, 3 H, 
PhCH3), 4.01 (q, 3J = 7.6 Hz, 2 H, OCH2CH3), 4.28 (q, 3J = 7.4 
Hz, 2 H, OCH2CH3), 6.66 (m, 1 H, CHAr), 6.67 − 6.83 (m, 2 H, 
2 CHAr), 7.04 (m, 1 H, CHAr), 7.07 − 7.08 (m, 2 H, CHAr), 11.16 
(s, 1 H, OH). 13C NMR (62 MHz, CDCl3):  = 13.7, 14.1, 23.6 
(CH3), 61.4, 62.3 (CH2), 114.8 (2CHAr), 116.4 (CAr), 121.7, 122.2 (CHAr), 129.3 (CHAr), 
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129.8, 132.1, 137.1, 140.0 (CAr), 156.3 (COH), 158.4 (CAr), 165.1, 170.8 (CO).                     
IR (neat, cm-1): ν̃ = 2980 (w), 1727 (m), 1661 (m), 1489 (m), 1412 (m), 1371 (m), 1296 (m), 
1236 (s), 1016 (s), 747 (m), 687 (m). GC-MS (EI, 70 eV): m/z (%) = 344 ([M+], 63), 298 (38), 
269 (8), 253 (20), 226 (100), 197 (13), 177 (5), 148 (6), 121 (6), 105 (48).  
5-Ethyl 2-methyl 3-hydroxybiphenyl-2,5-dicarboxylate (118a):  
Starting with 117a (0.439 g, 1.5 mmol) and 22a (0.430 g, 1.65 mmol), 118a was isolated after 
chromatography (silica gel, n-heptane/EtOAc) as a pale yellowish oil, (0.194 g, 43%).  
1H NMR (300 MHz, CDCl3): δ = 1.31 (t, 3J = 7.5 Hz, 3 H, 
CH3), 3.43 (s, 3 H, OCH3), 4.31 (q, 3J = 7.1 Hz, 2 H, OCH2), 
7.14 - 7.18 (m, 2 H, CHAr), 7.26 - 7.33 (m, 3 H, CHAr), 7.39 
(d, 4J = 1.7 Hz, 1 H, CHAr), 7.57 (d, 4J = 1.8 Hz, 1 H, CHAr), 
10.41 (s, 1 H, OH). 13C NMR (CDCl3, 250 MHz):  = 14.33 
(CH3), 52.19 (OCH3), 60.38 (OCH2) 115.51 (CAr), 117.67, 
122.90, 127.16 (CHAr), 127.75 (2 CHAr), 128.13 (2 CHAr), 134.76, 141.93, 145.00 (CAr), 
160.96 (COH), 165.38, 170.82 (CO). IR (KBr, cm-1): ν̃ = 3065 (w), 3026 (w), 2959 (w), 2904 
(w), 1713 (s), 1671 (s), 1611 (m), 1567 (m), 1497 (w), 1433 (m), 1410 (m), 1367 (m), 1341 
(m), 1321 (m), 1307 (w), 1264 (m), 1238 (s), 1201 (s), 1155 (m), 1139 (m), 1113 (m), 1081 
(m), 1025 (m), 982 (m), 948 (m), 922 (w), 892 (m), 870 (w), 828 (m), 806 (m), 766 (s), 699 
(s), 666 (m), 648 (m), 621 (m), 607 (m), 563 (m). GC-MS (EI, 70 eV): m/z (%) = 300 ([M]+, 
28), 269 (20), 268 (100), 196 (12), 195 (14), 168 (10), 139 (20). HRMS (EI): Calcd. for 
C17H16O5 ([M]+): 300.09923; found: 300.099353. 
5-Ethyl 2-methyl 3-hydroxy-4-methylbiphenyl-2,5-dicarboxylate (118b):  
Starting with 117a 0.439 g, 1.5 mmol) and 22d (0.453 g, 1.65 mmol), 118b was isolated after 
chromatography (silica gel, n-heptane/EtOAc) as a yellowish oil, (0.231 g, 49%). 
 1H NMR (300 MHz, CDCl3) : δ = 1.24 (t, 3J = 7.5 Hz, 3 H, 
CH3), 2.35 (s, 3 H, PhCH3), 3.36 (s, 3 H, OCH3), 4.24 (q, 3J = 
7.4 Hz, 2 H, OCH2), 7.06 (s, 1 H, CHAr), 7.11 - 7.18 (m, 2 H, 
CHAr), 7.21 - 7.27 (m, 3 H, CHAr), 10.82 (s, 1 H, OH). 13C 
NMR (CDCl3, 250 MHz):  = 12.71, 14.34 (CH3), 51.96 
(OCH3), 60.37 (OCH2) 113.34 (CAr), 122.36 (CHAr), 126.75 (CAr), 126.95 (CHAr), 127.78 (2 
CHAr), 128.13 (2 CHAr), 135.43, 141.49, 142.28 (CAr), 159.98 (COH), 167.47, 171.51 (CO). 
IR (KBr, cm-1): ν̃ = 3025 (w), 2952 (w), 2929 (w), 2871 (w), 1723 (s), 1665 (s), 1600 (w), 
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1561 (w), 1499 (w), 1437 (m), 1394 (m), 1380 (m), 1367 (m), 1341 (m), 1298 (m), 1261 (s), 
1230 (s), 1194 (s), 1158 (s), 1138 (m), 1095 (s), 1049 (s), 1003 (m), 967 (m), 937 (m), 843 
(m), 810 (m), 800 (m), 785 (m), 759 (m), 699 (s), 628 (w), 613 (m),  581 (w). GC-MS (EI, 70 
eV): m/z (%) =  315 (11), (314 ([M]+, 53), 283 (21), 282 (100), 281 (13), 269 (23), 254 (13), 
253 (57), 226 (19), 210 (15), 209 (24), 197 (16), 182 (17), 181 (23), 153 (17), 152 (32), 151 
(10). HRMS (EI): Calcd. for C18H18O5 ([M]+): 314.11488; found: 314.114942. 
5-Ethyl 2-methyl 4-ethyl-3-hydroxybiphenyl-2,5-dicarboxylate (118c):  
Starting with 117a (0.439 g, 1.5 mmol) and 22f (0.476 g, 1.65 mmol), 118c was isolated after 
chromatography (silica gel, n-heptane/EtOAc) as a pale yellowish oil, (0.246 g, 50%). 
 1H NMR (300 MHz, CDCl3) : δ = 1.17 (t, 3J = 7.3 Hz, 3 H, 
CH3), 1.30 (t, 3J = 7.3 Hz, 3 H, CH3),  2.88 (q, 3J = 7.3Hz, 2 
H, PhCH2), 3.41 (s, 3 H, OCH3), 4.29 (q, 3J = 7.2Hz, 2 H, 
OCH2), 7.07 (s, 1 H, CHAr), 7.13 - 7.17 (m, 2 H, CHAr), 7.22 - 
7.31 (m, 3 H, CHAr), 10.81 (s, 1 H, OH). 13C NMR (CDCl3, 
250 MHz):  = 13.06, 13.20 (CH3), 19.45 (PhCH2), 50.90 
(OCH3), 60.31 (OCH2) 112.50 (CAr), 121.49, 125.94 (CHAr), 126.70 (2 CHAr), 127.14 (2 
CHAr), 131.29, 134.30, 140.69, 141.22 (CAr), 159.13 (COH), 166.83, 170.47 (CO). IR (KBr, 
cm-1): ν̃ = 3025 (w), 2953 (w), 2934 (w), 2874 (w), 1723 (s), 1665 (s), 1600 (w), 1558 (w), 
1495 (w), 1437 (m), 1390 (m), 1367 (m), 1346 (m), 1283 (m), 1247 (s), 1222 (s), 1193 (s), 
1157 (s), 1138 (m), 1076 (s), 1028 (m), 1007 (m), 966 (m), 947 (m), 887 (w), 844 (m), 815 
(m), 800 (m), 785 (m), 759 (m), 699 (s), 627 (w), 581 (w). GC-MS (EI, 70 eV): m/z (%) =  
329 (21), (328 ([M]+, 100), 297 (22), 296 (94), 295 (22), 283 (35), 268 (39), 276 (67), 253 
(19), 251 (11), 249 (23), 240 (11), 225 (19), 224 (35), 223 (28), 221 (13), 197 (49), 196 (42), 
195 (25), 194 (10), 167 (10), 166 (14), 165 (51), 153 (12), 152 (34), 151 (11), 139 (14), 129 
(11), 115 (12). HRMS (EI): Calcd. for C19H20O5 ([M]+) : 328.13053; found: 328.130470. 
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5-Ethyl 2-methyl 4-butyl-3-hydroxybiphenyl-2,5-dicarboxylate (118d):  
Starting with 117a (0.439 g, 1.5 mmol) and 22h (0.522 g, 1.65 mmol), 118d was isolated after 
chromatography (silica gel, n-heptane/EtOAc) as a yellowish oil, (0.245 g, 46%).  
1H NMR (300 MHz, CDCl3): δ = 1.24 (t, 3J = 7.7 Hz, 3 H, 
CH3), 1.30 (t, 3J = 7.8 Hz, 3 H, CH3), 1.35 - 1.40 (m, 2 H,  
CH2), 1.49 - 1.57 (m, 2 H,  CH2), 2.87 (q, 3J = 7.5Hz, 2 H, 
PhCH2), 3.41 (s, 3 H, OCH3), 4.28 (q, 3J = 7.2Hz, 2 H, OCH2), 
7.07 (s, 1 H, CHAr), 7.13 - 7.17 (m, 2 H, CHAr), 7.24 - 7.30 (m, 
3 H, CHAr), 10.81 (s, 1 H, OH). 13C NMR (CDCl3, 250 MHz): 
 = 13.02, 13.24 (CH3), 22.10, 28.67, 30.93 (CH2) 50.91 (OCH3), 60.53 (OCH2) 112.55 (CAr), 
121.40, 125.93 (CHAr), 126.74 (2 CHAr), 127.14 (2 CHAr), 130.20, 134.46, 140.66, 141.28 
(CAr), 158.75 (COH), 166.61, 170.42 (CO). IR (KBr, cm-1): ν̃ = 3058 (w), 3026 (w), 2954 (m), 
2925 (m), 2856 (m), 1724 (s), 1666 (s), 1600 (m), 1555 (w), 1438 (m), 1391 (m), 1367 (m), 
1345 (m), 1316 (m), 1290 (m), 1262 (s), 1232 (s), 1194 (s), 1156 (s), 1138 (m), 1092 (s), 
1030 (m), 1007 (m), 964 (m), 921 (w), 911 (w), 887 (w), 846 (m), 814 (w), 760 (m), 699 (s), 
653 (w), 631 (w), 583 (w). GC-MS (EI, 70 eV): m/z (%) =  (356 ([M]+, 38), 296 (13), 254 
(10), 253 (41), 252 (20), 251 (100), 225 (10), 224 (17), 209 (13), 152 (14). HRMS (EI): 
Calcd. for C21H24O5 ([M]+): 356.16183; found: 356.162654. 
 
5-Ethyl 2-methyl 3-hydroxy-4'-methylbiphenyl-2,5-dicarboxylate (118e):  
Starting with 117b (0.460 g, 1.5 mmol) and 22a (0.430 g, 1.65 mmol), 118e was isolated after 
chromatography (silica gel, n-heptane/EtOAc) as a yellowish oil (0.207 g, 44%). 
 1H NMR (300 MHz, CDCl3): δ = 1.30 (t, 3J = 7.2 Hz, 3 H, 
CH3), 2.33 (s, 3 H, PhCH3), 3.46 (s, 3 H, OCH3), 4.30 (q, 3J 
= 7.2 Hz, 2 H, OCH2), 7.04 - 7.08 (m, 2 H, CHAr), 7.09 - 
7.13 (m, 2 H, CHAr), 7.39 (d, 4J = 1.6 Hz, 1 H, CHAr), 7.55 
(d, 4J = 1.7 Hz, 1 H, CHAr), 10.31 (s, 1 H, OH). 13C NMR 
(CDCl3, 250 MHz):  = 13.26, 20.10 (CH3), 51.12 (OCH3), 
60.31 (OCH2) 114.68 (CAr), 116.37, 122.02 (CHAr), 126.92 (2 CHAr), 127.50 (2 CHAr), 
133.73, 136.00, 138.00, 144.07 (CAr), 159.84 (COH), 164.48, 169.92 (CO). IR (KBr, cm-1): 
ν̃ = 3305 (w), 2952 (w), 2870 (w), 1720 (s), 1669 (s), 1610 (w), 1567 (m), 1515 (w), 1492 
(w), 1437 (m), 1402 (m), 1369 (m), 1343 (m), 1314 (m), 1236 (s), 1198 (s), 1112 (s), 1079 
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(m), 1022 (s), 976 (m), 949 (m), 892 (m), 863 (w), 831 (m), 806 (m), 770 (s), 726 (m), 707 
(m), 649 (w), 625 (m), 614 (m), 583 (m), 558 (w). GC-MS (EI, 70 eV): m/z (%) = 314 ([M]+, 
37), 283 (24), 282 (100), 254 (10), 210 (12), 209 (10), 153 (14), 152 (10). HRMS (EI): Calcd. 
for C18H18O5 ([M]+): 314.11488; found: 314.114722. 
5-Ethyl 2-methyl 3-hydroxy-4,4'-dimethylbiphenyl-2,5-dicarboxylate (118f):  
Starting with 117b (0.460 g, 1.5 mmol) and 22d (0.453 g, 1.65 mmol), 118f was isolated after 
chromatography (silica gel, n-heptane/EtOAc) as a pale yellowish oil, (0.227 g, 46%).  
1HNMR (300 MHz, CDCl3): δ = 1.29 (t, 3J = 7.2 Hz, 3 H, 
CH3), 2.32(s, 3 H, PhCH3), 2.40 (s, 3 H, PhCH3), 3.45 (s, 3 
H, OCH3), 4.29 (q, 3J = 7.1 Hz, 2 H, OCH2), 7.02 - 7.06 
(m, 2 H, CHAr), 7.08 - 7.11 (m, 3 H, CHAr), 10.79 (s, 1 H, 
OH). 13C NMR (CDCl3, 250 MHz):  = 12.68, 14.24, 21.20 
(CH3), 51.96 (OCH3), 61.32 (OCH2) 113.47 (CAr), 122.51 
(CHAr), 126.42 (CAr), 128.04 (2 CHAr), 128.43 (2 CHAr), 135.39, 136.63, 139.23, 141.50 
(CAr), 159.77 (COH), 167.47, 171.75 (CO). IR (KBr, cm-1): ν̃ = 2951 (w), 2924 (w), 2854 (w), 
1723 (s), 1664 (s), 1606 (w), 1561 (w), 1517 (w), 1436 (m), 1392 (m), 1367 (m), 1340 (m), 
1312 (w), 1297 (w), 1261 (s), 1229 (s), 1194 (s), 1157 (s), 1137 (s), 1111 (m), 1048 (s), 1003 
(m),  932 (w), 888 (w), 847 (m), 821 (m), 809 (m), 782 (m), 723 (m), 624 (w), 600 (w), 545 
(w). GC-MS (EI, 70 eV): m/z (%) =  329 (12), (328 ([M]+, 56), 297 (21), 296 (100), 283 (21), 
281 (10), 268 (10), 267 (49), 253 (39), 240 (11), 224 (10), 223 (27), 196 (13), 195 (14), 165 
(18), 152 (18). HRMS (EI): Calcd. for C19H20O5 ([M]+): 328.13053; found: 328.130451. 
5-Ethyl 2-methyl 4-ethyl-3-hydroxy-4'-methylbiphenyl-2,5-dicarboxylate (118g):  
Starting with 117b (0.460 g, 1.5 mmol) and 22f (0.476 g, 1.65 mmol), 118g was isolated after 
chromatography (silica gel, n-heptane/EtOAc) as a pale yellowish oil, (0.236 g, 46%).  
1H NMR (250 MHz, CDCl3):  δ = 1.15 (t, 3J = 7.6Hz, 3 H, 
CH3), 1.30 (t, 3J = 7.5 Hz, 3 H, CH3), 2.32 (s, 3 H, PhCH3), 
2.87 (q, 3J = 7.6Hz, 2 H, PhCH2), 3.45 (s, 3 H, OCH3), 4.29 
(q, 3J = 7.2 Hz, 2 H, OCH2), 7.01 - 7.11  (m, 5 H, 5CHAr), 
10.72 (s, 1 H, OH). 13C NMR (CDCl3, 250 MHz):  = 
13.10, 13.22 (CH3), 19.55 (CH2), 20.17 (CH3), 50.95 
(OCH3), 60.37 (OCH2) 112.64 (CAr), 121.50 (CHAr), 127.00 (2 CHAr), 127.42 (2 CHAr), 
131.04, 134.33, 135.63, 138.23, 140.71 (CAr), 158.56 (COH), 166.67, 170.58 (CO).  
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IR (KBr, cm-1): ν̃ = 3023 (w), 2971 (w), 2933 (w), 2874 (w), 1723 (s), 1664 (s), 1604 (m), 
1555 (w), 1517 (w), 1437 (m), 1389 (m), 1367 (m), 1344 (m), 1312 (w), 1282 (m), 1247 (s), 
1222 (s), 1193 (s), 1156 (s), 1137 (m), 1111 (w), 1075 (s), 1030 (m), 1007 (m), 967 (w), 949 
(m), 908 (w), 888 (w), 846 (w), 823 (m), 784 (m), 723 (w), 709 (w), 670 (w), 654 (w), 627 
(w), 598 (w), 567 (w). GC-MS (EI, 70 eV): m/z (%) =  343 (22), (342 ([M]+, 98), 311 (23), 
310 (100), 309 (16), 297 (31), 295 (30), 282 (25), 281 (49), 267 (38), 265 (10), 263 (26), 254 
(13), 239 (14), 238 (28), 237 (32), 235 (10), 211 (33), 210 (37), 209 (18), 179 (10), 178 (12), 
166 (16), 165 (38), 153 (10), 152 (14). HRMS (EI): Calcd. for C20H22O5 ([M]+): 342.14618; 
found:  342.146471. 
5-Ethyl 2-methyl 3-hydroxy-4-methyl-4'-nitrobiphenyl-2,5-dicarboxylate (118h):  
Starting with 117c (0.506 g, 1.5 mmol) and 22d (0.453 g, 1.65 mmol), 118h was isolated after 
chromatography (silica gel, n-heptane/EtOAc) as a pale yellowish solid, m.p. = 123-125, 
(0.356 g, 66%). 
 1H NMR (300 MHz, CDCl3): δ = 1.27 (t, 3J = 7.3 Hz, 3 
H, CH3), 2.37 (s, 3 H, CH3), 3.39 (s, 3 H, OCH3), 4.25 (q, 
3J = 7.4 Hz, 2 H, OCH2), 6.99 (s, 1 H, CHAr), 7.24 - 7.28 
(m, 2 H, CHAr), 8.09 - 8.13 (m, 2 H, CHAr ), 11.13 (s, 1 H, 
OH). 13C NMR (CDCl3, 250 MHz): δ = 11.48, 12.85 
(CH3), 50.83 (OCH3), 60.18 (OCH2) 110.90 (CAr), 120.52 
(CHAr), 121.58 (2CHAr), 127.12 (CAr) 127.71 (2 CHAr), 134.37, 137.57, 145.50, 147.74 (CAr), 
159.35 (COH), 165.62, 169.25 (CO). IR (KBr, cm-1): ν̃ = 3115 (w), 3053 (w), 2988 (w), 2954 
(m), 2906 (w), 2849 (w), 1730 (s), 1671 (s), 1594 (m), 1567 (w), 1513 (m), 1471 (w), 1435 
(m), 1393 (m), 1377 (m), 1366 (m), 1342 (s), 1312 (m), 1194 (s), 1166 (s), 1137 (m), 1105 
(m), 1050 (m), 1002 (s), 936 (m), 898 (w), 840 (s), 809 (s), 789 (s), 747 (s), 701 (s), 656 (w), 
617 (w), 586 (m), 559 (m). GC-MS (EI, 70 eV): m/z (%) =  (395 ([M]+, 44), 328 (21), 327 
(100), 314 (18), 299 (11), 298 (38), 271 (18), 255 (17), 254 (9), 253 (10), 242 (22), 227 (13), 
226 (15), 152 (17), 151 (12), 139 (10). HRMS (EI): Calcd. for C18H17O7N ([M]+) : 359.09995; 
found: 359.100038 
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5-Ethyl 2-methyl 4-ethyl-3-hydroxy-4'-nitrobiphenyl-2,5-dicarboxylate (118i):  
Starting with 117c (0.506 g, 1.5 mmol) and 22f (0.476 g, 1.65 mmol), 118i was isolated after 
chromatography (silica gel, n-heptane/EtOAc) as a yellowish solid (0.375 g, 67%), m.p. = 90-
92 °C.  
1HNMR (250 MHz, CDCl3): δ = 1.19 (t, 3J = 7.7 Hz, 3 H, 
CH3), 1.31 (t, 3J = 7.7 Hz, 3 H, CH3), 2.90 (q, 3J = 7.2 Hz, 
2 H, PhCH2), 3.45 (s, 3 H, OCH3), 4.31 (q, 3J = 7.2 Hz, 2 
H, OCH2), 7.00 (s, 1 H, CHAr), 7.28 - 7.34 (m, 2 H, CHAr), 
8.14 - 8.20 (m, 2 H, CHAr ), 11.12 (s, 1 H, OH). 13C NMR 
(CDCl3, 250 MHz):  = 12.95, 13.19 (CH3), 19.65 (CH2), 
51.34 (OCH3), 60.70 (OCH2) 111.80 (CAr), 121.16 (CHAr), 122.12 (2 CHAr), 128.36 (2 CHAr), 
133.16, 134.60, 138.44, 146.11, 148.27 (CAr), 159.79 (COH), 166.27, 169.63 (CO). IR (KBr, 
cm-1): ν̃ = 3071 (w), 3049 (w), 2963 (m), 2930 (m), 2871 (m), 2852 (m), 2450 (w), 2357 (w), 
2123 (w), 2123 (w), 1935 (w), 1804 (w), 1730 (s), 1669 (s), 1594 (m), 1562 (m), 1504 (s), 
1446 (m), 1412 (m), 1390 (m), 1345 (s), 1315 (m), 1290 (m), 1257 (s), 1227 (s), 1195 (s), 
1153 (s), 1135 (s), 1106 (s), 1074 (s), 1062 (s), 1027 (m), 1008 (m), 970 (m), 944 (s), 897 
(m), 852 (s), 913 (m), 776 (s), 749 (s), 702 (s), 672 (m), 644 (w), 622 (m), 588 (m), 573 (m). 
GC-MS (EI, 70 eV): m/z (%) =  374 (22), (373 ([M]+, 100), 342 (20), 341 (84), 328 (38), 314 
(14), 313 (74), 312 (57), 298 (16), 296 (13), 295 (10), 285 (10), 270 (23), 269 (60), 268 (13), 
267 (12), 243 (10), 242 (68), 241 (38), 240 (22), 239 (13), 223 (12), 222 (14), 221 (51), 220 
(10), 194 (11), 193 (10), 166 (10), 165 (42), 164 (13), 163 (12), 152 (15), 151 (10), 139 (15). 
HRMS (EI): Calcd. for C19H19O7N ([M]+):  373.11560; found:  373.115597. 
5-Ethyl 2-methyl 4'-bromo-3-hydroxybiphenyl-2,5-dicarboxylate (118j):  
Starting with 117d (0.557 g, 1.5 mmol) and 22a (0.430 g, 1.65 mmol), 118j was isolated after 
chromatography (silica gel, n-heptane/EtOAc) as a pale brownish oil (0.301 g, 53%). 
1H NMR (300 MHz, CDCl3):  δ = 1.26 (t, 3J = 7.0 Hz, 3 H, 
CH3), 3.43(s, 3 H, OCH3), 4.25 (q, 3J = 7.1 Hz, 2 H, OCH2), 
6.97 - 7.01 (m, 2 H, CHAr), 7.28 (d, 4J = 1.7 Hz, 1 H, CHAr), 
7.36 - 7.41 (m, 2 H, CHAr), 7.54 (d, 4J = 1.8 Hz, 1 H, CHAr), 
10.47 (s, 1 H, OH). 13C NMR (CDCl3, 75 MHz): δ = 14.2 
(CH3), 52.2 (OCH3), 61.6 (OCH2), 115.1 (CAr), 118.2 
(CHAr), 121.4 (CAr), 122.7 (CHAr), 129.8 (2 CHAr), 130.9 (2 CHAr), 135.0, 140.9, 143.6, (CAr), 
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161.3 (COH), 165.2, 170.5 (CO). IR (neat, cm-1): ν̃ = 3064 (w), 2980 (w), 2953 (w), 2905 (w), 
2872 (w), 2852 (w), 1721 (m), 1672 (m), 1611 (m), 1571 (m), 1493 (m), 1439 (m), 1392 (m), 
1345 (m), 1238 (s), 1200 (s), 1114 (s), 1069 (m), 1023 (m), 1010 (m), 948 (m), 881 (m), 835 
(m), 807 (m), 770 (m), 681 (m), 622 (m), 574 (m). GC-MS (EI, 70 eV): m/z (%) = 378 ([M+], 
79Br, 28), 349 (18), 348 (100), 276 (7), 194 (16), 139 (14). HRMS (EI, 70 eV): Calcd. for 
C17H15O5Br ([M]+, 79Br): 378.00974; found: 378.009529. 
5-Ethyl 2-methyl 4'-bromo-3-hydroxy-4-methylbiphenyl-2,5-dicarboxylate (118k): 
Starting with 117d (0.557 g, 1.5 mmol) and 22d (0.453 g, 1.65 mmol), 118k was isolated 
after chromatography (silica gel, n-heptane/EtOAc) as a pale brownish oil, (0.323g, 55%).  
1H NMR (300 MHz, CDCl3):  δ = 1.30 (t, 3J = 7.2 Hz, 3 H, 
CH3), 2.40 (s, 3 H, PhCH3), 3.47(s, 3 H, OCH3), 4.30 (q, 3J 
= 7.2 Hz, 2 H, OCH2), 7.00 - 7.05 (m, 3 H, CHAr), 7.40 - 
7.44 (m, 2 H, CHAr), 10.99 (s, 1 H, OH). 13C NMR (CDCl3, 
75 MHz): δ = 11.7, 13.2 (CH3), 51.1 (OCH3), 60.4 (OCH2), 
111.9, 120.1 (CAr), 121.2 (CHAr), 126.3 (CAr), 128.8 (2 
CHAr), 129.8 (2 CHAr), 134.6, 139.2, 140.2 (CAr), 159.3 (COH), 166.3, 170.2 (CO). IR (neat, 
cm-1): ν̃ = 3046 (w), 2979 (w), 2952 (w), 2904 (w), 2873 (w), 1722 (m), 1665 (m), 1607 (m), 
1567 (w), 1492 (w), 1437 (m), 1390 (m), 1367 (m), 1342 (m), 1305 (m), 1261 (s), 1230 (s), 
1194 (s), 1157 (s), 1137 (m), 1071 (m), 1048 (s), 1009 (s), 933 (m), 918 (m), 889 (w), 828 
(m), 782 (m), 742 (m), 724 (m), 665 (m), 618 (w), 588 (m), 557 (w). GC-MS (EI, 70 eV): m/z 
(%) = 392 ([M+], 79Br, 47), 360 (100), 333 (30), 304 (15), 253 (55), 196 (12), 180 (9), 152 
(38), 139 (10), 104 (8), 76 (11).  HRMS (EI): Calcd. for C18H17O5Br ([M]+, 79Br): 392.02539; 
found: 392.025473. 
5-Ethyl 2-methyl 4'-bromo-4-ethyl-3-hydroxybiphenyl-2,5-dicarboxylate (118l):  
Starting with 117d (0.557 g, 1.5 mmol) and 22f (0.476 g, 1.65 mmol), 118l was isolated after 
chromatography (silica gel, n-heptane/EtOAc) as a pale brownish oil (0.359 g, 59%). 
1H NMR (300 MHz, CDCl3): δ = 1.18 (t, 3J = 7.5 Hz, 3 H, 
CH3), 1.31 (t, 3J = 7.2 Hz, 3 H, CH3), 2.88 (q, 3J = 7.4 Hz, 2 
H, PhCH2), 3.47(s, 3 H, OCH3), 4.30 (q, 3J = 7.2 Hz, 2 H, 
OCH2), 7.01 - 7.05 (m, 3 H, CHAr), 7.40 - 7.44 (m, 2 H, 
CHAr), 10.94 (s, 1 H, OH). 13C NMR (CDCl3, 75 MHz): δ = 
13.0, 13.2 (CH3), 19.6 (CH2), 51.1 (OCH3), 60.4 (OCH2), 
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112.1, 120.1 (CAr), 121.2 (CHAr), 128.8 (2 CHAr), 129.8 (2 CHAr), 131.8, 134.5, 139.4, 140.2 
(CAr), 159.0 (COH), 166.4, 170.2 (CO). IR (neat, cm-1): ν̃ = 2972 (w), 2954 (w), 2935 (w), 
2875 (w), 2854 (w), 1723 (m), 1665 (m), 1605 (m), 1567 (w), 1490 (w), 1437 (m), 1387 (m), 
1368 (m), 1347 (m), 1309 (m), 1282 (m), 1248 (s), 1222 (s), 1194 (m), 1158 (s), 1075 (s), 
1029 (m), 1009 (m), 967 (m), 948 (m), 890 (w), 830 (m), 784 (m), 734 (m), 721 (m), 665 (m), 
620 (w), 587 (m), 560 (w). GC-MS (EI, 70 eV): m/z (%) = 406 ([M+], 79Br, 92), 376 (98), 348 
(32), 331 (16), 302 (34), 275 (50), 249 (17), 221 (89), 194 (21), 165 (72), 152 (24), 128 (7), 
82 (11). HRMS (EI): Calcd. for C19H19O5Br ([M]+, 79Br): 406.04104; found: 406.041136. 
5-Ethyl 2-methyl 4'-bromo-4-hexyl-3-hydroxybiphenyl-2,5-dicarboxylate (118m): 
Starting with 117d (0.557 g, 1.5 mmol) and 22j (0.569 g, 1.65 mmol), 118m was isolated 
after chromatography (silica gel, n-heptane/EtOAc) as a brownish oil (0.347 g, 50%).  
1H NMR (300 MHz, CDCl3): δ = 0.67-0.75 (m,  6 H, 2CH3), 
1.16 – 1.20 (m,  6 H, 3CH2), 1.40 – 1.46 (m, 2 H, CH2), 2.74 
(t, 3J = 7.7 Hz, 2 H, CH2), 3.36 (s, 3 H, OCH3), 4.19 (q, 3J = 
7.1 Hz, 2 H, OCH2),  6.90 – 6.94 (m, 3 H, CHAr), 7.29 - 7.34 
(m, 2 H, CHAr), 10.83 (s, 1 H, OH). 13C NMR (CDCl3, 75 
MHz): δ = 15.3, 15.5 (CH3), 23.9, 28.2, 31.0, 32.8, 32.9, 
(CH2), 53.3 (OCH3), 62.6 (OCH2), 114.2, 122.3 (CAr), 123.4 (CHAr), 131.0 (2 CHAr), 132.0 (2 
CHAr), 133.0, 136.8, 141.5, 142.4 (CAr), 161.3 (COH), 168.7, 172.4 (CO). IR (neat, cm-1): 
ν̃ = 2953 (w), 2926 (m), 2855 (w), 1934 (w), 1725 (m), 1667 (m), 1605 (w),  1566 (w), 1554 
(w), 1492 (w), 1437 (m), 1388 (m), 1368 (m), 1347 (m), 1313 (w), 1248 (m), 1231 (m), 1195 
(m), 1155 (m), 1099 (m), 1071 (m), 1010 (m), 953 (m), 920 (w), 843 (m), 785 (m), 720 (m), 
673 (w), 663 (w), 628 (w), 588 (w). GC-MS (EI, 70 eV): m/z (%) = 462 ([M+], 79Br, 42), 419 
(10), 357 (100), 331 (42), 302 (13), 278 (17), 253 (26), 196 (19), 152 (17). HRMS (EI): 
Calcd. for C23H27O5Br ([M]+, 79Br): 462.10364; found: 462.104001. 
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5-Ethyl 2-methyl 4'-bromo-4-heptyl-3-hydroxybiphenyl-2,5-dicarboxylate (118n): 
Starting with 117d (0.557 g, 1.5 mmol) and 22k (0.592 g, 1.65 mmol), 13n was isolated after 
chromatography (silica gel, n-heptane/EtOAc) as a brownish oil, (0.357 g, 50%).  
1H NMR (300 MHz, CDCl3): δ = 0.78-0.83 (m, 6 H, 2CH3), 
1.28 – 1.33 (m,  8 H, 4CH2), 1.35 – 1.39 (m,  2 H, CH2), 
2.84 (t, 3J = 7.4 Hz, 2 H, CH2), 3.47(s, 3 H, OCH3), 4.29 (q, 
3J = 7.1 Hz, 2 H, OCH2),  7.00 - 7.04 (m, 3 H, CHAr), 7.40 - 
7.44 (m, 2 H, CHAr), 10.93 (s, 1 H, OH). 13C NMR (CDCl3, 
75 MHz): δ = 13.1, 13.2 (CH3), 21.6, 26.3, 28.1, 28.7, 30.3, 
30.8 (CH2), 51.7 (OCH3), 60.4 (OCH2), 112.0, 120.1 (CAr), 121.2 (CHAr), 128.8 (2 CHAr), 
129.8 (2 CHAr), 130.7, 134.6, 139.3, 140.2 (CAr), 159.1 (COH), 166.7, 170.2 (CO). IR (neat, 
cm-1): ν̃ = 2972 (w), 2954 (w), 2935 (w), 2875 (w), 2854 (w), 1723 (m), 1665 (m), 1605 (m), 
1567 (w), 1490 (w), 1437 (m), 1387 (m), 1368 (m), 1347 (m), 1309 (m), 1282 (m), 1248 (s), 
1222 (s), 1194 (m), 1158 (s), 1075 (s), 1029 (m), 1009 (m), 967 (m), 948 (m), 890 (w), 830 
(m), 784 (m), 734 (m), 721 (m), 665 (m), 620 (w), 587 (m), 560 (w). GC-MS (EI, 70 eV): m/z 
(%) = 476 ([M+], 79Br, 30), 416 (7), 373 (100), 333 (30), 292 (18), 253 (17), 196 (11), 152 (9). 
HRMS (EI): Calcd. for C24H29O5Br ([M]+, 79Br): 476.11929; found: 476.119450. 
Methyl 4-ethoxy-3-methyl-2-oxobut-3-butenoate (125b):  
Starting with 123b (11.75 mL, 106.1 mmol) and methyl chlorooxoacetate (4.89 mL, 53.1 
mmol), the product was collected after drying under vacuum as a reddish oil (8.86 g, 97%).  
1H NMR (250 MHz, CDCl3): δ = 1.33 (t, 3J = 7.1 Hz, 3 H, 
OCH2CH3), 1.70 (s, 3 H, CH3), 3.81 (s, 3 H, OCH3), 4.14 (q, 3J= 
7.1 Hz, 2 H, OCH2CH3), 7.54 (s, 1 H, CHolf). 13C NMR (CDCl3, 
75 MHz): δ = 7.4, 15.2 (CH3), 52.4 (OCH3), 71.3 (OCH2), 114.7 
(C), 164.6 (CO), 165.7 (CHolf), 185.6 (CO). IR (neat, cm-1): 
ν̃ = 2985 (w), 2956 (w), 2903 (w), 2254 (w), 2254 (w), 1731 (m), 1617 (s), 1476 (w), 1437 
(w), 1388 (w), 1369 (w), 1330 (w), 1210 (s), 1146 (m), 1108 (m), 1049 (m), 1025 (m), 971 
(m), 910 (m), 845 (w), 824 (w), 779 (w), 726 (s), 647 (w). GC-MS (EI, 70 eV): m/z (%) = 172 
([M+], 3), 144 (1), 113 (82), 85 (100), 83 (5), 55 (5), 39 (4), 29 (20). HRMS (EI): Calcd. for 
C8H12O4 ([M]+):172.07301; found: 172.073090 
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Methyl 3-(ethoxymethylene)-2-oxopentanoate (125c):  
Starting with 123c (13.64 mL, 106.1 mmol) and methyl chlorooxoacetate (4.89 mL, 53.1 
mmol), the product was collected after drying under vacuum as a redish oil (9.38 g, 95%).  
1H NMR (250 MHz, CDCl3): δ = 0.91 (t, 3J = 7.6 Hz, 3 H, 
CH2CH3), 1.31 (t, 3J= 7.1 Hz, 3 H, OCH2CH3), 2.24 (q, 3J= 7.5 
Hz, 2 H, CH2CH3), 3.79 (s, 3 H, OCH3), 4.12 (q, 3J= 7.5 Hz, 2 
H, OCH2CH3), 7.46 (s, 1 H, CHolf). 13C NMR (CDCl3, 75 MHz): 
δ = 12.6, 15.0 (CH3), 16.0 (CH2), 52.3 (OCH3), 71.1 (OCH2), 
120.7 (C), 164.5 (CO), 165.7 (CHolf), 185.3 (CO). IR neat, cm-1): ν̃ = 2970 (w), 2937 (w), 
2878 (w), 1731 (m), 1652 (w), 1615 (s), 1456 (w), 1439 (w), 1388 (w), 1370 (w), 1321 (m), 
1301 (m), 1273 (m), 1207 (s), 1146 (m), 1108 (m), 1083 (s), 1021 (m), 965 (m), 898 (m), 871 
(m), 798 (w), 777 (w), 732 (m), 706 (m), 648 (w), 547 (w). GC-MS (EI, 70 eV): m/z (%) = 
186 ([M+], 4), 127 (100), 99 (90), 83 (4), 69 (4), 53 (7), 43 (10), 29 (6). HRMS (ESI): Calcd. 
for C9H15O4 ([M+H]+): 187.09649; found: 187.09595 
Dimethyl 2-hydroxyterephthalate (126a):  
Starting with 125a (0.237 g, 1.5 mmol) and 22a (0.430 g, 1.65 mmol), 126a was isolated after 
chromatography (silica gel, n-heptane/EtOAc) as a white solid (0.127 g, 40%) m.p. 88-91 °C.  
1H NMR (300 MHz, CDCl3): δ = 3.85 (s, 3 H, OCH3), 3.90 (s, 
3 H, OCH3), 7.45 (dd, 3J = 8.1 Hz, 4J = 1.6 Hz,1 H, CHAr), 7.56 
- 7.57 (m, 1 H, CHAr), 7.83 (d, 3J = 8.4 Hz, 1 H, CHAr), 10.67 
(s, 1 H, OH). 13C NMR (CDCl3, 75 MHz): δ = 51.4, 51.6 
(OCH3), 114.6 (CAr), 117.9, 118.6, 129.0 (CHAr), 135.4 (CAr), 
160.3 (COH), 164.9, 168.9 (CO). IR (neat, cm-1): ν̃ = 3115 (w), 
3079 (w), 2959 (w), 2916 (m), 2848 (m), 1725 (m), 1678 (s), 1579 (m), 1504 (m), 1435 (m), 
1393 (w), 1343 (m), 1297 (s), 1209 (s), 1104 (s), 980 (m), 953 (m), 923 (m), 845 (w), 823 
(m), 795 (m), 750 (s), 706 (m), 690 (s), 570 (m), 564 (m). GC-MS (EI, 70 eV): m/z (%) = 210 
([M]+, 42), 178 (100), 147 (10), 120 (10), 119 (63), 63 (12). HRMS (EI): Calcd. for C10H10O5 
([M]+): 210.05227; found: 210.052499. 
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Dimethyl 2-hydroxy-5-methylterephthalate (126b):  
Starting with 125b (0.258 g, 1.5 mmol) and 22a (0.430 g, 1.65 mmol), 126b was isolated after 
chromatography (silica gel, n-heptane/EtOAc) as a yellowish oil (0.150 g, 45%).  
1H NMR (300 MHz, CDCl3): δ = 2.41 (s, 3 H, PhCH3), 3.83 (s, 
3 H, OCH3), 3.98 (s, 3 H, OCH3), 7.41 (s, 1 H, CHAr), 7.62 (s, 
1 H, CHAr), 10.37 (s, 1 H, OH). 13C NMR (CDCl3, 75 MHz): δ 
= 19.3 (CH3), 51.1, 51.5 (OCH3), 113.7 (CAr), 118.4 (CHAr), 
128.5 (CAr), 131.2 (CHAr), 139.3 (CAr), 157.0 (COH), 166.0, 
168.9 (CO). IR (neat, cm-1): ν̃ = 3112 (w), 2956 (w), 2922 (m), 
2852 (w), 1723 (m), 1682 (m), 1619 (w), 1572 (w), 1388 (w), 1435 (m), 1387 (w), 1368 (w), 
1287 (m), 1249 (m), 1205 (m), 1192 (m), 1102 (s), 1046 (m), 1016 (m),  958 (m), 910 (w), 
888 (w), 849 (w), 784 (s), 740 (m), 676 (m), 603 (w), 578 (w). GC-MS (EI, 70 eV): m/z (%) = 
224 ([M]+, 46), 193 (39), 192 (100), 133 (24), 132 (32), 77 (10), 51 (9). HRMS (EI): Calcd. 
for C11H12O5 ([M]+): 224.06792; found: 224.067938. 
Dimethyl 5-ethyl-2-hydroxyterephthalate (126c):  
Starting with 125c (0.279 g, 1.5 mmol) and 22a (0.430 g, 1.65 mmol), 126c was isolated after 
chromatography (silica gel, n-heptane/EtOAc) as a yellowish oil (0.168 g, 47%).  
1H NMR (300 MHz, CDCl3): δ = 1.13 (t, 3J = 7.2 Hz, 3 H, 
CH3), 2.79 (q, 3J = 8.4 Hz, 2 H, PhCH2), 3.83 (s, 3 H, OCH3), 
3.90 (s, 3 H, OCH3), 7.34 (s, 1 H, CHAr), 7.65 (s, 1 H, CHAr), 
10.39 (s, 1 H, OH). 13C NMR (CDCl3, 75 MHz): δ = 14.8 
(CH3), 25.6 (CH2), 51.1, 51.5 (OCH3), 113.7 (CAr), 118.3, 
129.9 (CHAr), 134.4, 135.2 (CAr), 157.9 (COH), 168.8, 168.9 
(CO). IR (neat, cm-1): ν̃ = 3205 (w), 2957 (w), 2929 (w), 2872 (w), 1729 (m), 1682 (m), 1636 
(w), 1572 (w), 1487 (m), 1439 (m), 1375 (w), 1319 (w), 1281 (m), 1203 (s), 1103 (s), 1066 
(m), 961 (m), 908 (w), 844 (w), 794 (m), 759 (m), 697 (m), 647 (w), 622 (w). GC-MS (EI, 70 
eV): m/z (%) = 238 ([M]+, 45), 223 (9), 206 (100), 191 (56), 174 (11), 146 (27), 133 (8), 119 
(7), 91 (11), 65 (6). HRMS (EI): Calcd. for C12H14O5 ([M]+): 238.08358; found: 238.083603. 
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Dimethyl 3-hydroxy-4-methylphthalate (127a):  
Starting with 125a (0.237 g, 1.5 mmol) and 22d (0.453 g, 1.65 mmol), 127a was isolated after 
chromatography (silica gel, n-heptane/EtOAc) as a yellowish solid (0.141 g, 42%), m.p. 76 -
78 °C.  
1HNMR (300 MHz, CDCl3): δ = 2.37 (s, 3 H, PhCH3), 3.83 (s, 
3 H, OCH3), 3.98 (s, 3 H, OCH3), 7.17 (d, 3J = 7.6 Hz, 1 H, 
CHAr), 7.64 (d, 3J = 8.3 Hz, 1 H, CHAr), 11.11 (s, 1 H, OH). 
13C NMR (CDCl3, 75 MHz): δ = 11.45 (CH3), 51.2, 51.5 
(OCH3), 112.4 (CAr), 118.3, 125.6 (CHAr), 126.9, 136.2 (CAr), 
159.3 (COH), 166.4, 169.9 (CO). IR (neat, cm-1): ν̃ = 3152 (w), 2954 (w), 2924 (m), 2852 
(w), 1724 (m), 1674 (m), 1616 (w), 1573 (w), 1439 (m), 1380 (w), 1327 (m), 1285 (m), 1249 
(s), 1191 (m), 1148 (s), 1098 (m), 1050 (s), 1006 (m), 966 (w), 910 (w), 869 (w), 821 (w), 803 
(m), 755 (s), 728 (m), 644 (w), 578 (w). GC-MS (EI, 70 eV): m/z (%) = 224 ([M]+, 40), 193 
(29), 192 (47), 165 (10), 164 (100),  133(13), 105 (14), 77 (12), 51 (10).  HRMS (EI): Calcd. 
for C11H12O5 ([M]+): 224.06792; found: 224.068299. 
2-Ethyl 1-methyl 4-ethyl-3-hydroxyphthalate (127b):  
Starting with 125a (0.237 g, 1.5 mmol) and 22g (0.499 g, 1.65 mmol), 127b was isolated after 
chromatography (silica gel, n-heptane/EtOAc) as a yellowish oil (0.170 g, 45%).  
1HNMR (300 MHz, CDCl3): δ = 0.78 (t, 3J = 7.5 Hz, 3 H, 
CH2CH3), 1.18 (t, 3J = 7.2 Hz, 3 H, OCH2CH3), 2.84 (q, 3J = 
8.4 Hz, 2 H, PhCH2), 3.84 (s, 3 H, OCH3), 4.33 (q, 3J = 7.8 
Hz, 2 H, OCH2CH3), 7.11 (d, 3J = 8.4 Hz, 1 H, CHAr), 7.65 
(d, 3J = 8.0 Hz, 1 H, CHAr), 11.18 (s, 1 H, OH). 13C NMR 
(CDCl3, 75 MHz): δ = 13.0, 13.1 (CH3), 19.3 (CH2), 51.2 (OCH3), 60.7 (OCH2), 112.8 (CAr), 
118.1, 125.7 (CHAr), 132.4 (CAr), 135.9 (CAr), 159.2 (COH), 166.7, 169.2 (CO).                    
IR (neat, cm-1): ν̃ = 3133 (w), 2956 (w), 2923 (m), 2853 (w), 1727 (m), 1673 (m), 1615 (w), 
1572 (w), 1461 (m), 1398 (w), 1372 (m), 1330 (m), 1291 (s), 1267 (m), 1240 (s), 1222 (m), 
1148 (s), 1077 (s), 1018 (m), 952 (w), 864 (w), 806 (m), 757 (s), 732 (m), 644 (w), 577 (w). 
GC-MS (EI, 70 eV): m/z (%) = 252 ([M]+, 30), 221 (11), 207 (10), 206 (10), 191 (11), 179 
(12), 178 (100), 146 (28), 91 (11). HRMS (EI): Calcd. for C13H16O5 ([M]+): 252.09923; 
found: 252.098543. 
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Dimethyl 4-butyl-3-hydroxyphthalate (127c):  
Starting with 125a (0.237 g, 1.5 mmol) and 22h (0.522 g, 1.65 mmol), 127c was isolated after 
chromatography (silica gel, n-heptane/EtOAc) as a yellowish oil (0.171 g, 43%).  
1H NMR (300 MHz, CDCl3): δ = 0.86 (t, 3J = 6.8 Hz, 3 H, 
CH3), 1.30 - 1.32 (m, 2 H, CH2), 1.46 - 1.48 (m, 2 H, CH2), 
2.83 (t, 3J = 7.7 Hz, 2 H, PhCH2),  3.83 (s, 3 H, OCH3), 3.89 
(s, 3 H, OCH3), 7.11 (d, 3J = 8.2 Hz, 1 H, CHAr), 7.64 (d, 3J 
= 8.0 Hz, 1 H, CHAr), 11.08 (s, 1 H, OH). 13C NMR (CDCl3, 
75 MHz): δ = 12.9 (CH3), 22.0, 29.3, 30.9 (CH2), 51.2, 51.5 (OCH3), 112.5 (CAr), 118.1, 
125.7 (CHAr), 131.3 (CAr), 136.2 (CAr), 159.2 (COH), 166.7, 169.5 (CO). IR (neat, cm-1): 
ν̃ = 3152 (w), 2954 (m), 2924 (m), 2854 (m), 1727 (m), 1677 (m), 1616 (w), 1572 (w), 1440 
(m), 1366 (w), 1335 (m), 1296 (m), 1252 (s), 1199 (m), 1149 (s), 1093 (s), 1025 (m), 958 (w), 
841 (m), 806 (m), 758 (s), 722 (m), 659 (w), 578 (w). GC-MS (EI, 70 eV): m/z (%) = 266 
([M]+, 60), 235 (33), 233 (12), 224 (17), 223 (36), 207 (41), 206 (56), 205 (23), 192 (24), 191 
(100), 176 (12), 175 (81), 174 (23), 173 (11), 164 (52), 145 (11), 133 (20), 131 (10), 105 (13), 
104 (12), 77 (15). HRMS (EI): Calcd. for C14H18O5 ([M]+): 266.11488; found: 266.114803. 
Dimethyl 3-hydroxy-4-octylphthalate (127d):  
Starting with 125a (0.237 g, 1.5 mmol) and 22l (0.615 g, 1.65 mmol), 127d was isolated after 
chromatography (silica gel, n-heptane/EtOAc) as a yellowish oil (0.217 g, 45%). 
 1H NMR (300 MHz, CDCl3): δ = 0.82 (t, 3J = 6.9 Hz, 3 H, 
CH3), 1.30 - 1.37 (m, 10 H, 5 CH2), 1.48 - 1.54 (m, 2 H, 
CH2), 2.81 (t, 3J = 7.8 Hz, 2 H, PhCH2),  3.83 (s, 3 H, 
OCH3), 3.89 (s, 3 H, OCH3), 7.11 (d, 3J = 8.2 Hz, 1 H, 
CHAr), 7.64 (d, 3J = 8.5 Hz, 1 H, CHAr), 11.08 (s, 1 H, OH). 
13C NMR (CDCl3, 75 MHz): δ = 13.0 (CH3), 21.6, 26.2, 28.2, 28.3, 28.6, 30.8, 30.8 (CH2), 
51.2, 51.6 (OCH3), 112.5 (CAr), 118.3, 125.7 (CHAr), 131.3, 136.2 (CAr), 159.2 (COH), 166.6, 
169.6 (CO). IR (neat, cm-1): ν̃ = 2953 (m), 2922 (s), 2853 (m), 1727 (m), 1678 (m), 1619 (w), 
1441 (m), 1376 (w), 1336 (w), 1291 (m), 1254 (m), 1229 (s), 1193 (m), 1148 (m), 1101 (m), 
1026 (m), 841 (m), 803 (m), 759 (m), 721 (m), 660 (w), 578 (w). GC-MS (EI, 70 eV): m/z 
(%) = 322 ([M]+, 53), 291 (27), 289 (16), 264 (16), 263 (85), 247 (22), 232 (17), 231 (97), 
224 (28), 223 (45), 205 (27), 192 (41), 191 (100), 178 (14), 177 (14), 173 (12), 165 (10), 164 
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(42), 160 (10), 133 (16), 105 (10), 77 (10), 41 (12). HRMS (EI): Calcd. for C18H26O5 ([M]+): 
322.17748; found: 322.177861. 
Dimethyl 3-hydroxy-4,6-dimethylphthalate (127e):  
Starting with 125b (0.258 g, 1.5 mmol) and 22d (0.453 g, 1.65 mmol), 127e was isolated after 
chromatography (silica gel, n-heptane/EtOAc) as a colourless solid (0.160 g, 45%), m.p. 53-
54.  
1H NMR (300 MHz, CDCl3): δ = 2.11 (s, 3 H, PhCH3), 2.14 (s, 
3 H, PhCH3), 3.85 (s, 3 H, OCH3), 3.87 (s, 3 H, OCH3), 7.46 (s, 
1 H, CHAr), 10.86 (s, 1 H, OH). 13C NMR (CDCl3, 75 MHz): δ 
= 11.6, 17.6 (CH3), 51.1, 51.4 (OCH3), 110.8 (CAr), 122.6, 
123.1 (CAr), 127.1 (CHAr), 139.6 (CAr), 157.0 (COH), 168.4, 
169.5 (CO). IR (neat, cm-1): ν̃ = 2953 (m), 2922 (s), 2852 (m), 1735 (m), 1677 (m), 1618 (w), 
1440 (m), 1378 (w), 1343 (m), 1283 (m), 1259 (m), 1233 (s), 1204 (m), 1146 (s), 1094 (m), 
1052 (m), 1020 (m), 840 (w), 795 (s), 755 (m), 722 (m), 610 (w), 563 (w). GC-MS (EI, 70 
eV): m/z (%) = 238 ([M]+, 45), 207 (38), 206 (65), 179 (12), 178 (100), 147 (12), 91 (11). 
HRMS (EI): Calcd. for C12H14O5 ([M]+): 238.08358; found: 238.0833769. 
Dimethyl 3-hydroxy-6-methyl-4-pentylphthalate (127f):  
Starting with 125b (0.258 g, 1.5 mmol) and 22i (0.546 g, 1.65 mmol), 127f was isolated after 
chromatography (silica gel, n-heptane/EtOAc) as a yellowish oil (0.203 g, 46%).  
1H NMR (300 MHz, CDCl3): δ = 0.82 (t, 3J = 6.6 Hz, 3 H, 
CH3), 1.23 - 1.29 (m, 4 H, 2CH2), 1.47 - 1.57 (m, 2 H, CH2), 
2.12 (s, 3 H, PhCH3), 2.54 (t, 3J = 7.7 Hz, 2 H, PhCH2), 3.81 
(s, 3 H, OCH3), 3.83 (s, 3 H, OCH3), 7.08 (s, 1 H, CHAr), 
10.92 (s, 1 H, OH). 13C NMR (CDCl3, 75 MHz): δ = 13.0, 
17.4 (CH3), 21.6, 27.7, 28.8, 30.6 (CH2), 50.8, 51.9 (OCH3), 107.8, 124.1, 130.9, 131.8 (CAr), 
136.2 (CHAr), 157.1 (COH), 168.8, 168.9 (CO). IR (neat, cm-1): ν̃ = 2954 (w), 2928 (w), 2859 
(w), 1735 (m), 1672 (m), 1610 (w), 1587 (w), 1433 (s), 1342 (m), 1253 (s), 1207 (s), 1179 
(m), 1160 (m), 1097 (w), 1049 (m), 992 (w), 962 (w), 898 (w), 869 (w), 846 (w), 801 (m), 
744 (m), 650 (w), 529 (w). GC-MS (EI, 70 eV): m/z (%) = 294 ([M]+, 24), 263 (20), 247 (19), 
219 (31), 206 (100), 148 (8), 91 (5). HRMS (ESI): Calcd. for C16H23O5 ([M+H] +): 295.154 ; 
found: 295.1532. 
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Dimethyl 6-ethyl-3-hydroxy-4-methylphthalate (127g):  
Starting with 125c (0.279 g, 1.5 mmol) and 22d (0.453 g, 1.65 mmol), 127g was isolated after 
chromatography (silica gel, n-heptane/EtOAc) as a yellowish oil (0.181 g, 48%).  
1H NMR (300 MHz, CDCl3): δ = 1.10 (t, 3J = 7.5 Hz, 3 H, 
CH3), 2.19 (s, 3 H, CH3), 2.40 (q, 3J = 7.7 Hz, 2 H, PhCH2), 
3.81 (s, 3 H, OCH3), 3.83 (s, 3 H, OCH3), 7.13 (s, 1 H, CHAr), 
10.98 (s, 1 H, OH). 13C NMR (CDCl3, 75 MHz): δ = 14.8, 14.9 
(CH3), 24.9 (CH2), 51.2, 51.8 (OCH3), 107.1, 127.6, 130.3, 
130.4 (CAr), 135.7 (CHAr), 157.3 (COH), 168.6, 168.9 (CO). IR (neat, cm-1): ν̃ = 3116 (w), 
2953 (w), 2875 (w), 1732 (s), 1672 (s), 1612 (w), 1588 (w), 1431 (m), 1378 (m), 1351 (m), 
1277 (s), 1255 (m), 1204 (s), 1177 (s), 1160 (s), 1046 (m), 988 (m), 895 (m), 867 (w), 805 
(m), 789 (m), 734 (m), 639 (m), 563 (m). GC-MS (EI, 70 eV): m/z (%) = 252 ([M]+, 30), 220 
(100), 205 (16), 188 (18), 162 (40), 134 (27), 103 (10), 91 (8), 77 (13). HRMS (EI): Calcd. for 
C13H16O5 ([M]+): 252.09923; found: 252.099036. 
3-Ethoxy-2-nitro-1-phenylprop-2-en-1-one (131a): 
Starting with 130a (1.7 g, 10.0 mmol), triethyl orthoformiate (2.0 ml, 12.0 mmol) and acetic 
anhydride (1.9 ml, 20 mmol), 131a was isolated as a redish viscos oil (1.8 g, 81%).  
1H NMR (300 MHz, CDCl3):  = 1.27 (t, 3J = 7.0 Hz, 3 H, 
OCH2CH3), 4.20 (q, 3J= 6.9 Hz, 2 H, OCH2CH3), 7.37 - 7.42 
(m, 3 H, CHAr), 7.76 - 7.79 (m, 2 H, CHAr), 8.28 (s, 1 H, 
CHolf). 13C NMR (75 MHz, CDCl3):  = 15.1 (CH3), 74.2 
(OCH2), 128.1 (C), 128.8 (2 CHAr), 129.0 (2 CHAr), 134.1 
(CHAr), 135.9 (CAr), 164.1 (CHolf), 185.3 (CO). IR (neat, cm-1): ν̃ = 3063 (w), 2935 (w), 1778 
(w), 1674 (m), 1597 (w), 1562 (w), 1535 (m), 1500 (m), 1449 (w), 1338 (w), 1300 (m), 1222 
(m), 1153 (w), 1124 (w), 1001 (w), 908 (m), 873 (w), 728 (s), 689 (m), 648 (w). MS (EI 70 
eV): m/z (%) = 221 ([M]+, 8), 128 (12), 105 (100), 100 (41), 94 (16), 7 (70), 72 (17), 51 (19), 
29 (11). HRMS (EI): Calcd. for C11H11NO4: 221.06826; found: 221.068910.  
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3-Ethoxy-2-nitro-1-o-tolylprop-2-en-1-one (131b):  
Starting with 130b (1.8 g, 10.0 mmol), triethyl orthoformiate (2.0 ml, 12.0 mmol) and acetic 
anhydride (1.9 ml, 20 mmol), 131b was isolated as a red oil (1.9 g, 81%).  
1H NMR (300 MHz, CDCl3):  = 1.29 (t, 3J = 7.1 Hz, 3 H, 
OCH2CH3), 2.33 (s, 3 H, CH3), 4.20 (q, 3J = 7.0 Hz, 2 H, 
OCH2CH3), 7.15 - 7.18 (m, 2 H, CHAr), 7.31 - 7.39 (m, 2 H, 
CHAr), 8.23 (s, 1 H, CHolf). 13C NMR (75 MHz, CDCl3):  = 
15.1, 20.8 (CH3), 74.3 (OCH2), 121.8 (C), 125.7, 127.0, 131.0, 
133.0 (CHAr), 136.9, 139.6 (CAr), 161.6 (CHolf), 187.2 (CO). IR (neat, cm-1): ν̃ = 3064 (w), 
2927 (w), 1698 (m), 1634 (m), 1561 (m), 1532 (m), 1456 (m), 1367 (m), 1300 (m), 1219 (s), 
1163 (m), 1094 (m), 1002 (m), 909 (m), 873 (m), 839 (w), 796 (w), 731 (s), 696 (w), 649 (m). 
HRMS (EI): Calcd. for C12H13NO4: 235.08456; found: 235.084510. 
1-(2-Chlorophenyl)-3-ethoxy-2-nitroprop-2-en-1-one (131c):  
Starting with 130c (2.0 g, 10.0 mmol), triethyl orthoformate (2.0 ml, 12.0 mmol) and acetic 
anhydride (1.9 ml, 20 mmol), 131c was isolated as a redish viscos oil (2.1 g, 82%).  
1H NMR (300 MHz, CDCl3):  = 1.30 (t, 3J = 7.0 Hz, 3 H, 
OCH2CH3), 4.27 (q, 3J = 6.9 Hz, 2 H, OCH2CH3), 7.29 - 
7.30 (m, 1 H, CHAr), 7.34 - 7.35 (m, 2 H, CHAr), 7.49 - 7.51 
(m, 1 H, CHAr), 8.29 (s, 1 H, CHolf). 13C NMR (75 MHz, 
CDCl3):  = 15.1 (CH3), 75.1 (OCH2), 126.6 (C), 128.9, 
130.1, 131.9 (CHAr), 132.3 (CAr), 132.4 (CHAr), 136.4 (CAr), 160.0 (CHolf), 184.2 (CO). IR 
(neat, cm-1): ν̃ = 3068 (w), 2930 (w), 1777 (w), 1683 (m), 1587 (m), 1560 (s), 1523 (m), 1470 
(m), 1368 (m), 1319 (m), 1212 (m), 1163 (m), 1064 (m), 1037 (m), 917 (m), 816 (m), 739 (s), 
684 (m), 606 (m), 583 (w), 549 (w). HRMS (EI): Calcd. for C11H10ClNO4: 255.02986; found: 
255.02985. 
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Methyl 3-hydroxy-6-nitrobiphenyl-2-carboxylate (132a): 
Starting with 131a (0.332 g, 1.5 mmol) and 22a (0.430 g, 1.65 mmol), 132a was isolated after 
chromatography (silica gel, heptanes/EtOAc) as a yellowish solid (0.230 g, 56%), m.p. = 137-
138 °C. 
 1H NMR (300 MHz, CDCl3): δ = 3.35 (s, 3 H, OCH3), 7.02 
(d, 3J = 9.0 Hz, 1 H, CHAr), 7.07 - 7.10 (m, 2 H, CHPh), 7.27-
7.31 (m, 3 H, CHPh), 7.82 (d, 3J = 8.9 Hz, 1 H, CHAr), 11.07 (s, 
1 H, OH). 13C NMR (CDCl3, 75 MHz):  = 52.5 (OCH3), 
113.6 (CCOOCH3), 117.7, 127.7, 127.7, 127.7, 127.8, 127.8, 
128.5 (CHAr), 133.7, 136.2, 139.0 (CAr), 163.8 (COH), 170.2 
(CO). IR (KBr, cm-1): ν̃ = 3086 (w), 3062 (w), 2954 (w), 1735 (w), 1670 (m), 1599 (w), 1576 
(w), 1525 (m), 1501 (w), 1442 (m), 1324 (m), 1220 (m), 1156 (w), 1132 (m), 1095 (w), 1074 
(w), 1026 (w), 970 (w), 907 (m), 837 (w), 813 (w), 769 (w), 727 (s), 698 (m), 672 (m), 648 
(w), 584 (w). GC-MS (EI, 70 eV): m/z (%) = 273 ([M]+, 80), 242 (17), 241 (100), 224 (15), 
213 (25), 212 (13), 196 (14), 185 (18), 184 (11), 183 (13), 159 (16), 157 (11), 155 (20), 140 
(15), 139 (66), 138 (10), 129 (25), 128 (14), 127 (19), 115 (10), 113 (10), 102 (10), 77 (12), 
63 (11). HRMS (EI): Calcd. for C14H11O5N ([M]+): 273.06317; found: 273.063020. 
Methyl 3-hydroxy-4-methyl-6-nitrobiphenyl-2-carboxylate (132b):  
Starting with 131a (0.332 g, 1.5 mmol) and 22d (0.457 g, 1.65 mmol), 132b was isolated after 
chromatography (silica gel, heptanes/EtOAc) as a yellowish solid (0.245 g, 57%), m.p. = 57-
59 °C.  
1H NMR (300 MHz, CDCl3): δ = 2.28 (s, 3 H, CH3), 3.33 (s, 3 
H, OCH3), 7.05 - 7.08 (m, 2 H, CHPh), 7.26 - 7.29 (m, 3 H, 
CHPh), 7.71 (s, 1H, CHAr), 11.33 (s, 1 H, OH). 13C NMR 
(CDCl3, 75 MHz):  = 15.9 (CH3), 52.4 (OCH3), 112.6 
(CCOOCH3), 127.6 (CHAr), 127.7 (2CHAr), 127.9 (3 CHAr), 
133.2, 136.3, 136.6, 142.6 (CAr), 162.3 (COH), 170.8 (CO). IR 
(KBr, cm-1): ν̃ = 3062 (w), 2958 (w), 1737 (w), 1665 (m), 1574 (w), 1526 (m), 1495 (w), 1441 
(m), 1373 (m), 1302 (m), 1251 (m), 1200 (m), 1170 (m), 1129 (m), 1070 (m), 1031 (w), 1001 
(w), 983 (w), 902 (w), 864 (w), 812 (w), 778 (m), 727 (m), 696 (m), 663 (m), 610 (m), 574 
(m). GC-MS (EI, 70 eV): m/z (%) = 287 ([M]+, 80), 256 (17), 255 (100), 239 (15), 238 (75), 
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209 (15), 208 (76), 180 (10), 129 (14), 127 (10), 115 (14), 77 (10). HRMS (EI): Calcd. for 
C15H13O5N ([M]+): 287.07882; found: 287.078935. 
Ethyl 4-ethyl-3-hydroxy-6-nitrobiphenyl-2-carboxylate (132c):  
Starting with 131a (0.332 g, 1.5 mmol) and 22g (0.499 g, 1.65 mmol), 132c was isolated after 
chromatography (silica gel, heptanes/EtOAc) as a viscos yellowish oil (0.306 g, 65%).  
1H NMR (300 MHz, CDCl3): δ = 0.52 (t, 3J = 7.6 Hz, 3 H, 
CH2CH3), 1.12 (t, 3J = 7.5 Hz, 3 H, OCH2CH3), 2.59 (q, 3J= 
7.5 Hz, 2 H, CH2CH3), 3.75 (q, 3J= 7.5 Hz, 2 H, OCH2CH3), 
6.96 -7 .0 (m, 2 H, CHPh), 7.16 - 7.18 (m, 3 H, CHPh), 7.61 (s, 
1 H, CHAr), 11.42 (s, 1 H, OH). 13C NMR (CDCl3, 75 MHz): 
 = 12.8, 13.0 (CH3), 22.8, 61.8 (CH2), 112.8 (CCOOCH3), 
127.6 (CHAr), 127.7 (2 CHAr), 128.1 (3 CHAr), 133.3, 136.2, 136.8, 142.8 (CAr), 162.2 (COH), 
170.4 (CO). IR (neat, cm-1): ν̃ = 3083 (w), 3002 (w), 2963 (w), 1737 (w), 1657 (m), 1600 (w), 
1567 (w), 1512 (m), 1443 (m), 1329 (m), 1298 (m), 1241 (m), 1191 (s), 1149 (m), 1063 (m), 
1018 (m), 968 (w), 900 (m), 822 (m), 803 (m), 733 (s), 695 (s), 668 (s), 621 (m), 581 (m), 524 
(m). GC-MS (EI, 70 eV): m/z (%) = 315 ([M]+, 54), 270 (10), 269 (50), 253 (19), 252 (100), 
223 (18), 222 (89), 165 (22), 152 (21), 129 (8). HRMS (EI): Calcd. for C17H17O5N ([M]+): 
315.11012; found: 315.110219. 
Methyl 4-butyl-3-hydroxy-6-nitrobiphenyl-2-carboxylate (132d):  
Reaction starting with 131a (0.332 g, 1.5 mmol) and 22h (0.522 g, 1.65 mmol), 132d was 
isolated after chromatography (silica gel, heptanes/EtOAc) as a viscos yellowish oil (0.285 g, 
58%).  
1H NMR (300 MHz, CDCl3): δ = 0.88 (t, 3J = 7.2 Hz, 3 H, 
CH3), 1.28-1.40 (m, 2 H, CH2), 1.52 - 1.62 (m, 2 H, CH2), 
2.64 (t, 3J = 7.2 Hz, 2 H, PhCH2), 3.31 (s, 3 H, OCH3), 7.04-
7.07 (m, 2 H, CHPh), 7.23 - 7.27 (m, 3 H, CHPh), 7.68 (s, 1 H, 
CHAr), 11.27 (s, 1 H, OH). 13C NMR (CDCl3, 75 MHz):  = 
13.9 (CH3), 22.5, 29.4, 31.0 (CH2), 52.4 (OCH3), 112.9 
(CCOOCH3), 127.6 (CHAr), 127.7 (2 CHAr), 127.9 (2 CHAr), 128.9 (CHAr), 132.1, 136.2, 
136.6, 142.7 (CAr), 162.0 (COH), 170.8 (CO). IR (neat, cm-1): ν̃ = 3065 (w), 3006 (w), 2952 
(w), 1674 (m), 1581 (w), 1531 (w), 1438 (m), 1380 (w), 1356 (m), 1311 (s), 1232 (m), 1140 
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(m), 1090 (m), 1030 (w), 940 (w), 914 (m), 850 (w), 808 (m), 771 (m), 732 (m), 698 (s), 671 
(m), 628 (m), 608 (m). GC-MS (EI, 70 eV): m/z (%) = 329 ([M]+, 48), 281 (12), 280 (59), 255 
(18), 239 (15), 238 (100), 209 (10), 208 (36), 180 (10), 152 (21). HRMS (EI): Calcd. for 
C18H19O5N ([M]+): 329.12577; found: 329.125828. 
Methyl 3-hydroxy-6-nitro-4-octylbiphenyl-2-carboxylate (132e):  
Starting with 131a (0.332 g, 1.5 mmol) and 22l (0.615 g, 1.65 mmol), 132e was isolated after 
chromatography (silica gel, heptanes/EtOAc) as a yellowish oil (0.357 g, 62%).  
1H NMR (300 MHz, CDCl3): δ = 0.71 (t, 3J = 7.2 Hz, 3 H, 
CH3), 1.08 - 1.15 (m, 10 H, 5 CH2), 1.43 - 1.55 (m, 2 H, CH2), 
2.56 (t, 3J = 7.0 Hz, 2 H, PhCH2), 3.23 (s, 3 H, OCH3), 6.96-
6.99 (m, 2 H, CHPh), 7.17 - 7.19 (m, 3 H, CHPh), 7.60 (s, 1H, 
CHAr), 11.19 (s, 1 H, OH). 13C NMR (CDCl3, 75 MHz):  = 
14.1 (CH3), 22.6, 28.8, 29.2, 29.3, 29.4, 29.6, 31.8 (CH2), 52.3 
(OCH3), 112.9 (CCOOCH3), 127.6 (CHAr), 127.4 (2 CHAr), 127.9 (2 CHAr), 128.9 (CHAr), 
132.1, 136.2, 136.6, 142.7 (CAr), 162.0 (COH), 170.8 (CO). IR (neat, cm-1): ν̃ = 3060 (w), 
2952 (w), 2923 (m), 1666 (m), 1570 (w), 1526 (m), 1437 (m), 1336 (s), 1250 (m), 1164 (m), 
1126 (m), 1074 (w), 1029 (w), 964 (w), 914 (w), 843 (w), 814 (m), 754 (m), 733 (m), 697 (s), 
669 (m), 612 (w). GC-MS (EI, 70 eV): m/z (%) = 385 ([M]+, 64), 337 (23), 336 (95), 255 
(16), 254 (15), 239 (21), 238 (100), 209 (12), 208 (29), 180 (10), 152 (16). HRMS (EI): 
Calcd. for C12H27O5N ([M]+): 385.18837; found: 385.188315. 
Methyl 3-hydroxy-2'-methyl-6-nitrobiphenyl-2-carboxylate (132f):  
Starting with 131b (0.353 g, 1.5 mmol) and 22a (0.430 g, 1.65 mmol), 132f was isolated after 
chromatography (silica gel, heptanes/EtOAc) as a yellowish solid (0.292 g, 68%), m.p. = 74 
	76 °C.  
1H NMR (300 MHz, CDCl3): δ = 2.51 (s, 3 H, CH3), 3.28 (s, 3 
H, OCH3), 6.96 (d, 3J = 8.4 Hz, 1 H, CHAr), 7.11 - 7.15 (m, 3 
H, CHAr), 7.28 - 7.33 (m, 1 H, CHAr), 7.93 (d, 3J = 8.4 Hz, 1 
H, CHAr), 11.33 (s, 1 H, OH). 13C NMR (CDCl3, 75 MHz):  
= 19.8 (CH3), 52.6 (OCH3), 113.1 (CCOOCH3), 117.9, 125.2 
(CHAr), 128.3 (2 CHAr), 129.1, 130.0 (CHAr), 132.9, 135.9, 
139.0, 141.3 (CAr), 164.4 (COH), 170.2 (CO). IR (KBr, cm-1): ν̃ = 3063 (w), 2954 (w), 2649 
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(w), 1673 (m), 1598 (m), 1575 (m), 1518 (m), 1490 (m), 1441 (m), 1313 (s), 1313 (s), 1268 
(m), 1232 (s), 1221 (s), 1173 (m), 1132 (m), 1086 (m), 1052 (m), 1034 (w), 964 (m), 912 (m), 
832 (m), 814 (m), 763 (m), 733 (s), 689 (m), 658 (m), 593 (m), 531 (m). GC-MS (EI, 70 eV): 
m/z (%) = 287 ([M]+, 27), 270 (14), 269 (15), 256 (17), 239 (19), 238 (100), 237 (21), 228 
(52), 226 (14), 181 (15), 153 (25), 127 (13), 115 (20), 63 (9). HRMS (EI): Calcd. for 
C15H13O5N ([M]+): 287.07882; found: 287.078912. 
Methyl 3-hydroxy-2',4-dimethyl-6-nitrobiphenyl-2-carboxylate (132g):  
Starting with 131b (0.353 g, 1.5 mmol) and 22d (0.453 g, 1.65 mmol), 132g was isolated after 
chromatography (silica gel, heptanes/EtOAc) as a yellowish solid (0.324 g, 72%), m.p. = 70 
	72 °C.  
1H NMR (300 MHz, CDCl3): δ = 1.99 (s, 3 H, CH3), 2.29 (s, 
3 H, CH3), 3.34 (s, 3 H, OCH3), 6.82 - 6.84 (m, 1 H, CHAr), 
7.03 - 7.16 (m, 3 H, CHAr), 7.79 (s, 1 H, CHAr), 11.63 (s, 1 H, 
OH). 13C NMR (CDCl3, 75 MHz):  = 15.9, 19.9 (CH3), 52.6 
(OCH3), 112.2 (CCOOCH3), 125.2, 127.3 (CHAr), 127.7 
(CAr), 128.8, 129.0, 130.1 (CHAr), 136.0, 136.2, 136.3, 142.3 
(CAr), 163.0 (COH), 170.8 (CO). IR (KBr, cm-1): ν̃ = 3061 (w), 2953 (w), 2854 (w), 1664 (m), 
1573 (m), 1523 (m), 1494 (w), 1380 (m), 1334 (s), 1285 (m), 1254 (s), 1202 (s), 1166 (m), 
1133 (m), 1133 (m), 1104 (m), 1041 (w), 1018 (m), 964 (m), 899 (m), 871 (w), 813 (m), 753 
(m), 723 (s), 661 (m), 589 (m), 531 (m). GC-MS (EI, 70 eV): m/z (%) = 301 ([M]+, 29), 384 
(12), 383 (10), 270 (17), 254 (15), 252 (100), 251 (21), 242 (41), 240 (12), 239 (31), 238 (54), 
225 (13), 222 (63), 211 (11), 195 (10), 194 (16), 168 (12), 166 (23), 165 (62), 153 (14), 151 
(11), 139 (14), 128 (12), 115 (23), 82 (12), 77 (10). HRMS (EI): Calcd. for C16H15O5N ([M]+): 
301.09447; found: 301.093882. 
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Methyl 2'-chloro-3-hydroxy-6-nitrobiphenyl-2-carboxylate (132h):  
Starting with 131c (0.383 g, 1.5 mmol) and 22a (0.430 g, 1.65 mmol), 132h was isolated after 
chromatography (silica gel, heptanes/EtOAc) as a yellowish solid (0.258 g, 56%), m.p. = 
101	103 °C.  
1H NMR (300 MHz, CDCl3): δ = 3.41 (s, 3 H, OCH3), 
6.92–7.02 (m, 1 H, CHAr), 7.09 (d, 3J = 9.0 Hz, 1 H, CHAr), 
7.17-7.20 (m, 1 H, CHAr), 7.22 - 7.25 (m, 1 H, CHAr), 7.35 - 
7.38 (m, 1 H, CHAr), 8.01 (d, 3J = 9.0 Hz, 1 H, CHAr), 11.52 
(s, 1 H, OH). 13C NMR (CDCl3, 75 MHz):  = 52.8 (OCH3), 
113.0 (CCOOCH3), 118.6, 126.4, 128.7, 128.7, 129.2, 130.4 
(CHAr), 132.9, 135.8, 136.5, 142.3 (CAr), 164.8 (COH), 169.9 (CO). IR (KBr, cm-1): ν̃ = 3073 
(w), 2952 (w), 1673 (m), 1599 (m), 1578 (m), 1519 (m), 1480 (w), 1440 (s), 1323 (s), 1230 
(m), 1204 (s), 1127 (m), 1049 (m), 968 (m), 914 (m), 841 (m), 811 (m), 750 (s), 737 (s), 698 
(s), 644 (m), 592 (w). GC-MS (EI, 70 eV): m/z (%) = 307 ([M]+, 10), 273 (15), 272 (100), 241 
(10), 240 (66), 226 (12), 212 (18), 184 (15), 173 (10). HRMS (EI): Calcd. for C14H10O5NCl 
([M]+): 307.02420; found: 307.024320. 
Methyl 2'-chloro-3-hydroxy-4-methyl-6-nitrobiphenyl-2-carboxylate (132i):  
Starting with 131c (0.383 g, 1.5 mmol) and 22d (0.453 g, 1.65 mmol), 132i was isolated after 
chromatography (silica gel, heptanes/EtOAc) as a yellowish solid (0.337 g, 70%), m.p. = 100-
102 °C.  
1H NMR (300 MHz, CDCl3): δ = 2.31 (s, 3 H, CH3), 3.40 
(s, 3 H, OCH3), 6.99 (dd, 3J = 6.9 Hz, 4J = 1.8 Hz, 1 H, 
CHAr), 7.15 - 7.26 (m, 2 H, CHAr), 7.35 (dd, 3J = 7.7 Hz, 4J 
= 1.5 Hz, 1 H, CHAr), 7.90 (s, 1 H, CHAr), 11.79 (s, 1 H, 
OH). 13C NMR (CDCl3, 75 MHz):  = 16.0 (CH3), 52.8 
(OCH3), 112.0 (CCOOCH3), 126.4 (CHAr), 128.5 (CAr), 
128.6, 128.8, 129.0, 130.5 (CHAr), 133.0, 133.8, 136.2, 141.6 (CAr), 163.4 (COH), 170.5 
(CO). IR (KBr, cm-1): ν̃ = 2955 (w), 2853 (w), 1731 (w), 1664 (s), 1574 (m), 1521 (m), 1429 
(m), 1378 (m), 1341 (s), 1265 (s), 1200 (s), 1128 (m), 1057 (m), 98 (m), 946 (w), 899 (m), 
859 (w), 810 (m), 754 (m), 739 (s), 698 (s), 657 (m), 630 (m), 534 (w). GC-MS (EI, 70 eV): 
m/z (%) = 321 ([M]+, 10), 287 (17), 286 (100), 255 (12), 254 (77), 226 (12), 198 (17), 152 
(24), 139 (10). HRMS (EI): Calcd. for C15H12O5NCl ([M]+): 321.03985; found: 321.039927. 
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Methyl 6-amino-3-hydroxybiphenyl-2-carboxylate (133a):  
Starting with 132a (0.130 g, 0.476 mmol), 133a was isolated (0.099 g, 86%) by column 
chromatography (silica gel, heptanes/EtOAc) as a yellowish solid, m.p. = 95 - 97 °C.  
1H NMR (300 MHz, CDCl3): δ = 3.02 (br, 2 H, NH2), 3.30 (s, 
3 H, OCH3), 6.82-6.84 (m, 2 H, CHAr), 7.08 - 7.11 (m, 2 H, 
CHPh), 7.22 - 7.35 (m, 3 H, CHPh), 10.07 (br, 1 H, OH). 13C 
NMR (CDCl3, 75 MHz):  = 51.6 (OCH3), 112.5 (CCOOCH3), 
117.7, 123.1, 127.0, (CHAr), 127.5 (CAr), 128.5 (2 CHAr), 
128.9 (2 CHAr), 136.9, 139.1 (CAr), 154.7 (COH), 171.3 (CO). 
IR (KBr, cm-1): ν̃ = 3742 (w), 3060 (w), 2922 (w), 2788 (w), 2671 (w), 1721 (s), 1586 (m), 
1488 (m), 1455 (m), 1433 (m), 1348 (m), 1302 (m), 1277 (s), 1239 (m), 1217 (s), 1158 (m), 
1110 (m), 1087 (m), 1029 (w), 982 (m), 949 (m), 911 (m), 871 (m), 807 (m), 776 (m), 750 
(m), 730 (m), 719 (s), 698 (s), 646 (m), 613 (m), 549 (m). GC-MS (EI, 70 eV): m/z (%) = 243 
([M]+, 32), 212 (16), 211 (100), 183 (24), 155 (15), 154 (67), 128 (16), 127 (10), 77 (10).  
HRMS (EI): Calcd. for C14H13O3N ([M]+): 243.08899; found: 243.089209. 
Methyl 6-amino-3-hydroxy-4-methylbiphenyl-2-carboxylate (133b):  
Starting with 132b (0.140 g, 0.487 mmol), 133b was isolated (0.107 g, 85%) by column 
chromatography (silica gel, heptanes/EtOAc) as a yellowish oil.  
1H NMR (300 MHz, CDCl3): δ = 2.17 (s, 3 H, CH3), 3.09 
(br, 2 H, NH2), 3.28 (s, 3 H, OCH3), 6.73 (s, 1 H, CHAr), 
7.06-7.09 (m, 2 H, CHAr), 7.22 - 7.25 (m, 1 H, CHAr), 7.29 - 
7.34 (m, 2 H, CHAr), 10.36 (br, 1 H, OH). 13C NMR (CDCl3, 
75 MHz):  = 16.3 (CH3), 51.5 (OCH3), 111.7 (CCOOCH3), 
124.2 (CHAr), 125.0 (CAr), 126.8 (CHAr), 128.4 (2 CHAr), 
129.3 (2 CHAr), 132.5, 136.0, 139.4 (CAr), 153.1 (COH), 171.7 (CO). IR (neat, cm-1): ν̃ = 3444 
(w), 3057 (w), 2924 (w), 2851 (w), 1726 (w), 1658 (m), 1587 (m), 1499 (w), 1434 (m), 1347 
(m), 1306 (m), 1280 (m), 1208 (s), 1149 (m), 1106 (m), 1072 (m), 1023 (m), 983 (m), 907 
(m), 863 (m), 802 (m), 764 (m), 730 (s), 700 (s), 689 (s), 645 (m), 565 (m). GC-MS (EI, 70 
eV): m/z (%) = 257 ([M]+, 33), 226 (17), 225 (100), 197 (24), 169 (11), 168 (53), 167 (14), 
154 (12), 128 (9). HRMS (EI): Calcd. for C15H15O3N ([M]+): 257.10464; found: 257.104582. 
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Ethyl 6-amino-4-ethyl-3-hydroxybiphenyl-2-carboxylate (133c):  
Starting with 132c (0.130 g, 0.412 mmol), 133c was isolated (0.113 g, 96%) by column 
chromatography (silica gel, heptanes/EtOAc) as a yellowish oil.  
1H NMR (300 MHz, CDCl3): δ = 0.58 (t, 3J = 7.0 Hz, 3 H, 
CH2CH3), δ = 1.17 (t, 3J = 7.6 Hz, 3 H, OCH2CH3), 2.60 (q, 
3J= 7.6 Hz, 2 H, CH2CH3), 3.09 (br, 2 H, NH2), 3.81 (q, 3J= 
7.0 Hz, 2 H, OCH2CH3), 6.76 (s, 1 H, CHAr), 7.08 - 7.11 
(m, 2 H, CHAr), 7.21 - 7.34 (m, 3 H, CHAr), 10.58 (br, 1 H, 
OH). 13C NMR (CDCl3, 75 MHz):  = 12.8, 13.7 (CH3), 
23.0 (CH2), 60.6 (OCH2), 111.8 (CCOOCH3), 122.5 (CHAr), 125.1 (CAr), 126.7 (CHAr), 128.4 
(2 CHAr), 129.1 (2 CHAr), 132.7, 136.0, 139.7 (CAr), 153.0 (COH), 171.4 (CO).                     
IR (neat, cm-1): ν̃ = 3447 (w), 3056 (w), 2964 (w), 2872 (w), 1654 (m), 1611 (m), 1585 (m), 
1496 (w), 1429 (m), 1371 (m), 1326 (m), 1264 (m), 1205 (s), 1149 (m), 1106 (m), 1065 (m), 
1014 (m), 968 (w), 909 (m), 853 (m), 803 (m), 762 (m), 731 (m), 699 (s), 681 (m), 645 (m), 
569 (m). GC-MS (EI, 70 eV): m/z (%) = 285 ([M]+, 30), 240 (17), 239 (100), 221 (11), 211 
(13), 196 (25), 167 (11). HRMS (EI): Calcd. for C17H19O3N ([M]+): 285.13594; found: 
285.135726. 
 Methyl 6-amino-4-butyl-3-hydroxybiphenyl-2-carboxylate (133d):  
Starting with 132d (0.130 g, 0.395 mmol), 133d was isolated (0.108 g, 91%) by column 
chromatography (silica gel, heptanes/EtOAc) as a yellowish oil.  
1H NMR (300 MHz, CDCl3): δ = 0.82 (t, 3J = 6.7 Hz, 3 H, 
CH3), 1.15 - 1.18 (m, 2 H, CH2), 1.50 - 1.59 (m, 2 H, CH2), 
2.56 (t, 3J = 7.6 Hz, 2 H, PhCH2), 3.06 (br, 2 H, NH2), 3.29 
(s, 3 H, OCH3), 6.75 (s, 1 H, CHAr), 7.07 - 7.12 (m, 2 H, 
CHAr), 7.21 - 7.25 (m, 1 H, CHAr), 7.32 - 7.36 (m, 2 H, 
CHAr), 10.35 (br, 1 H, OH). 13C NMR (CDCl3, 75 MHz):  = 
13.9 (CH3), 22.5, 29.4, 31.0 (CH2), 51.4 (OCH3), 112.0 (CCOOCH3), 123.5 (CHAr), 125.0 
(CAr), 126.7 (CHAr), 128.5 (2 CHAr), 129.1 (2 CHAr), 131.4, 136.0, 139.5 (CAr), 152.8 (COH), 
171.3 (CO). IR (neat, cm-1): ν̃ = 3454 (w), 3055 (w), 2922 (m), 2851 (w), 1660 (m), 1598 (m), 
1493 (w), 1433 (m), 1315 (m), 1263 (m), 1207 (s), 1152 (m), 1108 (m), 1071 (w), 998 (w), 
920 (w), 871 (w), 809 (w), 764 (m), 721 (m), 700 (s), 683 (m), 647 (m), 569 (m). HRMS (EI): 
Calcd. for C18H21O3N ([M]+): 299.15299; found: 299.152209. 
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Methyl 6-amino-3-hydroxy-4-octylbiphenyl-2-carboxylate (133e):  
Starting with 132e (0.150 g, 0.389 mmol), 133e was isolated (0.124 g, 90%) by column 
chromatography (silica gel, heptanes/EtOAc) as a yellowish oil. 
 1H NMR (300 MHz, CDCl3): δ = 0.81 (t, 3J = 6.5 Hz, 3 H, 
CH3), 1.17 - 1.25 (m, 10 H, 5 CH2), 1.51 - 1.61 (m, 2 H, CH2), 
2.56 (t, 3J = 7.8 Hz, 2 H, PhCH2), 3.08 (br, 2 H, NH2), 3.28 (s, 3 
H, OCH3), 6.74 (s, 1 H, CHAr), 7.07 - 7.11 (m, 2 H, CHAr), 7.20-
7.25 (m, 1 H, CHAr), 7.30 - 7.35 (m, 2 H, CHAr), 10.34 (br, 1 H, 
OH). 13C NMR (CDCl3, 75 MHz):  = 14.1 (CH3), 22.6, 29.3, 
29.5, 29.5, 29.6, 30.3, 31.9 (CH2), 51.5 (OCH3), 111.9 (CCOOCH3), 123.4 (CHAr), 125.1 
(CAr), 126.8 (CHAr), 128.4 (2 CHAr), 129.0 (2 CHAr), 131.5, 135.9, 139.4 (CAr), 152.9 (COH), 
171.7 (CO). IR (neat, cm-1): ν̃ = 3455 (w), 3056 (w), 2922 (m), 2852 (w), 1659 (m), 1599 (m), 
1497 (w), 1434 (m), 1317 (m), 1263 (m), 1208 (s), 1150 (m), 1108 (m), 1071 (w), 997 (w), 
919 (w), 881 (w), 804 (w), 764 (m), 721 (m), 700 (s). GC-MS (EI, 70 eV): m/z (%) = 355 
([M]+, 65), 324 (27), 323 (100), 322 (11), 306 (12), 266 (25), 252 (18), 324 (27), 323 (100), 
322 (11), 306 (12), 266 (25), 252 (18), 238 (27), 225 (41), 224 (47), 209 (10), 208 (10), 197 
(10), 196 (30), 180 (11), 168 (23), 167 (21), 41 (10). HRMS (EI): Calcd. for C22H29O3N 
([M]+): 355.21420; found: 355.214070. 
Methyl 6-amino-3-hydroxy-2'-methylbiphenyl-2-carboxylate (133f):  
Starting with 132f (0.120 g, 0.418 mmol), 133f was isolated (0.097 g, 90%) by column 
chromatography (silica gel, heptanes/EtOAc) as a yellowish viscos oil.  
1H NMR (300 MHz, CDCl3): δ = 1.98 (s, 3 H, CH3), 3.02 (br, 
2 H, NH2), 3.31 (s, 3 H, OCH3), 6.68 (d, 3J = 8.0 Hz, 1 H, 
CHAr), 6.92 - 6.94 (m, 1 H, CHAr), 7.18 - 7.23 (m, 3 H, 
CHAr), 8.0 (d, 3J = 8.2 Hz, 1 H, CHAr), 9.98 (br, 1 H, OH). 
13C NMR (CDCl3, 75 MHz):  = 19.5 (CH3), 51.7 (OCH3), 
112.1 (CCOOCH3), 117.6, 123.8, 126.1, 127.4 (CHAr), 127.8 
(CAr), 128.9, 129.9 (CHAr), 135.3, 136.2, 138.1 (CAr), 153.5 (COH), 171.7 (CO).                    
IR (neat, cm-1): ν̃ = 3451 (w), 3060 (w), 2921 (w), 2851 (w), 1664 (m), 1598 (m), 1489 (w), 
1463 (m), 1436 (m), 1411 (w), 1335 (m), 1312 (m), 1287 (m), 1212 (s), 1119 (m), 1087 (m), 
1037 (m), 982 (w), 913 (m), 806 (m), 757 (m), 734 (s), 689 (m), 624 (m), 565 (m). GC-MS 
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(EI, 70 eV): m/z (%) = 257 ([M]+, 39), 226 (17), 225 (100), 169 (15), 168 (50), 167 (10), 154 
(10), 115 (9). HRMS (EI): Calcd. for C15H15O3N ([M]+): 257.10464; found: 257.104502. 
Methyl 6-amino-3-hydroxy-2',4-dimethylbiphenyl-2-carboxylate (133g):  
Starting with 132g (0.140 g, 0.465 mmol), 133g was isolated (0.112 g, 89%) by column 
chromatography (silica gel, heptanes/EtOAc) as a yellowish oil.  
1H NMR (300 MHz, CDCl3): δ = 1.98 (s, 3 H, CH3), 2.19 (s, 3 
H, CH3), 3.04 (br, 2 H, NH2), 3.30 (s, 3 H, OCH3), 6.77 (s, 1 
H, CHAr), 6.88 - 6.91 (m, 1 H, CHAr), 7.12 - 7.18 (m, 3 H, 
CHAr), 10.61 (br, 1 H, OH). 13C NMR (CDCl3, 75 MHz):  = 
16.0, 19.5 (CH3), 51.6 (OCH3), 111.3 (CCOOCH3), 124.3 
(CHAr), 124.5 (CAr), 126.0 (CHAr), 126.6 (CAr), 127.2, 128.8, 
129.7 (CHAr), 135.5, 136.4, 138.6 (CAr), 153.5 (COH), 171.7 (CO). IR (neat, cm-1): ν̃ = 3447 
(w), 3057 (w), 2920 (w), 2850 (w), 1726 (w), 1658 (m), 1610 (m), 1456 (m), 1434 (s), 1377 
(m), 1342 (m), 1284 (m), 1208 (s), 1150 (m), 1101 (m), 1023 (m), 983 (m), 909 (w), 869 (m), 
804 (m), 758 (s), 728 (s), 678 (m), 645 (m), 578 (m). GC-MS (EI, 70 eV): m/z (%) = 271 
([M]+, 39), 240 (17), 239 (100), 183 (10), 182 (25), 168 (30), 167 (13). HRMS (EI): Calcd. 
for C16H17O3N ([M]+): 271.12029; found: 271.120370. 
Methyl 6-amino-2'-chloro-3-hydroxybiphenyl-2-carboxylate (133h):  
Starting with 132h (0.120 g, 0.390 mmol), 133h was isolated (0.095 g, 88%) by column 
chromatography (silica gel, heptanes/EtOAc) as a brown oil.  
1H NMR (300 MHz, CDCl3): δ = 3.03 (br, 2 H, NH2), 3.30 
(s, 3 H, OCH3), 6.85 (d, 3J = 8.0 Hz, 1 H, CHAr), 7.09 - 7.11 
(m, 2 H, CHAr), 7.23 - 7.28 (m, 2 H, CHAr), 7.32 - 7.37 (m, 
2 H, CHAr), 10.29 (br, 1 H, OH). 13C NMR (CDCl3, 75 
MHz):  = 51.6 (OCH3), 112.4 (CCOOCH3), 117.7, 123.3, 
127.0 (CHAr), 127.8 (CAr), 128.5, 128.5, 128.8 (CHAr), 
135.5, 136.4, 139.0 (CAr), 154.8 (COH), 171.2 (CO). IR (neat, cm-1): ν̃ = 3445 (w), 3056 (w), 
2950 (w), 2850 (w), 1728 (w), 1663 (m), 1594 (m), 1463 (m), 1435 (s), 1335 (m), 1285 (m), 
1209 (s), 1092 (m), 1027 (m), 982 (m), 805 (m), 759 (m), 732 (m), 700 (s), 626 (m), 580 (m). 
GC-MS (EI, 70 eV): m/z (%) = 277 ([M]+, 42), 246 (14), 245 (100), 211 (19), 210 (59), 183 
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(10), 182 (52), 154 (62), 153 (13), 127 (14), 77 (11). HRMS (EI): Calcd. for C14H12O3NCl 
([M]+): 277.05002; found: 277.050203. 
Methyl 6-amino-2'-chloro-3-hydroxy-4-methylbiphenyl-2-carboxylate (133i):  
Starting with 132i (0.120 g, 0.373 mmol), 133i was isolated (0.097 g, 89%) by column 
chromatography (silica gel, heptanes/EtOAc) as a brown oil. 
 1H NMR (300 MHz, CDCl3): δ = 2.19 (s, 3 H, CH3), 3.02 
(br, 2 H, NH2), 3.29 (s, 3 H, OCH3), 6.78 (s, 1 H, CHAr), 
7.07 - 7.10 (m, 1 H, CHAr), 7.23 - 7.26 (m, 1 H, CHAr), 7.30 -
7.35 (m, 2 H, CHAr), 10.42 (br, 1 H, OH). 13C NMR (CDCl3, 
75 MHz):  = 16.0 (CH3), 51.5 (OCH3), 111.7 (CCOOCH3), 
124.3 (CHAr), 125.3 (CAr), 126.8 (CHAr), 127.8 (CAr), 128.4 
(2 CHAr), 129.0 (CHAr), 132.5, 135.5, 139.2 (CAr), 153.4 (COH), 171.6 (CO). IR (neat, cm-1): 
ν̃ = 3447 (w), 3056 (w), 2949 (w), 2851 (w), 1731 (w), 1658 (m), 1612 (m), 1599 (m), 1498 
(w), 1434 (s), 1377 (m), 1280 (m), 1206 (s), 1149 (m), 1105 (m), 1072 (m), 1005 (m),  983 
(m), 919 (w), 803 (m), 763 (m), 700 (s), 644 (m), 588 (m). GC-MS (EI, 70 eV): m/z (%) = 
257 ([M]+, 33), 226 (17), 225 (100), 197 (22), 168 (49), 167 (14), 154 (11). HRMS (EI): 
Calcd. for C15H14O3NCl ([M]+): 291.07029; found: 291.070370. 
4-(Phenylselanyl)heptane-3,5-dione 136b: 
To a suspension of selenium dioxide(1.11 gm, 10 mmol) in 35 ml of dichloromethane 
containing diphenyl diselenide(6.24 gm, 20 mmol) and a catalytic amount of sulfuric 
acid(0.11 ml, 2 mmol) was added 3,5-heptanedione (2.31 ml, 17 mmol)  at 10°C. The mixture 
was stirred overnight, the reaction mixture was poured in dichloromethane (100 ml) and 
washed with saturated aqueous sodium hydrogen carbonate (20 ml% 2). The organic layer 
was dried (sodium sulfate) and evaporated to yellowish oil, which was purified by silica gel 
column chromatography to afford 4-(phenylselanyl)heptane-3,5-dione as a yellowish oil  
(1.33 gm, 47 %). 
1H NMR (300.13 MHz, CDCl3): δ = 1.02 (t, 3J = 7.4 Hz, 6 
H, 2 CH3), 2.71 (q, 3J = 7.6Hz, 4 H, 2 CH2), 7.07 - 7.12 (m, 
2H, 2 CHAr ), 7.13 - 7.20 (m,3H, 3 CHAr ), one H is missing. 
13C NMR (75 MHz, CDCl3): δ = 13.7, 13.9 (CH3), 31.2, 31.3 
(CH2), 112.45 (C), 125.0 (CHAr), 126.6, 128.3 (2 CHAr), 
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Chemical Formula: C15H14ClNO3
Exact Mass: 291,07
Cl
H3C
CH2CH3
OO
Se
H3CH2C
Chemical Formula: C13H16O2Se
Exact Mass: 284,03
Experimental part 
 
132 
 
130.5 (CAr), 197.0, 200.0 (CO). IR (neat, cm	1): v~ = 3069 (w), 2976 (w), 2937 (w), 2877 (w), 
1695 (m), 1575 (m), 1557 (m), 1475 (m), 1458 (m), 1436 (m), 1401 (m), 1375 (m), 1337 (m), 
1296 (m), 1240 (m), 1187 (m), 1156 (m), 1099 (m), 1064 (m), 1019 (m), 997 (m), 886 (w), 
847 (m), 805 (m), 731 (s), 688 (s), 666 (m), 614 (w).MS (GC-MS, 70 eV): m/z (%):  284 (M+, 
43), 282 (10), 280 (22), 255 (14), 254 (11), 253 (13), 230 (23), 228 (21), 226 (14), 225 (13), 
224 (14), 172 (11), 171 (43), 170 (11), 168 (21), 159 (14), 158 (13), 157 (24), 156 (17), 155 
(11), 154 (15), 149 (12), 129 (17), 128 (14), 118 (10), 99 (23), 91 (29), 77 (22), 58 (11), 57 
(100), 55 (14), 51 (12), 50 (16), 43 (17), 39 (10), 29 (40).HRMS (EI): Calcd. for C13H16O2Se: 
284.031191; found: 284.03100 
Methyl 6-hydroxy-2,4-dimethyl-3-(phenylselanyl)benzoate (137a): 
Starting with 136a (0.491 g, 1.5 mmol) and 22a (0.430 g, 1.65 mmol), 137a was isolated sfter 
column chromatography (ethyl acetate/heptanes) as a colorless oil (0.297 g, 59%).  
1H NMR (300.13 MHz, CDCl3): δ = 2.34 (s, 3 H, CH3), 2.66 
(s, 3 H, CH3), 3.83 (s, 3 H, OCH3), 6.75 (s, 1 H, CHAr), 6.94 -
6.98 (m, 2 H, 2 CHAr ), 7.05 - 7.14 (m, 3 H, 3 CHAr ), 10.91 
(s, 1 H, OH).13C NMR (75 MHz, CDCl3): δ = 24.4, 25.7 
(CH3), 52.3 (OCH3), 112.2 (CAr), 117.3 (CHAr), 123.1 (CAr), 
125.5 (CHAr), 128.2, 129.2 (2 CHAr), 133.4, 146.6, 151.2 
(CAr), 162.4 (COH), 171.7 (CO). IR (neat, cm	1): v~ = 3054 
(w), 2950 (w), 2922 (w), 2852 (w), 1730 (w), 1689 (w), 1656 (s), 1631 (m), 1593 (m), 1475 
(m), 1375 (w), 1348 (s), 1298 (s), 1223 (s), 1186 (s), 1125 (s), 1101 (s), 1064 (s), 1020 (m), 
997 (m), 947 (w), 858 (w), 801 (m), 731 (s), 688 (m), 664 (m), 589 (m).MS (GC-MS, 70 eV): 
m/z (%): 338 (16), 337 (15), 336 (M+, 79), 334 (40), 333 (15), 332 (15), 306 (21), 305 (23), 
304 (100), 303 (17), 302 (52), 301 (23), 300 (20), 224 (25), 196 (15), 195 (12), 168 (13), 167 
(21), 165 (10), 152 (11), 119 (12), 91 (25), 77 (12), 65 (13), 51 (10).HRMS (EI): Calcd. for 
C16H16O3Se: 336.02592; found: 336.025935. 
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Chemical Formula: C16H16O3Se
Exact Mass: 336,03
Experimental part 
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Methoxyethyl 6-hydroxy-2,4-dimethyl-3-(phenylselanyl)benzoate (137b): 
Starting with 136a (0.491 g, 1.5 mmol) and 22b (0.502 g, 1.65 mmol), 137b was isolated after 
column chromatography (ethyl acetate/heptanes) as a white solid m.p. 60-62 (0.324 g, 57%).  
1H NMR (300.13 MHz, CDCl3): δ = 2.39 (s, 3 H, CH3), 
2.73 (s, 3 H, CH3), 3.32 (s, 3 H, OCH3), 3.61 - 3.65 (m, 2 
H, CH2), 4.41 - 4.45  (m, 2 H, CH2), 6.79 (s, 1 H, CHAr), 
6.95 - 6.98 (m, 2 H, 2 CHAr ), 7.01 - 7.10 (m, 3 H, 3 CHAr ), 
10.57 (s, 1H, OH).13C NMR (75 MHz, CDCl3): δ = 24.5, 
25.9 (CH3), 59.0 (OCH3), 64.3, 70.3 (CH2), 112.7 (CAr), 
117.6 (CHAr), 123.6 (CAr), 125.7 (CHAr), 128.4, 129.3 (2 
CHAr), 133.4, 147.0, 151.4 (CAr), 161.9 (COH), 170.8 (CO). IR (neat, cm	1): v~ = 3392 (w), 
3054 (w), 2923 (w), 2881 (w), 2819 (w), 1728 (w), 1654 (s), 1593 (m), 1576 (m), 1556 (m), 
1475 (m), 1449 (m), 1437 (m), 1372 (m), 1342 (m), 1295 (m), 1224 (s), 1199 (m), 1187 (m), 
1130 (m), 1107 (m), 1092 (m), 1064 (m), 1020 (s), 997 (m), 859 (m), 801 (m), 732 (s), 688 
(m), 623 (m), 589 (m), 538 (w). MS (GC-MS, 70 eV): m/z (%): 380 (M+, 38), 378 (18), 306 
(19), 305 (21), 304 (100), 303 (15), 302 (48), 301 (19), 300 (17), 248 (10), 224 (34), 196 (25), 
195 (16), 181 (11), 168 (14), 167 (24), 165 (13), 158 (15), 155 (12), 154 (10), 153 (12), 152 
(15), 148 (16), 119 (13), 91 (40), 82 (15), 80 (16), 79 (13), 78 (60), 77 (33), 76 (10), 69 (17), 
67 (12), 65 (19), 59 (17), 51 (19), 50 (11), 45 (34), 44 (42), 43 (15), 41 (10).HRMS (EI): 
Calcd. for C18H20O4Se: 380.05213; found: 380.051850. 
Methyl 2-hydroxy-3,4,6-trimethyl-5-(phenylselanyl)benzoate (137c): 
Starting with 136a (0.491 g, 1.5 mmol) and 22d (0.453 g, 1.65 mmol), 137c was isolated sfter 
coloumn chromatography (ethyl acetate/heptanes) as a colorless oil (0.356 g, 68%).  
1H NMR (300.13 MHz, CDCl3): δ = 2.11 (s, 3 H, CH3), 2.40 
(s, 3 H, CH3), 2.64 (s, 3 H, CH3), 3.81 (s, 3 H, OCH3), 6.89 -
6.96 (m, 2 H, 2 CHAr ), 6.98 - 7.06 (m, 3 H, 3 CHAr ), 11.16 
(s, 1H, OH).13C NMR (75 MHz, CDCl3): δ = 13.1, 22.5, 24.7 
(CH3), 52.4 (OCH3), 111.8, 123.6, (CAr), 125.7 (CHAr), 128.3, 
129.2 (2 CHAr), 131.5, 133.8, 143.2, 148.0 (CAr), 160.5 
(COH), 172.5 (CO). IR (neat, cm	1): v~ = 3054 (w), 2950 (w), 
2872 (w), 1727 (w), 1652 (s), 1576 (m), 1546 (m), 1475 (m), 1437 (s), 1377 (m), 1344 (m), 
1279 (m),  1263 (m), 1235 (s), 1194 (m), 1159 (m), 1095 (m), 1067 (m), 1020 (s), 997 (m), 
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Chemical Formula: C18H20O4Se
Exact Mass: 380,05
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Chemical Formula: C17H18O3Se
Exact Mass: 350,04
H3C
Experimental part 
 
134 
 
846 (m), 805 (m), 731 (s), 687 (m), 665 (m), 594 (w).MS (GC-MS, 70 eV): m/z (%): 352 (13), 
351 (14), 350 (M+, 65), 348 (34), 347 (12), 346 (11), 320 (19), 318 (100), 317 (16), 316 (48), 
315 (23), 314 (18), 181 (12), 166 (10), 165 (12), 133 (12), 105 (16), 103 (10), 91 (10), 78 
(10), 77 (26). HRMS (EI): Calcd. for (M-H)- :C17H17O3Se: 349.03493; found: 349.03493. 
Methyl 3-ethyl-2-hydroxy-4,6-dimethyl-5-(phenylselanyl)benzoate (137d): 
Starting with 136a (0.491 g, 1.5 mmol) and 22f (0.476 g, 1.65 mmol), 137d was isolated after 
column chromatography (ethyl acetate/heptanes) as a pale yellowish oil (0.381 g, 70%). 
 1H NMR (300.13 MHz, CDCl3): δ = 1.13 (t, 3J = 7.4 Hz, 3 
H, CH3), 2.41 (s, 3 H, CH3), 2.62 (s, 3 H, CH3),  2.89 (q, 3J 
= 7.3 Hz, 2 H, PhCH2),  3.83 (s, 3 H, OCH3), 6.88 - 6.97 (m, 
2 H, 2 CHAr ), 6.96 - 7.07(m, 3 H, 3 CHAr ), 11.17 (s, 1H, 
OH). 13C NMR (75 MHz, CDCl3): δ = 13.1 (CH3), 20.7 
(CH2), 21.5, 24.7 (CH3), 52.2 (OCH3), 111.9, 123.6 (CAr), 
125.3 (CHAr), 128.0, 129.1 (2 CHAr), 131.5, 133.8, 143.2, 
148.2 (CAr), 160.2 (COH), 172.4 (CO). IR (neat, cm	1): v~ = 3055 (w), 2952 (w), 2871 (w), 
1726 (w), 1654 (s), 1576 (m), 1544 (w), 1475 (m), 1436 (s), 1374 (m), 1344 (m), 1274 (m),  
1257 (s), 1226 (s), 1194 (m), 1158 (m), 1106 (m), 1067 (m), 1020 (m), 997 (w), 989 (w), 848 
(m), 808 (m), 731 (s), 687 (m), 665 (m), 631 (w),  579 (w). MS (GC-MS, 70 eV): m/z (%): 
364 (M+, 7), 279 (13), 167 (32), 150 (11), 149 (100), 71 (12), 70 (11), 57 (16).HRMS (EI): 
Calcd. for C18H20O3Se: 364.05722; found: 364.056964. 
 Methyl 3-butyl-2-hydroxy-4,6-dimethyl-5-(phenylselanyl)benzoate (137e): 
Starting with 136a (0.491 g, 1.5 mmol) and 22h (0.522 g, 1.65 mmol), 137a was isolated after 
column chromatography (ethyl acetate/heptanes) as a pale yellowish oil (0.405g, 69%).  
1H NMR (300.13 MHz, CDCl3): δ = 0.86 (t, 3J = 7.6 Hz, 3 
H, CH3), 1.18 - 1.21 (m, 2 H, CH2), 1.37 - 1.40 (m, 2 H, 
CH2), 2.48 (s, 3 H, CH3), 2.54 (q, 3J = 7.5 Hz, 2 H, PhCH2), 
2.68 (s, 3 H, CH3),  3.86 (s, 3 H, OCH3), 6.86 - 6.96 (m, 2 H, 
2 CHAr ), 6.97-7.10 (m, 3 H, 3 CHAr ), 11.15 (s, 1H, OH).13C 
NMR (75 MHz, CDCl3): δ = 13.9, 21.8 (CH3), 23.1 (CH2), 
24.6 (CH3), 27.2, 31.2 (CH2), 52.3 (OCH3), 111.7, 123.6 
(CAr), 125.3 (CHAr), 128.0 (2 CHAr), 128.5 (CAr), 129.1 (2 CHAr), 133.7, 143.2, 148.5 (CAr), 
OOH
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CH3
Se
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Chemical Formula: C18H20O3Se
Exact Mass: 364,06
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160.4 (COH), 172.4 (CO). IR (neat, cm	1): v~ = 3056 (w), 2953 (m), 2869 (w), 1728 (m), 1654 
(s), 1577(m), 1545 (w), 1494 (w), 1475 (w), 1436 (s), 1374 (m), 1350 (m), 1277 (m),  1262 
(m), 1233 (s), 1194 (m), 1157 (m), 1115 (m), 1080 (w), 1055 (w), 1021 (m), 997 (w), 963 
(w), 895 (m), 852 (m), 807 (s), 731 (s), 688 (m), 665 (m), 631 (w),  575 (w).MS (GC-MS, 70 
eV): 266 (29), 264 (65), 262 (30), 260 (10), 230 (10), 186 (13), 183 (12), 169 (14), 158 (15), 
157 (37), 156 (10), 155 (22), 154 (10), 105 (17), 99 (100), 78 (23), 77 (24), 71 (52), 69 (10), 
55 (14), 51 (11), 43 (71), 41 (22), 39 (10). HRMS (EI): Calcd. for M-H)- :C20H23O3Se: 
391.08189; found: 391.08163. 
Methyl 3-hexyl-2-hydroxy-4,6-dimethyl-5-(phenylselanyl)benzoate (137f): 
Starting with 136a (0.491 g, 1.5 mmol) and 22j (0.569 g, 1.65 mmol), 137f was isolated after 
column chromatography (ethyl acetate/heptanes) as a yellowish oil (0.390 g, 62%).  
1H NMR (300.13 MHz, CDCl3): δ = 0.93 (t, 3J = 7.5 Hz, 3 
H, CH3), 1.34-1.40 (m, 6 H, 3 CH2), 1.50 - 1.55 (m, 2 H, 
CH2), 2.61 (s, 3 H, CH3), 2.78 (q, 3J = 7.4 Hz, 2 H, PhCH2), 
2.81 (s, 3 H, CH3),  4.00 (s, 3 H, OCH3), 6.98 - 7.12 (m, 2 H, 
2 CHAr ), 7.16-7.27 (m, 3 H, 3 CHAr ), 11.31 (s, 1 H, OH). 
13C NMR (75 MHz, CDCl3): δ = 14.1, 22.0 (CH3), 22.7 
(CH2), 24.8 (CH3), 27.3, 28.9, 30.0, 31.9, (CH2), 52.3 
(OCH3), 111.9, 123.6 (CAr), 125.4 (CHAr), 128.1 (2 CHAr), 128.6 (CAr), 129.2 (2 CHAr), 133.8, 
143.3, 148.3 (CAr), 160.2 (COH), 172.1 (CO). IR (neat, cm	1): v~ = 3056 (w), 2952 (m), 2923 
(m), 1747 (w), 1655 (s), 1575(m), 1541 (w), 1472 (w), 1435 (s), 1377 (m), 1347 (m), 1271 
(m),  1227 (s), 1189(m), 1150 (m), 1117 (m), 1067 (w), 1056 (w), 1021 (m), 995 (w), 958 
(w), 891 (m), 849 (m), 807 (s), 729 (s), 688 (m), 666 (m), 631 (w),  575 (w). HRMS (EI): 
Calcd. for C23H30O3Se: 420.11636; found: 420.116371. 
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Methyl 3-heptyl-2-hydroxy-4,6-dimethyl-5-(phenylselanyl)benzoate (137g): 
Starting with 136a (0.491 g, 1.5 mmol) and 22k (0.592g, 1.65 mmol), 137a was isolated after 
column chromatography (ethyl acetate/heptanes) as a yellowish oil (0.403 g, 62%). 
1H NMR (300.13 MHz, CDCl3): δ = 0.95 (t, 3J = 7.5 Hz, 3 
H, CH3), 1.33 - 1.43 (m, 8 H, 4 CH2), 1.52 - 1.56 (m, 2 H, 
CH2), 2.63 (s, 3 H, CH3), 2.80 (q, 3J = 7.4 Hz, 2 H, PhCH2), 
2.84 (s, 3H, CH3),  4.01 (s, 3H, OCH3), 7.11 - 7.15 (m, 2 H, 
2 CHAr ), 7.18 - 7.28 (m, 3 H, 3 CHAr ), 11.30 (s, 1H, 
OH).13C NMR (75 MHz, CDCl3): δ = 14.0, 21.9 (CH3), 22.6 
(CH2), 24.7 (CH3),27.2,  28.9, 29.3, 29.9,  31.9,  (CH2), 52.2 
(OCH3), 111.8, 123.7 (CAr), 125.3 (CHAr), 128.0 (2 CHAr), 128.5 (CAr),  129.1 (2 CHAr), 
133.8, 143.2, 148.4 (CAr), 160.3 (COH), 172.4 (CO). IR (neat, cm	1): v~ = 3056 (w), 2952 (m), 
2922 (m), 1749 (w), 1655 (s), 1577(m), 1545 (w), 1475 (w), 1437 (s), 1375 (m), 1350 (m), 
1275 (m),  1229 (s), 1194 (m), 1158 (m), 1119 (m), 1067 (w), 1057 (w), 1021 (m), 997 (w), 
958 (w), 895 (m), 852 (m), 807 (s), 731 (s), 688 (m), 666 (m), 631 (w),  575 (w).MS (GC-MS, 
70 eV): 434 (M+, 26), 432 (12), 402 (17), 318 (11), 239 (11), 214 (44), 211 (12), 196 (10), 
172 (11), 158 (22), 153 (12), 141 (10), 140 (10), 130 (19), 129 (80), 117 (12), 116 (100), 101 
(20), 99 (11), 98 (20), 97 (17), 96 (12), 85 (37), 83 (12), 71 (60), 69 (31), 59 (11), 57 (82), 56 
(12), 55 (43), 43 (62), 41 (39). HRMS (EI): Calcd. for C23H30O3Se: 434.13547; found: 
434.135841. 
Methyl 2-hydroxy-4,6-dimethyl-3-octyl-5-(phenylselanyl)benzoate (137h): 
Starting with 136a (0.491 g, 1.5 mmol) and 22l (0.615 g, 1.65 mmol), 137h was isolated after 
column chromatography (ethyl acetate/heptanes) as a yellowish oil (0.396 g, 59%).  
1H NMR (300.13 MHz, CDCl3): δ = 0.93 (t, 3J = 7.5 Hz, 3 
H, CH3), 1.34 - 1.47 (m, 10 H, 5 CH2), 1.51 - 1.57 (m, 2 H, 
CH2), 2.62 (s, 3 H, CH3), 2.82 (q, 3J = 7.4 Hz, 2 H, PhCH2), 
2.82 (s, 3 H, CH3),  4.03 (s, 3 H, OCH3), 7.10 - 7.14 (m, 2 H, 
2 CHAr ), 7.17-7.29 (m, 3 H, 3 CHAr ), 11.31 (s, 1H, OH). 13C 
NMR (75 MHz, CDCl3): δ = 14.1, 21.9 (CH3), 22.7 (CH2), 
23.8 (CH3), 27.5, 29.0, 29.5, 29.7, 30.0, 31. 8 (CH2), 52.2 
(OCH3), 111.9, 123.8 (CAr), 125.4 (CHAr), 128.0 (2 CHAr), 128.6 (CAr), 129.2 (2 CHAr), 133.9, 
143.2, 148.5 (CAr), 160.4 (COH), 172.5 (CO). IR (neat, cm	1): v~ = 2952 (m), 2921 (s), 2851 
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Chemical Formula: C24H32O3Se
Exact Mass: 448,15
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(m),  1655 (s), 1577(m), 1545 (w), 1475 (w), 1437 (s), 1375 (m), 1351 (m), 1262 (m),  1231 
(s), 1194 (m), 1157 (m), 1119 (m), 1065 (w), 1053 (w), 1021 (m), 998 (w), 962 (w), 895 (m), 
847 (m), 807 (s), 731 (s), 688 (m), 666 (m), 614 (w),  597 (w). MS (GC-MS, 70 eV): 450 
(10), 449 (11), 448 (M+, 48), 446 (23), 418 (17), 416 (30), 414 (15), 401 (11), 399 (11), 371 
(16), 359 (10), 329 (10), 326 (13), 325 (13), 323 (11), 318 (23), 317 (14), 316 (13), 315 (14), 
292 (16), 288 (14), 287 (10), 279 (10), 260 (13), 246 (15), 245 (100), 243 (13), 239 (13), 237 
(10), 197 (11), 196 (20), 195 (20), 175 (11), 163 (11), 162 (78), 161 (68), 160 (10), 155 (13), 
135 (10), 134 (14), 133 (11), 116 (12), 105 (10), 103 (10), 97 (13), 91 (17), 85 (25), 79 (11), 
78 (13), 77 (16), 71 (35), 69 (19), 67 (10), 57 (49), 55 (27), 43 (37), 41 (27). HRMS (EI): 
Calcd. for C24H32O3Se: 448.151620; found: 448.15112. 
Methyl 2,4-diethyl-6-hydroxy-3-(phenylselanyl)benzoate (137i): 
Starting with 136b (0.533 g, 1.5 mmol) and 22a (0.430 g, 1.65 mmol), 137i was isolated after 
column chromatography (ethyl acetate/heptanes) as a colorless oil (0.305 g, 56%).  
1H NMR (300.13 MHz, CDCl3): δ = 0.98 - 1.05 (m, 6 H, 2 
CH3), 2.69 (q, 3J = 7.5 Hz, 2 H, PhCH2), 3.15 (q, 3J = 7.5 
Hz, 2 H, PhCH2), 3.84 (s, 3 H, OCH3), 6.77 (s, 1 H, CHAr), 
6.85-6.89 (m, 2 H, 2 CHAr ), 6.90 -7.04 (m, 3 H, 3 CHAr ), 
10.85 (s, 1 H, OH).13C NMR (75 MHz, CDCl3): δ = 14.9, 
16.1 (CH3), 30.1, 31.3 (CH2), 52.5 (OCH3), 111.8 (CAr), 
116.1(CHAr), 121.6 (CAr), 125.3 (CHAr), 127.6, 129.1 (2 
CHAr), 134.5, 152.7, 157.0 (CAr), 162.8 (COH), 171.5 (CO). IR (neat, cm	1): v~ = 3055 (w), 
2964 (w), 2931 (w), 2871 (w), 1731 (w), 1657 (s), 1592 (m), 1577 (m), 1555 (w), 1475 (m), 
1435 (m), 1347 (m), 1318 (m), 1302 (m), 1244 (m), 1216 (s), 1099 (s), 1067 (m), 1020 (m), 
997 (w), 962 (w), 938 (m), 866 (m), 808 (m), 730 (s), 688 (m), 665 (w). MS (GC-MS, 70 eV): 
m/z (%): 366  (M+, 13), 365 (13), 364 (63), 362 (33), 361 (12), 360 (12), 334 (20), 333 (21), 
332 (100), 331 (13), 330 (51), 329 (20), 328 (19), 252 (10), 91 (12), 77 (11). HRMS (EI): 
Calcd. for C18H20O3Se: 364.05722; found: 364.057718. 
 
 
 
 
OOH
OCH3
CH2CH3
Se
H3CH2C
Chemical Formula: C18H20O3Se
Exact Mass: 364,06
Experimental part 
 
138 
 
2-Methoxyethyl 2,4-diethyl-6-hydroxy-3-(phenylselanyl)benzoate (137j): 
Starting with 136b (0.533 g, 1.5 mmol) and 22b (0.502 g, 1.65 mmol), 137j was isolated after 
column chromatography (ethyl acetate/heptanes) as a pale yellowish solid m.p. 73-75 (0.336 
g, 55%).  
1H NMR (300.13 MHz, CDCl3): δ = 0.91 - 1.01 (m, 6 H, 
2 CH3), 2.63 (q, 3J = 7.4 Hz, 2 H, PhCH2), 3.06 (q, 3J = 
7.5 Hz, 2 H, PhCH2), 3.20 (s, 3 H, OCH3),  3.51 - 3.54 
(m, 2 H, CH2), 4.30 - 4.34 (m, 2 H, CH2), 6.69 (s, 1 H, 
CHAr), 6.83 - 6.88 (m, 2 H, 2 CHAr ), 6.88 - 6.97 (m, 3 H, 
3 CHAr ), 10.39 (s, 1H, OH).13C NMR (75 MHz, CDCl3): 
δ = 14.8, 16.3 (CH3), 29.7, 31.2 (CH2), 58.5 (CH3), 64.0, 
69.8 (CH2), 112.5 (CAr), 116.1(CHAr), 121.6 (CAr), 125.2 (CHAr), 127.6, 129.1 (2 CHAr), 
134.6, 152.8, 156.9 (CAr), 162.1 (COH), 170.3 (CO). IR (neat, cm	1): v~ = 3399 (w), 3055 (w), 
2964 (w), 2928 (w), 2872 (w), 1892 (w), 1777 (w), 1729 (m), 1656 (s), 1592 (m), 1577 (m), 
1553 (w), 1475 (m), 1436 (m), 1398 (m), 1341 (m), 1298 (s), 1243 (m), 1216 (s), 1199 (s), 
1185 (s), 1086 (s), 1020 (m), 998(w), 981 (w), 867 (m), 838 (m), 808 (m),  730 (s), 688 (s), 
665 (m). MS (GC-MS, 70 eV): m/z (%):  408 (M+, 25), 407 (27), 406 (100), 405 (16), 404 
(52), 403 (20), 402 (19),330 (18), 329 (37),328 (61), 327 (47),326 (37),325 (38),324 (16),281 
(18), 253 (10),249 (16),248 (17),247 (29),207 (21), 115 (13),91 (10),77 (15), 75 (37).HRMS 
(EI): Calcd. for C20H24O4Se: 408.08343; found: 408.083839. 
 
 
 
 
 
 
 
 
 
 
OOH
OCH2CH2OCH3
CH2CH3
Se
H3CH2C
Chemical Formula: C20H24O4Se
Exact Mass: 408,08
Experimental part 
 
139 
 
3.5 X-Ray crystal structural analysis: 
 
Table 24: Crystal data and structure refinement 110b. 
Empirical formula  C12 H14 O4 
Formula weight  222.23 
Temperature  173(2) K 
Wavelength  0.71073 Å 
Crystal system  Triclinic 
Space group (H.-M.)  P1   
Space group (Hall)  -P 1 
Unit cell dimensions a = 7.4507(4) Å = 77.052(4)°. 
 b = 10.6081(6) Å 
= 78.918(3)°. 
 c = 14.7549(9) Å  = 81.775(3)°. 
Volume 1109.24(11) Å3 
Z 4 
Density (calculated) 1.331 Mg/m3 
Absorption coefficient 0.100 mm-1 
F(000) 472 
Crystal size 0.59 x 0.15 x 0.05 mm3 
Experimental part 
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 range for data collection 1.44 to 30.65°. 
Index ranges -9≤h≤10, -15≤k≤15, -20≤l≤21 
Reflections collected 29877 
Independent reflections 6765 [R(int) = 0.0356] 
Completeness to  = 30.65° 98.5 %  
Absorption correction Semi-empirical from equivalents 
Max. and min. transmission 0.9950 and 0.9435 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 6765 / 0 / 305 
Goodness-of-fit on F2 1.017 
Final R indices [I>2(I)] R1 = 0.0503, wR2 = 0.1178 
R indices (all data) R1 = 0.0949, wR2 = 0.1407 
Largest diff. peak and hole 0.325 and -0.228 e.Å-3 
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Table 25: Crystal data and structure refinement for 110k. 
Empirical formula  C17H15ClO5 
Formula weight  334.74 
Temperature  298(2) K 
Wavelength  0.71073 Å 
Crystal system  Monoclinic 
Space group (H.-M.)  P21/n   
Space group (Hall)  -P 2yn 
Unit cell dimensions a = 4.0186(2) Å = 90°. 
 b = 33.9422(15) Å 
= 98.435(3)°. 
 c = 11.3074(5) Å  = 90°. 
Volume 1525.65(12) Å3 
Z 4 
Density (calculated) 1.457 Mg/m3 
Absorption coefficient 0.274 mm-1 
F(000) 696 
Crystal size 0.55 x 0.08 x 0.06 mm3 
 range for data collection 2.18 to 24.54°. 
Index ranges -4≤h≤4, -39≤k≤25, -13≤l≤13 
Reflections collected 8127 
Independent reflections 2550 [R(int) = 0.0781] 
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Completeness to  = 24.54° 99.6 %  
Absorption correction Semi-empirical from equivalents 
Max. and min. transmission 0.9837 and 0.8639 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 2550 / 1 / 216 
Goodness-of-fit on F2 0.899 
Final R indices [I>2(I)] R1 = 0.0437, wR2 = 0.0895 
R indices (all data) R1 = 0.0857, wR2 = 0.1008 
Largest diff. peak and hole 0.334 and -0.348 e.Å-3 
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Table 26: Crystal data and structure refinement for 118h. 
Empirical formula  C18H17NO7 
Formula weight  359.33 
Temperature  T = 173(2) K 
Wavelength  0.71073 Å 
Crystal system  Triclinic 
Space group (H.-M.)  'P -1' 
Space group (Hall)  '-P 1' 
Unit cell dimensions a = 7.7885(5)Å = 108.560(2)°. 
 b = 11.1657(13)Å 
= 108.363(2)°. 
 c = 11.2899(8) Å  = 97.584(2)°. 
Volume 853.42(13) Å3 
Z 2 
Density (calculated) 1.398Mg/m3 
Absorption coefficient 0.109mm-1 
F(000) 376 
Crystal size 0.73 × 0.35 × 0.17mm3 
 range for data collection 2.0 to 30.0°. 
Index ranges -10≤h≤10, -15≤k≤15, -15≤l≤15 
Reflections collected 13214 
Independent reflections 4870 [R(int) = 0.036] 
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Completeness to  = 29.00° 98.3%  
Absorption correction multi-scan (SADABS; Sheldrick, 2004) 
Max. and min. transmission 0.925and 0.982 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 4102 / 0 / 242 
Goodness-of-fit on F2 1.10 
Final R indices [I>2(I)] R1 = 0.046, wR2 = 0.137 
R indices (all data) R1 = 0.0541, wR2 = 0.144 
Largest diff. peak and hole 0.428 and -0.321 e.Å-3 
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Table 27: Crystal data and structure refinement for 118m.  
Empirical formula  C23 H27 Br O5 
Formula weight  463.36 
Temperature  173(2) K 
Wavelength  0.71073 Å 
Crystal system  Triclinic 
Space group (H.-M.) 1P  
Space group (Hall) -P 1 
Unit cell dimensions a = 4.6786(2) Å = 70.466(2)°. 
 b = 15.1674(6) Å 
= 87.482(3)°. 
 c = 16.2811(7) Å  = 88.334(2)°. 
Volume 1087.67(8) Å3 
Z 2 
Density (calculated) 1.415 Mg/m3 
Absorption coefficient 1.920 mm-1 
F(000) 480 
Crystal size 0.66 x 0.10 x 0.09 mm3 
 range for data collection 4.61 to 30.00°. 
Index ranges -6h6, -21k21, -22l22 
Reflections collected 22474 
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Independent reflections 6209 [R(int) = 0.0375] 
Completeness to  = 30.00° 97.5 %  
Absorption correction Semi-empirical from equivalents 
Max. and min. transmission 0.8461 and 0.3638 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 6209 / 0 / 269 
Goodness-of-fit on F2 1.007 
Final R indices [I>2(I)] R1 = 0.0395, wR2 = 0.0810 
R indices (all data) R1 = 0.0813, wR2 = 0.0969 
Largest diff. peak and hole 0.385 and -0.316 e.Å-3 
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Table 28: Crystal data and structure refinement for 132i. 
Empirical formula                            C15 H12 Cl NO5 
Formula weight  321.71 
Temperature  298(2) K 
Wavelength  0.71073 Å 
Crystal system  Triclinic 
Space group (H.-M.)   1P   
Space group (Hall)  -P 1 
Unit cell dimensions a = 8.0110(2) Å = 98.145(2)°. 
 b = 9.6287(3) Å 
= 107.553(2)°. 
 c = 10.6550(3) Å  = 103.766(2)°. 
Volume 740.61(4) Å3 
Z 2 
Density (calculated) 1.443 Mg/m3 
Absorption coefficient 0.281 mm-1 
F(000) 332 
Crystal size 0.98 x 0.96 x 0.41 mm3 
 range for data collection 2.67 to 30.00°. 
Index ranges -11≤h≤11, -13≤k≤13, -14≤l≤14 
Reflections collected 23731 
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Independent reflections 4287 [R(int) = 0.0176] 
Completeness to  = 30.00° 99.2 %  
Absorption correction Semi-empirical from equivalents 
Max. and min. transmission 0.8935 and 0.7704 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 4287 / 0 / 206 
Goodness-of-fit on F2 1.060 
Final R indices [I>2(I)] R1 = 0.0406, wR2 = 0.1132 
R indices (all data) R1 = 0.0485, wR2 = 0.1272 
Extinction coefficient 0.012(4) 
Largest diff. peak and hole 0.291 and -0.373 e.Å-3 
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Table 29: Crystal data and structure refinement for 133a. 
Empirical formula  C14 H13 N O3 
Formula weight  243.25 
Temperature  173(2) K 
Wavelength  0.71073 Å 
Crystal system  Monoclinic 
Space group (H.-M.) P21/c 
Space group (Hall) -P 2ybc 
Unit cell dimensions a = 25.215(5) Å = 90°. 
 b = 7.6790(15) Å 
= 91.99(3)°. 
 c = 25.030(5) Å  = 90°. 
Volume 4843.5(17) Å3 
Z 16 
Density (calculated) 1.334 Mg/m3 
Absorption coefficient 0.095 mm-1 
F(000) 2048 
Crystal size 0.7 x 0.26 x 0.14 mm3 
 range for data collection 2.87 to 30.00°. 
Index ranges -34h35, -10k10, -35l35 
Reflections collected 52571 
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Independent reflections 14030 [R(int) = 0.0390] 
Completeness to  = 30.00° 99.3 %  
Absorption correction Semi-empirical from equivalents 
Max. and min. transmission 0.9877 and 0.9406 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 14030 / 0 / 689 
Goodness-of-fit on F2 1.087 
Final R indices [I>2(I)] R1 = 0.0626, wR2 = 0.1539 
R indices (all data) R1 = 0.0872, wR2 = 0.1719 
Largest diff. peak and hole 0.504 and -0.305 e.Å-3 
 
 
 
 
 
 
 
 
 
 
 
 
Experimental part 
 
151 
 
Table 30: Crystal data and structure refinement for 137b. 
 
Empirical formula  C18H20O4Se 
Formula weight  Mr = 379.30 
Temperature  173(2) K 
Wavelength  0.71073 Å 
Crystal system  Monoclinic 
Space group (H.-M.)  P21/n 
Space group (Hall)  -P 2yn 
Unit cell dimensions a = 11.593 (2) Å = 90.00°. 
 b = 17.836 (4) Å 
= 94.40 (3) 
 c = 16.587 (3) Å  = 90.00°. 
Volume 3419.4 (12) Å3 
Z 8 
Density (calculated) 1.474 Mg m−3 
Absorption coefficient 2.213 mm−1 
F(000) 1552 
Crystal size 0.58 × 0.34 × 0.09 mm3 
 range for data collection 4.2°° to 29.0°. 
Index ranges -15≤h≤10, -15≤k≤24, -22≤l≤22 
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Reflections collected 35127 
Independent reflections 8942 [R(int) = 0.041] 
Completeness to  = 29.00° 98.4%  
Absorption correction Semi-empirical from equivalents 
Max. and min. transmission 0.826and 0.360 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 6553 / 0/ 454 
Goodness-of-fit on F2 1.07 
Final R indices [I>2(I)] R1 = 0.042, wR2 = 0.0984 
R indices (all data) R1 = 0.0696, wR2 = 0.105 
Largest diff. peak and hole 1.09and −0.71 e.Å-3 
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Abstract: 
Cyclization reactions of 1,3-bis(trimethylsilyloxy)-1,3-butadienes with 1,3-
dielectrophiles, provide a powerful tool for the synthesis of highly substituted arenes. 
They proceed with high regioselectivity.  
 
A diversity-oriented, convenient and regioselective synthesis of a great variety of 1-
hydroxy-2,4-benzodioates (4-hydroxyisophthalates) by the first formal [3+3] cyclizations 
of 1,3-bis(silyloxy)-1,3-butadienes with 3-silyloxy- and 3-alkoxy-2-alkoxycarbonyl-2-en-
1-ones is reported. 
 
The synthesis of 3-hydroxy-5-methylphthalates is achieved by regioselective chelation-
controlled cyclizations of 1,3-bis(silyloxy)-1,3-butadienes with 4-silyloxy-2-oxo-3-
butenoates derived from acetylpyruvates. The employment of silylated benzoyl- instead 
of acetylpyruvates results in a change of the regioselectivity and formation of 6-aryl-2-
hydroxy-terephthalates. The regiodirecting effect of the aryl group is stronger than the 
one of the pyruvate-derived ester group. The cyclization of 1,3-bis(silyloxy)-1,3-
butadienes with 4-ethoxy-2-oxo-3-butenoates, readily available by condensation of enol 
ethers with methyl 2-chloro-2-oxoacetate, afforded 3-hydroxyphthalates and 2-
hydroxyterephthalates depending on the substitution pattern of the diene.  
 
Highly functionalized 4-nitro- and 4-aminophenols are synthesized by [3+3] 
cyclocondensation of 1,3-bis(trimethylsilyloxy)-1,3-butadienes with 3-ethoxy-2-nitro-2-
en-1-ones and subsequent reduction of the resulting nitrophenols.   
 
Various functionalized unsymmetrical diaryl selenides containing a salicylate 
substructure are prepared by [3+3] cyclocondensation of 1,3-bis(trimethylsilyloxy)-1,3-
butadienes with 3-silyloxy-2-phenylselenayl-2-en-1-ones. 
 
Keywords: 
Silyl enol ether, Arenes, Cyclization, Regioselectivity, Selenide. 
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Abstract: 
Cyclisierungsreaktionen von 1,3-Bis(trimethylsilyloxy)-1,3-butadienen mit 1,3-
Dielektrophilen stellen eine bedeutende Möglichkeit zur Synthese von mehrfach 
substituierten Arenen dar. Sie laufen unter hoher Regioselektivität ab. 
 
Es wird über neue Beiträge auf dem Gebiet der Synthese von mehrfach funktionalisierten 
Arenen ausgehend von acyclischen Verbindungen berichtet. 
 
Durch die ersten formellen [3+3] Cyclisierungen von 1,3-Bis(silyloxy)-1,3-butadienen 
mit 3-Silyloxy- und 3-Alkoxy-2-alkoxycarbonyl-2-en-1-onen wurden eine Reihe von 
gerichteten, milden und regioselektiven Synthesen für eine Vielzahl an 1-Hydroxy-2,4-
benzodioaten (4-Hydroxyisophthalaten) erschlossen. 
 
Es wird außerdem über die Synthese von 3-Hydroxy-5-methylphthalaten durch 
regioselektive chelat-kontrollierte Cyclisierung von 1,3-Bis(silyloxy)-1,3-butadienen mit 
4-Silyloxy-2-oxo-3-butenoaten berichtet, die von Acetylpyruvaten abgeleitet sind. Der 
Einsatz von silylierten Benzoyl- anstelle von Acetylpyruvaten führt zu einer Änderung 
der Regioselektivität, so dass es zur Bildung von 6-Aryl-2-hydroxy-terephthalaten 
kommt. Der regiodirigierende Effekt der Arylgruppe ist stärker als der der Pyruvat-Ester-
Gruppe. Die Cyclisierung von 1,3-Bis(silyloxy)-1,3-butadienen mit 4-Ethoxy-2-oxo-3-
butenoaten, die durch Kondensation von Enolethern mit Methyl-2-chlor-2-oxoacetat 
erhalten werden, ergab 3-Hydroxyphthalate und 2-Hydroxyterephthalate in Abhängigkeit 
vom Substitutionsmuster des Diens. 
 
Zusätzlich wurde die regioselektive Synthese von mehrfach funktionalisierten 4-Nitro- 
und 4-Aminophenolen basierend auf [3+3] Cyclokondensation von 1,3-
Bis(trimethylsilyloxy)-1,3-butadienen mit 3-Ethoxy-2-nitro-2-en-1-onen und 
anschließender Reduktion der erhaltenen Nitrophenole untersucht. 
 
Schließlich wurde durch Cyclokondensation von 1,3-Bis(trimethylsilyloxy)-1,3-
butadienen mit 3-Silyloxy-2-phenylselenayl-2-en-1-onen eine Synthese für verschiedene 
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funktionalisierte unsymmetrische Diarylselenide entwickelt, welche eine Salicylat-
Substruktur enthalten. 
 
Schlüsselwörter: 
Silylenolether, Arene, Cyclisierungen, Regioselektivität, Selenide. 
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